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Abstract
ABSTRACT
GLUTAMATE TRANSPORT AFFECTS MITOCHONDRIA AND CALCIUM SIGNALING IN ASTROCYTIC
PROCESSES UNDER NORMAL AND PATHOLOGICAL CONDITIONS
John Charles O’Donnell
Michael B. Robinson
Mitochondria are responsible for synthesis and metabolism of the primary excitatory neurotransmitter,
glutamate, which is cleared from synapses via Na+-dependent transporters on astrocytes. Astrocytic
clearance of glutamate is required to prevent excitotoxic neuronal death. Mitochondria also participate in
calcium signaling in various cell types. Astrocytic calcium signaling is implicated in neurovascular
coupling. Glutamate transport and calcium signaling are central to the function of astrocytic processes
that are in turn vital for normal brain function. We recently confirmed that mitochondria are present
throughout astrocytic processes. Using confocal microscopy and hippocampal slice cultures along with a
variety of biochemical assays, we sought to elucidate the physiological and pathological interactions
between mitochondria, glutamate transport, and calcium signaling in astrocytic processes. We found that
glutamate uptake is reduced after displacing hexokinase from the voltage-dependent anion channel on
the outer mitochondrial membrane, but coimmunoprecipitations between transporter and mitochondrial
proteins are not changed. As in neurons, we found that some astrocytic mitochondria are mobile. We
provide evidence that neuronal activity, activation of astrocytic glutamate transporters, and subsequent
reversal of the Na+/Ca2+ exchanger leads to immobilization of mitochondria near transporters and
synapses, where they can oxidize glutamate, buffer ions, and provide ATP. Finally, I found that following
transient oxygen/glucose deprivation (a model of ischemia/reperfusion injury), mitochondria in astrocytic
processes undergo fragmentation and autophagic degradation, culminating 24 h after insult with an
~50% reduction in mitochondrial size and the percentage of process length occupied by mitochondria.
This loss of mitochondria is independent of the accompanying excitotoxic neuropathology, and seems to
instead be driven by an extended period of high glutamate uptake. I also identified a previously
overlooked distinction between Ca2+ signals in astrocytic processes, showing two populations with
different properties based on their anatomical relationship to mitochondria. These Ca2+ signals were
greatly increased after mitochondrial loss and were no longer spatially restricted by the remaining
mitochondria. In summary, we found that glutamate transport positions mitochondria at sites of activity
in astrocytic processes where they shape calcium signals; but glutamate uptake under excitoxic
conditions leads to mitochondrial loss and dramatically altered calcium signaling, potentially impacting
neuronal injury and recovery.

Degree Type
Dissertation

Degree Name
Doctor of Philosophy (PhD)

Graduate Group
Pharmacology

First Advisor
Michael B. Robinson

Keywords
astrocytes, calcium, excitotoxicity, glutamate transport, mitochondria, stroke

Subject Categories
Neuroscience and Neurobiology | Pharmacology

This dissertation is available at ScholarlyCommons: https://repository.upenn.edu/edissertations/2504

GLUTAMATE TRANSPORT AFFECTS MITOCHONDRIA AND CALCIUM SIGNALING IN
ASTROCYTIC PROCESSES UNDER NORMAL AND PATHOLOGICAL CONDITIONS
John Charles O’Donnell
A DISSERTATION
in
Pharmacology
Presented to the Faculties of the University of Pennsylvania
in
Partial Fulfillment of the Requirements for the
Degree of Doctor of Philosophy
2016

Supervisor of Dissertation
_________________________
Michael B. Robinson, Ph.D.
Professor of Pediatrics

Graduate Group Chairperson
_________________________
Julie A. Blendy, Ph.D.
Professor of Pharmacology

Dissertation Committee
William M. Armstead, Ph.D., Research Professor of Anesthesiology and Critical Care
Erika L.F. Holzbaur, Ph.D., William Maul Measey Professor in Physiology
Harry Ischiropoulos, Ph.D., Research Professor of Pediatrics
David R. Lynch, MD, Ph.D., Professor of Neurology

GLUTAMATE TRANSPORT AFFECTS MITOCHONDRIA AND CALCIUM SIGNALING IN
ASTROCYTIC PROCESSES UNDER NORMAL AND PATHOLOGICAL CONDITIONS
COPYRIGHT
2016
John Charles O’Donnell

This work is licensed under the
Creative Commons AttributionNonCommercial-ShareAlike 3.0
License
To view a copy of this license, visit

https://creativecommons.org/licenses/by-nc-sa/3.0/us/

ABSTRACT
GLUTAMATE TRANSPORT AFFECTS MITOCHONDRIA AND CALCIUM SIGNALING IN
ASTROCYTIC PROCESSES UNDER NORMAL AND PATHOLOGICAL CONDITIONS
John Charles O’Donnell
Michael B. Robinson

Mitochondria are responsible for synthesis and metabolism of the primary
excitatory neurotransmitter, glutamate, which is cleared from synapses via Na+dependent transporters on astrocytes. Astrocytic clearance of glutamate is required to
prevent excitotoxic neuronal death. Mitochondria also participate in calcium signaling in
various cell types. Astrocytic calcium signaling is implicated in neurovascular coupling.
Glutamate transport and calcium signaling are central to the function of astrocytic
processes that are in turn vital for normal brain function. We recently confirmed that
mitochondria are present throughout astrocytic processes. Using confocal microscopy
and hippocampal slice cultures along with a variety of biochemical assays, we sought to
elucidate the physiological and pathological interactions between mitochondria,
glutamate transport, and calcium signaling in astrocytic processes.

We found that

glutamate uptake is reduced after displacing hexokinase from the voltage-dependent
anion channel on the outer mitochondrial membrane, but coimmunoprecipitations
between transporter and mitochondrial proteins are not changed. As in neurons, we
found that some astrocytic mitochondria are mobile. We provide evidence that neuronal
activity, activation of astrocytic glutamate transporters, and subsequent reversal of the
Na+/Ca2+ exchanger leads to immobilization of mitochondria near transporters and
synapses, where they can oxidize glutamate, buffer ions, and provide ATP. Finally, I
found

that

following

transient

oxygen/glucose

deprivation

(a

model

of

ischemia/reperfusion injury), mitochondria in astrocytic processes undergo fragmentation
and autophagic degradation, culminating 24 h after insult with an ~50% reduction in
iii

mitochondrial size and the percentage of process length occupied by mitochondria. This
loss of mitochondria is independent of the accompanying excitotoxic neuropathology,
and seems to instead be driven by an extended period of high glutamate uptake. I also
identified a previously overlooked distinction between Ca 2+ signals in astrocytic
processes, showing two populations with different properties based on their anatomical
relationship to mitochondria.

These Ca 2+ signals were greatly increased after

mitochondrial loss and were no longer spatially restricted by the remaining mitochondria.
In summary, we found that glutamate transport positions mitochondria at sites of activity
in astrocytic processes where they shape calcium signals; but glutamate uptake under
excitoxic conditions leads to mitochondrial loss and dramatically altered calcium
signaling, potentially impacting neuronal injury and recovery.
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CHAPTER 1
Background
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1.1

Introduction
Through its dual role as neurotransmitter and oxidative fuel, glutamate couples

the transfer of information with the energy needed to process it (for reviews, see
McKenna, 2013; Robinson and Jackson, 2016). Similar to the joint role of glutamate as
molecular substrate for information/energy, astrocytes couple information and energy at
the macroscopic level by coordinating changes in brain activity with blood flow, referred
to as neurovascular coupling (for review, see Bazargani and Attwell, 2016). Previously
overlooked electron micrographs
(Mugnaini, 1964; Fernandez et al.,
1983; Aoki et al., 1987; Xu et al.,
2003; Lovatt et al., 2007; Ito et al.,
2009; Oberheim et al., 2009;
Lavialle et al., 2011; Pardo et al.,
2011), along with more recent
confocal images (Genda et al.,
2011a;

Motori

et

al.,

2013;

Jackson et al., 2014; Derouiche et
al., 2015; Jackson and Robinson,
2015;

Stephen

et

al.,

2015;

O’Donnell et al., 2016; for review,
Figure 1.1. Mitochondria are found throughout astrocytic
processes.
This image shows an astrocyte (Green:
mitochondrially-targeted GFP; Red: plasma-membrane-targeted
mcherry driven by gfap promoter) intercalated throughout the apical
dendrites of a CA1 pyramidal neuron (Green: mitochondriallytargeted GFP) at its branch point in stratum radiatum of a rat
hippocampal slice. This image was published on the cover of The
Journal of Neuroscience, July 6, 2016, Volume 36, Issue 27 in
association with O’Donnell et al., 2016 found in Chapter 4 of this
dissertation.
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see Benjamin Kacerovsky and
Murai, 2016)
presence
throughout

have revealed the
of
fine

mitochondria
astrocytic

processes

(Fig.

1.1).

Mitochondria

in

astrocytic

processes

are

vital

for

information/energy coupling at the level of glutamate, through interactions with
transporters and glutamate oxidation (Genda et al., 2011a; Bauer et al., 2012; Jackson
et al., 2014, 2015; Ugbode et al., 2014; for review, see Robinson and Jackson, 2016),
and at the level of astrocytes, through their regulation of calcium signaling involved in the
neurovascular response (Jackson and Robinson, 2015; Stephen et al., 2015; O’Donnell
et al., 2016).

The following chapters present early, though hopefully insightful,

investigations of mitochondria in astrocytic processes, and suggest many exciting
discoveries to come.

1.2

Receptor-mediated signaling emergent from the intercellular metabolic flux

of glutamate
Glutamate is an acidic, negatively charged amino acid vital for several biological
functions that are mechanistically distinct, but intricately linked. It is an essential building
block of life as one of the twenty proteinogenic amino acids encoded in our DNA. It is
necessary for ammonia fixation and nitrogen biosynthesis through the activity of the
enzymes glutamate dehydrogenase and glutamine synthetase (for review, see Adeva et
al., 2012).

It serves as fuel for oxidative metabolism through conversion to α-

ketoglutarate and entry into the tricarboxylic acid cycle (for review, see McKenna, 2013).
And it is an intercellular signaling molecule in various tissues, including the central
nervous system where it functions as the primary excitatory neurotransmitter and as the
precursor for GABA, the primary inhibitory neurotransmitter.
The myriad of vital functions relying on glutamate was actually part of the
argument against its proposed role as the primary excitatory neurotransmitter. During a
3

pivotal period of neurotransmitter discovery beginning in the 1950s, many believed that
the excitatory signaling molecule they were searching for would be highly specialized for
receptor-mediated signaling, like the previously discovered acetylcholine (for reviews,
see Bennett and Balcar, 1999; Watkins and Jane, 2006; Krnjević, 2010). However, it
has since been postulated that glutamate’s ubiquitous role as intercellular metabolic
currency may have actually led to its role as a receptor-mediated signaling molecule (for
reviews, see Mangia et al., 2012; DiNuzzo, 2016). This process in which a previously
established trait is co-opted by evolution for a new purpose is commonly referred to as
exaptation (Gould and Vrba, 1982).

Biofilm communities of single-celled bacteria

regulate expansion and prevent starvation by communicating through glutamate
metabolic flux and associated electrochemical K+ signaling; functions that predate the
emergence of receptor-mediated intercellular glutamate signaling (Liu et al., 2015;
Prindle et al., 2015). Mammalian glutamate receptors share a common lineage with
those found in plants (Chiu et al., 1999), nematodes (Brockie and Maricq, 2003; Kano et
al., 2008), and even with chemosensory receptors that some bacteria rely on for finding
food (Van Houten et al., 2000; Janovjak et al., 2011; Ramoino et al., 2014). It appears
likely that intercellular metabolic flux of glutamate, and the existence of primitive
chemosensory receptors, converged over millions of years to give us the sophisticated
systems of receptor-mediated intercellular glutamate signaling observed in complex
multicellular organisms. It should come as little surprise that the intercellular metabolic
flux of neurotransmitter glutamate remains every bit as important as its more modern
excitatory signaling role for shaping brain function.

4

1.3

Metabolic flux of neurotransmitter glutamate is facilitated by astrocytic

mitochondria and glutamate transporters
Neuroactive amino acids (i.e. glutamate, GABA, aspartate, glutamine) are
predominantly restricted from crossing the blood brain barrier into the brain (for reviews,
see Smith, 2000; Hawkins et al., 2006).

Therefore, these vital molecules must be

derived from glucose in the brain through the TCA cycle, predominantly in astrocytic
mitochondria (Fig. 1.2). Astrocytic glucose is either converted to glycogen for storage or
to pyruvate via glycolysis. Pyruvate dehydrogenase can then convert pyruvate to acetyl
CoA for entry into the TCA cycle through combination with recycled oxaloacetate and
synthesis of citrate.

The enzyme pyruvate carboxylase provides a source of four-

carbon backbone for the TCA cycle through synthesis of new oxaloacetate from
pyruvate; this influx of four-carbon molecules shifts the TCA cycle from a catalytic to a
biosynthetic process, facilitating de novo synthesis of glutamate (for reviews, see
McKenna, 2007; Schousboe et al., 2014). Pyruvate carboxylase is an astrocyte-specific
enzyme in brain, thus de novo synthesis of glutamate in the brain takes place almost
exclusively in astrocytic mitochondria (for review, see Schousboe et al., 2013).
Astrocytes are responsible for ~30% of cerebral oxidative metabolism (for review, see
Hertz et al., 2007), and of the glucose oxidized in astrocytes, ~80% is used to synthesize
glutamate (for review, see Hertz, 2011). Oxidative glutamate synthesis has the benefit
of generating ATP (one glucose molecule nets 11 ATP and one glutamate), though not
as much as would be generated if that carbon backbone was to complete the TCA cycle
(one glucose molecule nets 32 ATP) (for review, see Hertz et al., 2007). At the cost of
one ATP, glutamate can then be converted to glutamine by the astrocyte-specific
enzyme glutamine synthetase (Norenberg and Martinez-Hernandez, 1979), and
transferred to presynaptic nerve terminals where mitochondrial glutaminase can convert
5

it back to glutamate for packaging in vesicles and entry into the neurotransmitter pool
(for reviews, see Kvamme et al., 2000; McKenna, 2007).
Neurotransmitter glutamate is released into the synaptic cleft, where it can
activate glutamate receptors on the postsynaptic neuron as well as those on surrounding
astrocytic processes.

Unlike acetylcholine, there is no known mechanism for

extracellular glutamate deactivation. Glutamatergic signaling events are terminated by
diffusion away from the cleft and uptake into astrocytes via Na +-dependent glutamate
transporters, GLT-1 and GLAST (for reviews, see Danbolt, 2001; Sheldon and
Robinson, 2007). The clearance of extracellular glutamate predominantly into astrocytes
is unique among neurotransmitters, which are typically taken back up into neurons or
enzymatically deactivated in the extracellular space.

The primary excitatory

neurotransmitter is also unique in that it is, somewhat paradoxically, a potent neurotoxin.
Astrocytic glutamate uptake is therefore vital for preventing overactivation of neuronal
glutamate receptors that could lead to the death of neurons through a process called
excitotoxicity

(for

reviews,

Waagepetersen, 2005).

see

Choi

and

Rothman,

1990;

Schousboe

and

Once inside the astrocyte, the majority of neurotransmitter

glutamate is converted to glutamine, presumably for safe transport back to neurons
where it can be converted back to glutamate for partial replenishment of the
neurotransmitter pool (for review, see McKenna, 2007). However, since a portion of this
glutamate is oxidized, the glutamate/glutamine cycle is not sufficient to maintain the
neurotransmitter pool, which therefore relies on de novo synthesis of glutamate in
astrocytic mitochondria (for review, see McKenna, 2007).

A significant portion of

neurotransmitter glutamate is oxidized in astrocytic mitochondria through conversion to
α-ketoglutarate and entry into the TCA cycle (Yu et al., 1982; McKenna et al., 2002; for
6

reviews, see McKenna, 2013; Dienel and McKenna, 2014; Sonnewald, 2014). This
oxidative metabolic route represents a vital, though previously controversial component
of the metabolic flux of neurotransmitter glutamate.
The controversy surrounding the oxidation of transported glutamate seems to
have stemmed from two assumptions: one, based mainly on extrapolation from
observations in primary astrocytic cultures, that astrocytes are almost exclusively
glycolytic (Pellerin and Magistretti, 1994); and two, based on the narrow diameter of
astrocytic processes, that mitochondria necessary for this oxidation could not be present
near transporters and synapses (Hertz et al., 2007).
assumptions were untrue.

We now know both of these

Studies utilizing in vivo nuclear magnetic resonance

spectroscopy and autoradiography found that oxidative metabolism in astrocytes was
equivalent to that of neurons, though it was still believed that fine processes were too
small to contain mitochondria, and therefore must be glycolytic compartments (for
review, see Hertz et al., 2007).

Electron micrographs displaying mitochondria in

astrocytic processes surrounding synapses (Lovatt et al., 2007; Ito et al., 2009;
Oberheim et al., 2009; Lavialle et al., 2011; Pardo et al., 2011) were, until recently,
largely overlooked in favor of a model in which these compartments simply converted
glutamate to glutamine and were dependent on glycolysis for ATP.

However, the

accumulation of these images along with growing evidence for oxidation of
neurotransmitter glutamate has forced the field to acknowledge that the presence of
mitochondria within astrocytic processes is likely central to determining the metabolic
fate of glutamate and the astrocytic energy economy.

7

Figure 1.2. Astrocytic mitochondria are required for de novo synthesis of brain glutamate and oxidation
of neurotransmitter glutamate. In this simplified schematic, astrocytic glucose transporters take up glucose from the
blood into the cytoplasm, where it can be stored as glycogen or converted to pyruvate via glycolysis. Pyruvate can enter
the TCA cycle in mitochondria via conversion to acetyl CoA (ACoA) by pyruvate dehydrogenase (PDH), or to oxaloacetate
(OAA) via the astrocyte-specific enzyme pyruvate carboxylase (PC). PC activity shifts the TCA cycle in favor of
biosynthesis. Citrate synthase uses OAA and ACoA to form citrate, which proceeds through the TCA cycle until formation
α-ketoglutarate, generating 11 molecules of ATP in the process. α-ketoglutarate is then converted to glutamate by
glutamate dehydrogenase (GDH) or one of several transaminases. Glutamate is then transported out of mitochondria and
converted to glutamine in the cytoplasm by the astrocyte-specific enzyme glutamine synthetase (GS). Glutamine can
then be transported to mitochondria within presynaptic nerve terminals for conversion back to glutamate by phosphateactivated glutaminase (PAG). Glutamate is then packaged in vesicles, released into the synapse and taken back up by
astrocytes via Na+-dependent glutamate transporters; after which some glutamate is converted back to glutamine by GS,
and some enters mitochondria to be converted back to α-ketoglutarate and complete the TCA cycle. By completing the
TCA cycle, glutamate can generate an additional 20 molecules of ATP.

8

A variable percentage of transported glutamate is converted to α-ketoglutarate
via the mitochondrial enzyme glutamate dehydrogenase, and oxidized via the TCA cycle
in mitochondria, producing ATP (Yu et al., 1982; McKenna et al., 2002; for reviews, see
McKenna, 2013; Dienel and McKenna, 2014; Sonnewald, 2014).

In fact, astrocytic

glutamate oxidation outpaces glucose oxidation in primary cultures from rat brain
(McKenna, 2012).

Inhibiting glutamate dehydrogenase reduces Na +-dependent

glutamate uptake in crude synaptosomes (Whitelaw and Robinson, 2013). Furthermore,
CNS-specific deletion of glutamate dehydrogenase increases glucose deployment from
the periphery to the brain to compensate for the loss glutamate as a fuel source (Karaca
et al., 2015). Oxidation of neurotransmitter glutamate allows astrocytes to recoup most
of the ATP lost to the incomplete TCA cycle during de novo glutamate synthesis; 2
glutamate molecules generate a net 20 molecules of ATP, so synthesis and oxidation of
2 molecules of neurotransmitter glutamate from 1 molecule of glucose nets 31 ATP,
compared to the 32 ATP that would have been generated if those carbons had not taken
a detour through neurotransmitter glutamate (Hertz et al., 2007).

1.4

Protein interactions between mitochondria and glutamate transporters
The astrocytic glutamate transporter GLT-1 is enriched in fine processes near

synapses (Chaudhry et al., 1995; Lehre et al., 1995). In keeping with the oxidation of
neurotransmitter glutamate, we recently demonstrated that glycolytic and mitochondrial
proteins coimmunoprecipitate with astrocytic glutamate transporters, and vice versa. We
also observed overlap of fluorescently labeled mitochondria and transporters in
astrocytic processes that was statistically greater than would be observed by chance,

9

suggesting physical and/or functional interactions between mitochondria and glutamate
transporters in astrocytic processes (Genda et al., 2011; Bauer et al., 2012).
Multiprotein complexes increase the efficiency of biological pathways by
increasing availability and decreasing diffusion distance of substrates exchanged within
the pathway. Multiprotein assemblies between transporters, receptors, ion channels,
and cytosolic proteins have been identified in brain, positioning receptors at synapses,
limiting nonspecific protein modification by tethering kinases and phosphatases, and
increasing substrate transfer efficiency between associated enzymes (Levitan, 2006;
Mandela and Ordway, 2006; Torres, 2006; Chen and Olsen, 2007; Müller et al., 2010).
A multiprotein complex between the voltage-dependent anion channel (VDAC) on
mitochondria and the IP3 receptor on endoplasmic reticulum facilitates calcium transfer
between the organelles, important for energy regulation and cell death signaling (Rizzuto
et al., 1998; Szabadkai et al., 2006; Csordás et al., 2010).
The michondria-ER interaction provides an example of a multi-membrane
complex involving mitochondria, and includes the cytoplasmic scaffolding protein Grp75
(Szabadkai et al., 2006). We hypothesized that similar scaffold architecture may exist
between the plasma membrane glutamate transporter and mitochondria. Identifying this
scaffold could allow us to stabilize or disrupt assembly of the complex, providing a
means by which to study the physiological relevance of the transporter-mitochondria
interaction. Hexokinase 1 (HK1), the enzyme that carries out the first and rate-limitimg
step of glycolysis, was identified from our GLT-1 proteome as a potential scaffold. The
HK isoform HK2 binds the plasma membrane glucose transporter GLUT4 (Zaid et al.,
2009), and the localization of both HK1 and 2 to mitochondria via their binding to VDAC
has been studied extensively (Lindén et al., 1982; Nakashima et al., 1986; BeltrandelRio
10

and Wilson, 1991; Sui and Wilson, 1997; Rodrigues-Ferreira et al., 2012). We therefore
hypothesized that displacing HK1 from VDAC would disrupt the transporter-mitochondria
complex. As you will read in Chapter 2, displacing HK1 from VDAC impairs glutamate
transport, but does not interfere with coimmunoprecipitation of the transporter and other
mitochondrial proteins (Jackson et al., 2015).

1.5

Mitochondrial mobility and distribution
In neurons, mitochondria are distributed at sites with high demand for ATP or

calcium buffering, including growth cones, axon branch points, synapses, and nodes of
Ranvier, (Morris and Hollenbeck, 1993; Ruthel and Hollenbeck, 2003; Zhang et al.,
2010). This distribution is established by cytoskeletal motors attached to mitochondria
(Morris and Hollenbeck, 1995; Ligon and Steward, 2000).

Immobilization of

mitochondria in areas of low ATP and high calcium is primarily attributed to calcium
binding to the motor adaptor protein Miro, resulting in motor deactivation (Schwarz,
2013). Mitochondrial mobility is required not only for establishing a distribution that can
support cellular functions and respond to changes in activity, but also has significant
overlap with fission and fusion events that are necessary for maintaining the health of
the mitochondrial population (for review, see Youle and Bliek, 2012).

Disruption of

mitochondrial mobility and dynamics in neurons is implicated in the progression of
several neurodegenerative diseases (Baloh et al., 2007; Waterham et al., 2007; for
review, see Sheng and Cai, 2012).
Given the reluctance in the field to accept that mitochondria were present in
astrocytic processes, relatively little was known about the mechanisms regulating
11

transport of mitochondria in astrocytes. As described above, much of the evidence for
the presence of mitochondria out in processes relied on two-dimensional electron
micrographs from small brain areas.

Block scan electron microscopy with three-

dimensional reconstruction is arduous and expensive, but without evidence of
mitochondrial distribution throughout the entire astrocyte, many were unwilling to reject
the longstanding belief that processes were too small to contain mitochondria. Unlike in
primary cultures, the complex morphology of astrocytes is maintained in organotypic
hippocampal slice cultures, along with neuronal circuitry (Stoppini et al., 1991;
Benediktsson et al., 2005).

Biolistic transfection of these cultures provides sparse

flourescent labeling of individual cells within the context of a greater cellular matrix. By
targeting fluorophores to mitochondria and plasma membrane within individual
astrocytes in a slice culture, we observed three-dimensional distribution of mitochondria
throughout the processes of astrocytes.

We also found that we could record

mitochondrial mobility in processes and manipulate activity within the slice to evaluate
mechanisms regulating that mobility.
Chapter 3 describes the first study examining the mobility of mitochondria in
astrocytic processes. We found that they move more slowly compared to their neuronal
counterparts, and that mitochondrial mobility in astrocytic processes is regulated by
neuronal activity and astrocytic glutamate uptake, positioning mitochondria near
transporters and synapses (Jackson et al., 2014). Similar findings have since been
reported by other groups using primary cultures (Ugbode et al., 2014) and a similar
hippocampal slice culture model (Stephen et al., 2015), and mitochondria have been
found even in ultra-fine peripheral astrocytic processes (Derouiche et al., 2015; for
review, see Benjamin Kacerovsky and Murai, 2016).
12

It is now apparent that

mitochondria occupy most of the volume of astrocytic processes, and we are just
beginning to understand the implications for astrocyte biology and brain function.

1.6

Ca2+ signaling in astrocytic processes is shaped by mitochondria and

glutamate transporters
Just as glutamate couples information and energy at the molecular level,
astrocytes provide more macroscopic information/energy coupling by coordinating
neuronal activity with changes in blood flow and regulation of breathing. Synapses are
the greatest consumers of energy in the brain (Harris et al., 2012), but they have little or
no contact with the vasculature from which energy is supplied.

Instead, astrocytes

ensheathe the vasculature and thousands of synapses, positioning them as gatekeepers
between systemic circulation and the brain.

Unlike neurons, astrocytes are not

considered electrochemically excitable since they are not myelinated and do not express
voltage-gated Na+ channels; instead they rely mainly on Ca 2+ signaling to propagate
information through processes and between cells via gap junctions (for review, see
Bazargani and Attwell, 2016).

Neuronally evoked elevations in astrocytic Ca 2+ can

cause release of arachidonic acid derivatives that regulate the tone of vascular smooth
muscle (Zonta et al., 2003; Mulligan and MacVicar, 2004; Gordon et al., 2008).
Additionally, Ca2+-activated calmodulin binds and activates several isoforms of nitric
oxide synthase, leading to increases in nitric oxide synthesis and diffusion to neighboring
cells, where it can cause relaxation of vascular smooth muscle (Chen and Wu, 2000;
Garcin et al., 2004; Spratt et al., 2007).
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Previously, the role of astrocytes in neurovascular coupling was brought into
question due to slow Ca2+ responses measured from the soma, and the lack of an effect
on vascular responsiveness when blocking IP 3R-mediated Ca2+ signals in astrocytes
(Schulz et al., 2012; Nizar et al., 2013). This controversy was resolved by the discovery
of Ca2+ signals out in astrocytic processes that are more rapid and frequent than their
somatic counterparts, precede the vascular response, and occur independent of IP3R
activity (Lind et al., 2013; Otsu et al., 2015; Srinivasan et al., 2015; Tang et al., 2015; for
review see Bazargani and Attwell, 2016).

In addition to mediating neurovascular

coupling, astrocytes in brainstem sense changes in partial pressure of oxygen via
mitochondrial respiration, triggering Ca 2+ signals that stimulate vesicular release of ATP
to increase breathing activity in response to changes in brain oxygenation (Gourine et
al., 2010; Kasymov et al., 2013; Angelova et al., 2015).
Investigations into the sources of IP3R-independent Ca2+ signaling in astrocytic
processes have focused on transmembrane routes of entry as an alternative to the IP3Rmediated release from internal endoplasmic reticulum Ca 2+ stores (Fig. 1.3).
Transmembrane Ca2+ entry mechanisms identified thus far include TRPA1 channels
(Shigetomi et al., 2012, 2013), G-protein coupled receptors associated with ion channels
(Srinivasan et al., 2015), purinergic P2X1/5 receptors and NMDA receptors unique to
cortical astrocytes (Hamilton et al., 2008; Palygin et al., 2010; for review, see
Verkhratsky et al., 2012), and plasma membrane transporters for glutamate and GABA
associated with reversal of Na+/Ca2+ exchangers (Schummers et al., 2008; Doengi et al.,
2009; Magi et al., 2013a; Rojas et al., 2013; Jackson and Robinson, 2015). However,
the endoplasmic reticulum is not the only source of internal Ca 2+ release. Mitochondria
also serve as internal Ca2+ stores, and participate in Ca2+ signaling in dissociated
14

astrocyte cultures (Parnis et al., 2013) and other cell types (for review, see Rizzuto et al.,
2012). Our lab and another recently found that Ca 2+ signaling influences the mobility of
mitochondria in astrocytic processes by binding to MIRO motor adaptor proteins, and
that these mitochondria in turn shape Ca 2+ signaling in processes (Jackson and
Robinson, 2015; Stephen et al., 2015).

Figure 1.3. IP3R-independent Ca2+ signaling in astrocytic processes is shaped by mitochondria, and mediates
neurovascular coupling and mitochondrial mobility. This simplified illustration depicts the various routes by which
extracellular Ca2+ can enter astrocytic processes. Ca2+-mediated immobilization of mitochondria is highlighted, as well
as the roles of mitochondria in Ca2+ signaling, to include buffering, spatial restriction, and possibly release. Ca2+mediated mechanisms of vascular signaling are displayed, and include arachidonic acid (AA) derivatives and nitric oxide
(NO).
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While performing live Ca2+ imaging experiments in transfected hippocampal slice
cultures using a highly sensitive genetic Ca 2+ sensor in tandem with a mitochondriallytargeted fluorescent marker, I discovered two anatomically distinct types of spontaneous
cytosolic Ca2+ signals in astrocytic processes (O’Donnell et al., 2016). As detailed in
Chapter 4, I observed extra-mitochondrial spikes with high spatial spread, as well as
persistent mitochondrially-centered signals that fluctuated with high frequency and
duration, appearing as Ca2+ clouds surrounding mitochondria. While that paper was
under review, Baljit Khakh’s group published a paper in which they also described two
distinct types of Ca2+ signals in astrocytic processes with similar properties to those we
had observed, but did not image mitochondria (Jiang et al., 2016). Though additional
investigations will provide more detail, there is compelling evidence that mitochondria
shape Ca2+ signals in astrocytic processes, and may even serve as an intracellular
source for IP3R-independent Ca2+ signaling. Furthermore, by regulating the distribution
of mitochondria in processes and serving as an extracellular source of Ca 2+ linked to
neuronal activity, glutamate transporters may play an important role in neurovascular
coupling.

1.7

Mitochondria in astrocytic processes under pathological conditions
In the brain, astrocytes are primarily responsible for ion homeostasis, facilitating

anabolic and catabolic metabolism, providing antioxidant protection, fixing NH 4,
incorporating nitrogen into biological molecules, preventing edema, removing glutamate
from the extracellular space, coupling neuronal activity to changes in blood flow and
glucose uptake, regulating breathing in response to changes in brain oxygenation,
directly participating in signaling and plasticity, and many other vital functions.
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Not

surprisingly, disruptions of each of these functions, often in combination, have been
implicated in acute trauma and neurodegenerative disease, and many of them directly
involve astrocytic mitochondria (for reviews, see Chen and Swanson, 2003; Rossi et al.,
2007; Barreto et al., 2011; Lange et al., 2012; Brambilla et al., 2013; Stary and Giffard,
2015).
Since mitochondria in astrocytic processes were largely overlooked until recently,
there have only been a few investigations into their pathological relevance. Using a
focal ischemia model in gerbils, Ito et al. observed neuronal death in and around the
cortical infarct with no increase in astrocyte death. Electron micrographs showed a
reduced number of “normal-appearing” peripheral processes and reduced mitochondrial
size with greater effects in areas of high neuronal death (Ito et al., 2009). Cortical stab
wound

in

transgenic

mice

caused

inflammation-dependent,

DRP1-mediated

fragmentation of mitochondria in the lesion core, while astrocytes in the penumbra
exhibited elongated mitochondria. The fragmentation of mitochondria was transient, and
reestablishing normal mitochondrial distribution and dynamics was prevented by
blocking autophagy (Motori et al., 2013). The specialized form of autophagy responsible
for degradation of damaged mitochondria is termed mitophagy (Lemasters, 2005). In
neurons, mitochondria are targeted for mitophagy via ubiquitination of surface proteins
by the E3 ubiquitin ligase Parkin (Matsuda et al., 2010 p.1; Chan et al., 2011; Wang et
al., 2011; Yoshii et al., 2011; Wong and Holzbaur, 2014, 2015). Autophagosomes engulf
mitochondria in distal neurites, and degradation proceeds during retrograde transport
back to the cell body (Maday et al., 2012).

Very little is known regarding the

mechanisms and relevance of mitophagy in astrocytic processes.
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Studies examining astrocytic mitochondria in primary culture have revealed
depolarization and dysfunction in response to various pathological conditions and a few
techniques to prevent that dysfunction (for review, see Stary and Giffard, 2015). Heat
shock proteins involved in mitochondrial Ca 2+ handling have been implicated in
mitochondrial dysfunction in primary astrocytes, and pharmacological or genetic
induction is neuroprotective in in vitro and in vivo models of ischemia (Ouyang et al.,
2005, 2006; Sun et al., 2006; Xu et al., 2010).

Astrocyte-targeted reduction of

microRNAs that have been implicated in mitochondrial homeostatic mechanisms are
neuroprotective in an in vivo model of ischemic stroke (Ouyang et al., 2011, 2012a,
2012b, 2013; Xu et al., 2015). Purinergic signaling plays a prominent role in astrocytic
communication during health and disease (for review, see Franke et al., 2012).
Calcium-mediated stimulation of mitochondrial metabolism in astrocytes via activation of
purinergic P2Y1 receptors provides neuroprotection against oxidative stress in primary
co-cultures (Wu et al., 2007), and reduces edema and infarct size in an in vivo
photothrombotic stroke model in mice (Zheng et al., 2010, 2013). While these studies
demonstrate the promise of targeting astrocytic mitochondria to provide neuroprotection
in vivo, data regarding the astrocytic mitochondria themselves were almost entirely
acquired using primary astrocyte cultures.
Astrocytes in primary culture provide a valuable, but limited, research platform
(for review, see Lange et al., 2012). They lack the complex morphology found in vivo,
and thus, cannot be used to study the unique cellular compartment of astrocytic
processes in which many vital functions transpire.

Organotypic hippocampal slice

cultures maintain circuits and morphologies very similar to what is found in vivo (Stoppini
et al., 1991), while allowing for high experimental control and easy access to various
18

output measures, including high resolution confocal microscopy.

Sparse flourescent

labeling of individual cells within slice cultures via biolistic transfection provides an
optimal model for single cell analyses in the context of a greater cellular matrix. This
slice culture model also exhibits delayed, progressive, excitotoxic neuropathology in
area CA1 following transient oxygen/glucose deprivation (OGD), modeling the
secondary pathology that emerges after cerebral ischemia/reperfusion injury in vivo
(Bonde et al., 2005; for review, see Noraberg et al., 2005). After dissecting slices from
rat pups 6-8 days postnatal, culturing slices for 14-18 days allows for synapse formation
and expression of NMDAR subunits that sensitize the slice to excitotoxic injury (Ahlgren
et al., 2011). At 14-18 days in vitro, there are still several weeks before spontaneous
epileptiform activity emerges in the cultures (Albus et al., 2013). Utilizing a 30 min
oxygen/glucose deprivation insult in biolistically transfected hippocampal slice cultures, I
was able to conduct the first study of mitochondria, mitophagy, and calcium signaling in
astrocytic processes during the development of secondary neuronal pathology, as
detailed in Chapter 4 (O’Donnell et al., 2016).
I found that mitochondrial occupancy was reduced from ~60% of the length of
astrocytic processes to ~30% due to fragmentation and, at least in part, autophagic
degradation over the 24 h following the insult. Surprisingly, we found that while blocking
astrocytic glutamate uptake with TFB-TBOA increased neuronal pathology in stratum
pyramidale, it completely blocked the loss of astrocytic mitochondria.

Additional

experiments utilizing extended exposure to high exogenous glutamate concentrations in
the presence of iGluR antagonists resulted in loss of astrocytic mitochondria in the
absence of neuropathology.

Taken together these results suggest that astrocytic

mitochondrial loss is driven by an extended period of high glutamate transporter activity,
and not by the concomitant neuronal damage.
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At 24 h after OGD, spontaneous

cytosolic calcium spikes in astrocytic processes were more intense and spread farther,
no longer spatially restricted by mitochondria.

The mitochondrially-centered signals

were also more intense, but spatially smaller, tracking with a reduction in mitochondrial
size in a manner that suggests that mitochondria may be the source of the Ca2+ signal.
As mentioned above, astrocytic Ca 2+ signals are involved in mediating
neurovascular coupling (Takano et al., 2006; Lind et al., 2013; Otsu et al., 2015;
Srinivasan et al., 2015; Tang et al., 2015; Bazargani and Attwell, 2016), which is
depressed after ischemia/reperfusion injury (Salinet et al., 2015). Astrocytic calcium
signals can also trigger vesicular release of glutamate from astrocytes, which is
increased after seizure or stroke and contributes to excitotoxic neuronal pathology (Ding
et al., 2007; Hines and Haydon, 2013; Takemiya and Yamagata, 2013). Altered Ca2+
signaling is unlikely to be the only consequence of mitochondrial loss in astrocytic
processes, and we are currently investigating the effects on glutamate transport and
metabolism.
Astrocytes are vital for brain metabolism, a myriad of essential homeostatic
functions, stemming the perpetual threat of excitotoxicity, and communicating between
brain and body. All of these functions in some way rely on mitochondria in fine astrocytic
processes, which appear to be uniquely susceptible to pathological conditions.
Compared to the cell death among neurons, mitochondrial dysfunction is far less severe
and very rarely fatal for astrocytes. Since astrocytes are capable of rescuing neurons
from a multitude of angles all at once, a therapeutic approach that targets the lesssevere dysfunction in astrocytes offers greater chances of success compared to
therapies focused on a single neuronal target.
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1.8

Summary
Mitochondria in astrocytic processes are central to the synthesis and metabolic

flux of neurotransmitter glutamate, as well as the Ca 2+ signaling that mediates
neurovascular coupling and other functions. They are also central to pathology from
acute brain trauma and neurodegenerative disease, offering unique opportunities for
therapeutic intervention. In the following chapters, you will read about the effects of
glutamate transporter activity on mitochondria and Ca 2+ signaling in astrocytic
processes.

In healthy cells, glutamate transport positions mitochondria near

transporters and synapses. This facilitates oxidation of neurotransmitter glutamate and
shapes Ca2+ signaling. Under pathological conditions, excessive, extended periods of
glutamate transport can cause mitochondrial fragmentation and autophagic degradation,
leading to drastically altered Ca2+ signaling in processes. The following results prompted
far more questions than they answered, indicating that science is working as it should,
and the field is ripe for discovery.
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Abstract
The glutamate transporter GLT-1 is the major route for the clearance of
extracellular glutamate in the forebrain, and most GLT-1 protein is found in astrocytes.
This protein is coupled to the Na +-electrochemical gradient, supporting the active
intracellular accumulation of glutamate. We recently used a proteomic approach to
identify proteins that may interact with GLT-1 in rat cortex, including the Na+/K+-ATPase,
most glycolytic enzymes, and several mitochondrial proteins.

We also showed that

most GLT-1 puncta (~70%) are overlapped by mitochondria in astroglial processes in
organotypic slices.

Based on this analysis, we proposed that the glycolytic enzyme

hexokinase 1 (HK1) might physically form a scaffold to link GLT-1 and mitochondria
because HK1 is known to interact with the outer mitochondrial membrane protein,
voltage-dependent anion channel (VDAC). In the present study, we first validated the
interactions

between

HK-1,

VDAC

and

GLT-1

using

forward

and

reverse

immunoprecipitations. We also provided evidence that a subfraction of HK1 co-localizes
with GLT-1 in vivo.

We found that a peptide, known to disrupt the interaction between

HK and VDAC, did not disrupt interactions between GLT-1 and several mitochondrial
proteins. In parallel experiments, we found that displacement of HK from VDAC reduced
GLT-1-mediated glutamate uptake. These results suggest that although HK1 forms coimmunoprecipitatable complexes with both VDAC and GLT-1, it does not physically link
GLT-1 to mitochondrial proteins. However, the interaction of HK1 with VDAC supports
GLT-1-mediated transport activity.
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2.1 Introduction
Glutamate is the principal excitatory neurotransmitter in the CNS.

Synaptic

concentrations of glutamate are maintained at low levels (approximately 25 nM) against
brain concentrations that approach 10 mmol/Kg in order to ensure proper signaling and
prevent excitotoxicity (Herman and Jahr 2007; Schousboe 1981). Glutamate is cleared
from the synapse by a family of Na +-dependent glutamate transporters of which GLT-1
and GLAST, the astroglial glutamate transporters, predominate (for reviews, see Danbolt
2001; Robinson 1999).

These transporters couple the uptake of one molecule of

glutamate with the co-transport of 3 Na+ ions and a H+, followed by the counter-transport
of a K+ ion (Zerangue and Kavanaugh 1996).
Using mass spectrometry, we previously identified subunits of the Na+/K+ATPase, most of the glycolytic enzymes, and several mitochondrial proteins in GLT-1
immunoprecipitates from rat cortical homogenates (Genda et al. 2011).

In this same

study, we also showed that GLT-1 and mitochondria overlap more than 70% of the time
in astroglial processes in cultured organotypic hippocampal slices and that this overlap
was greater than would be observed by chance, consistent with a physical interaction
between GLT-1 and mitochondria.

We proposed that this complex might provide

metabolic support to facilitate glutamate uptake. We also proposed that the glycolytic
enzyme HK1 might serve as a scaffolding protein linking plasma membrane GLT-1 with
mitochondrial proteins. A known interaction between HK and the plasma membrane
glucose transporter GLUT4 gave precedence to the possibility of direct HK interactions
with GLT-1 (Zaid et al. 2009).
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Hexokinase catalyzes the first and one of the rate limiting steps of glycolysis, the
phosphorylation of glucose to form glucose-6-phosphate. Glucose phosphorylation also
represents the first step in the synthesis of glycogen and the pentose phosphate shunt.
In brain, most HK1 is bound to mitochondria by a hydrophobic N-terminal domain that
interacts with the voltage dependent anion channel (VDAC) found in the outer
mitochondrial membrane (Linden et al. 1982; Nakashima et al. 1986 Sui and Wilson
1997).

VDAC interacts with the adenine nucleotide translocase (ANT) in the inner

mitochondrial membrane (Beutner et al. 1998 Crompton et al. 1998) and many of the
mitochondrial

proteins

form

supercomplexes

(Acin-Perez

et

al.

Hexokinase/VDAC interactions link glycolysis and oxidative phosphorylation.

2008).
HK1

binding of VDAC is thought to increase the catalytic efficiency of both processes by
facilitating mitochondrial ATP release from VDAC for glucose phosphorylation and by
channeling ADP into mitochondria for oxidative phosphorylation (BeltrandelRio and
Wilson 1991; Rodrigues-Ferreira et al. 2012).
Given the importance of glutamate signaling and the metabolic costs
associated with maintaining glutamate uptake, it is not surprising that glutamate uptake
is intimately associated with metabolism. Glutamate uptake and Na +/K+-ATPase activity
are fueled by glycolysis, glycogenolysis, and oxidative phosphorylation (FernandezMoncada and Barros 2014; Genda et al. 2011; Sickmann et al. 2009). Glutamate uptake
stimulates glycolysis (Pellerin and Magistretti 1994), glucose uptake (Hamai et al. 1999;
Loaiza et al. 2003), and glycogen formation (Hamai et al. 1999; Swanson et al. 1990). In
addition, glutamate can itself be oxidized within the mitochondria, potentially fueling its
own uptake (Sonnewald and McKenna 2002).

In fact, inhibitors of glutamate

dehydrogenase (GDH) block glutamate uptake (Whitelaw and Robinson 2013).
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In the present study, we validated GLT-1 interactions with VDAC and HK1 using
both forward and reverse immunoprecipitations. We then tested whether HK1 might
provide a mechanism to link the plasma membrane protein, GLT-1, with mitochondrial
proteins (e.g. VDAC, UQCRC2, ANT).

In addition, we determined if the interaction

between HK1 and VDAC contributes to supporting glutamate uptake.

2.2 Methods
All procedures involving the use of animals were reviewed and approved by the
Institutional Animal Care and Use Committee of the Children’s Hospital of Philadelphia
(Philadelphia, PA USA).
Preparation of tissue/immunoprecipitation. Cortical tissue was harvested from
adult male Sprague Dawley rats after euthanasia by decapitation to avoid potential
effects of anesthetic agents (Huang and Zuo 2005). Total tissue lysates were prepared
as previously described (Genda et al. 2011).

Tissue was homogenized in ice cold

immunoprecipitation buffer (18.4 ml per gram wet weight), containing 150 mM NaCl, 1
mM ethylene diamine tetraacetic acid (EDTA), 100 mM Tris HCl, pH 7.4, 1% Triton X100, and 1% sodium deoxycholate plus protease and phosphatase inhibitors (1µg/ml
leupeptin, 250 µM phenylmethylsulfonyl fluoride (PMSF), 1 µg/ml aprotinin, 1 mM
iodoacetamide, 10 mM NaF, 30 mM sodium pyrophosphate and 1 mM sodium
orthovanadate) using a Dounce Teflon/glass homogenizer (7 strokes at 400 RPM).
subsequent steps were performed keeping the tissue at 4º C.

All

Homogenates were

rotated on a shaker for 1 hr and then cleared of cellular debris by centrifugation at
13,000 g for 30 min. One ml of lysate was pre-cleared with 80 µl protein-A agarose
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beads (Invitrogen, Carlsbad, CA) for 1 hr followed by centrifugation (16,500 g for 15
min). After analyses of protein (bicinchoninic acid protein assay kit; Pierce, Rockford,
IL), an aliquot of the supernatant containing 500 µg of protein was mixed overnight with
either 15µg antibody or a species-matched IgG (mouse IgG was from Zymed
Laboratories/Life Technologies, Grand Island, NY, rabbit IgG was from Invitrogen,
Carlsbad, CA). Protein complexes were batch extracted using protein-A agarose beads
(30 µl) with gentle mixing for 2 hrs.

Agarose beads were washed four times in

immunoprecipitation buffer before elution of bound proteins by the addition of 25 μl SDSPAGE loading buffer followed by incubation at 25°C for 45 min or 95°C for 5 min.
Incubation at 25°C for 45 min reduces the formation of GLT-1 aggregates and was used
for Figure 1B and C (upper panel) and Figure 4B.
Crude synaptosomal membranes (P2) were prepared as previously described
(Robinson et al. 1991) except that the final P2 preparation was resuspended in 4.5 vols.
of sucrose (0.32 M). An aliquot (450 µl) of this P2 suspension (containing ~ 1.8 mg of
protein) was combined with 50 µl Hexokinase II VDAC binding domain peptide (fused to
Antennapedia homeo-domain) (Calbiochem #376816) or control Antennapedia homeodomain peptide (Calbiochem #287895) that had been resuspended in 0.32 M sucrose
(100 µM final concentration) for 30 minutes at 37°C.

An aliquot (65 µl) of this material

was placed on ice for measurement of uptake (see below).

The remainder of the

material was centrifuged at 20,000 x g for 20 min. Except for the analyses of HK1 and
VDAC interactions, the pellet was resuspended in 1 ml of immunoprecipitation buffer and
processed as described above with 200 μl of pre-cleared lysate containing ~240 μg of
protein.

To test for HK1-VDAC interactions, pre-cleared lysates were incubated
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overnight using a Pierce crosslink immunoprecipitation columns (Thermo Scientific,
Waltham, MA) prepared using 15 μg HK1 antibody or mouse IgG.
Western Blot Analysis: Proteins were separated using 10% SDS-polyacrylamide
gels and transferred to polyvinylidene fluoride membranes (PVDF-FL; Millipore, Billerica,
MA), and blocked for 1 hr at 25°C in TBS-T (50 mM Tris, 150 mM NaCl, pH 8.0, 0.1%
Tween) containing 5% nonfat dry milk. Membranes were then probed with the
appropriate primary antibody: rabbit or mouse anti-GLT-1 (1:5,000; courtesy of Dr. J.
Rothstein, Johns Hopkins University, Baltimore, MD USA) (Rothstein et al. 1994); mouse
anti-HK1 (1:500; Sigma, St. Louis, MO, #WH0003098M1); mouse anti-ubiquinolcytochrome-c reductase complex core protein 2 (UQCRC2) (1:5000; Abcam,
Cambridge, UK, #AB14745), rabbit anti-VDAC (1:1000; Abcam #AB15895); goat antiANT (1:50; Santa Cruz, Santa Cruz, CA, #SC9299). Membranes were incubated with
fluorescent dye-conjugated anti-rabbit, anti-mouse, or anti-goat secondary antibodies
(1:10,000; LiCor Biosciences, Lincoln, NE). Protein bands were visualized using an
Odyssey Infrared Imager (LiCor Biosciences).
Glutamate uptake in P2 membrane fraction. Sodium-dependent transport of L[3H]-glutamate was measured as previously described (Robinson et al. 1991; Whitelaw
and Robinson 2013). HKII or control treated synaptosomes (10 μL, containing ~40 μg of
protein) were incubated with 0.5 μM L-[3H]-glutamate (PerkinElmer, Waltham, MA USA)
in uptake buffer, containing 5 mM Tris base, 10 mM HEPES, 140 mM NaCl, 2.5 mM KCl,
1.2 mM CaCl2, 1.2 mM MgCl2, 1.2 mM K2HPO4, 10 mM glucose (pH=7.2) at 37ºC for 3
min.

We have previously determined that 3H-glutamate uptake is linear until at least 5

min in this system (Robinson 1991). Uptake was measured in the absence and presence
of sodium by substituting equimolar amounts of choline chloride for NaCl. The assay
40

was terminated by the addition of 2 ml of ice-cold choline-containing buffer. Following
termination, the suspensions were filtered onto glass filter paper (FP-100; Brandel,
Gaithersburg, MD USA) using a Brandel cell harvester and rinsed three times with 2 ml
of cold choline-containing buffer. Radioactivity was solubilized with 5 ml of Cytoscint ES
(MP Biochemicals, Solon, OH USA) and measured using scintillation spectrometry
(Beckman-Coulter Instruments LS 6500). Sodium dependent uptake was calculated as
the difference between the signal in the sodium-containing buffer from the signal in the
choline-containing buffer.
Immunofluorescence.

Adult rats (10–12 weeks) were anesthetized with

isoflurane and transcardially perfused with ice-cold phosphate buffered saline (PBS)
followed by 4% paraformaldehyde in PBS, pH 7.4. Brains were post-fixed overnight
(4ºC), equilibrated in 30% sucrose, flash frozen in isopentane (-50ºC), and stored at 80ºC. Sections were cut on a freezing-sliding microtome and processed as free-floating
sections. Sections were blocked in PBS containing 5% normal serum and 0.4% Triton
X-100 for 1 hr and then incubated with rabbit anti-GLT-1 (Rothstein, 1:100) and/or
mouse anti-HK1 (Sigma, St. Louis, MO; 1:100) overnight at 4ºC. After 3 rinses, they
were incubated in secondary antibody (either Alexa Fluor 488 or 633; 1:400, Invitrogen)
overnight at 4ºC. Sections were mounted on pre-coated slides, cover-slipped with
mounting media (VectaShield), and stored at 4ºC until analysis. Controls for each
experiment included incubations to confirm the species specificity of secondary
antibodies and to confirm that signal was dependent on the presence of primary
antibodies.

Sections were visualized on a Fluoview 1000 confocal microscope

(Olympus, Center Valley, PA) equipped with a PlanApo 60x objective (numerical
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aperture = 1.4). All images were collected in sequential scan mode to minimize crosscontamination of fluorophores.
Intensity correlation analysis / intensity co-localization quotient. Single optical
sections were background corrected and filtered using a Gaussian filter (r = 1). All image
analysis was conducted using NIH ImageJ software (http://rsb.info.nih.gov/ij/). Images
were automatically thresholded and the Intensity Co-localization Quotient (ICQ) values
calculated using the intensity correlation analysis (ICA) plug-in to the McMaster
Biophotonics Facility ImageJ collection. The ICQs were calculated as described by Li et
al (2004); results were compared to zero using a one-sample t test. Images representing
the product of the differences from the mean (PDM) intensity values were generated
using this plugin.

2.3 Results
Interaction between GLT-1, HK1, and VDAC in the cortex
In our earlier study, we identified a number of glycolytic enzymes and
mitochondrial proteins in GLT-1 immunoprecipitates from rat brain cortical lysates by
mass spectrometry (Genda et al. 2011).
validated

using

conventional

Many of these interactions were further

immunoprecipitation/western

blotting

and

reverse

immunoprecipitation using an antibody against the putative interacting protein. At the
time, we were unable to validate the interactions with either HK1 or with VDAC because
we could not identify suitable antibodies.
antibodies for this purpose.

For the present study, we found suitable

Using these antibodies, we performed a series of

immunoprecipitations followed by western blot analysis to test whether the glial
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glutamate transporter GLT-1, the glycolytic enzyme HK1, and the mitochondrial protein
VDAC

interact

in

rat

cortical

tissue.

Using

immunoprecipitation, we observe HK1 (Fig 2.1).

an

anti-GLT-1

antibody

for

In addition, we consistently found

ubiquinol-cytochrome-c reductase complex core protein 2 (UQCRC2), as was observed
in our earlier study (Genda et al. 2011). In mammals, there are three isoforms of VDAC
representing distinct gene products with high homology but different molecular weights
due to post-translational modifications (Yamamoto et al. 2006).

In the earlier mass

spectroscopy analysis, we identified VDAC2 and VDAC3 in GLT-1 immunoprecipitates
(Genda et al. 2011). Using an anti-VDAC antibody that recognizes all three isoforms, we
observed bands at approximately 29 and 31 kDa in GLT-1 immunoprecipitates. The
higher molecular weight band represents the VDAC1 and 2 isoforms, the lower
molecular weight band represents VDAC3 (Kerner et al. 2012; Shoshan-Barmatz and
Golan 2012; Yamamoto et al. 2006).

In these same immunoprecipitates, we also

verified the presence of GLT-1 (Fig. 2.1A, lower panel) that migrates as a monomer with
a molecular weight of approximately 66 kDa and a trimer of approximately 200 kDa
(Haugeto et al. 1996).

These analyses complement our earlier mass spectroscopic

analysis providing evidence that the proteins were appropriately identified, but they do
not rule out the possibility that the anti-GLT-1 antibodies directly interact with these
proteins.
To

address

this

possibility,

we

performed

a

series

of

‘reverse’

immunoprecipitations to determine if GLT-1 co-immunoprecipitates with these targets
using antibodies against these putative interacting proteins. Using an anti-HK1 antibody,
we find that UQCRC2, VDAC, and GLT-1 all co-immunoprecipitate with HK1 (Figure
2.1B, upper panels). Similarly, using an anti-VDAC antibody, we find that GLT-1, HK1,
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and UQCRC2 all co-immunoprecipitate with VDAC (Figure 1C, upper panels). In both of
these sets of immunoprecipitations, we confirmed that the intended target was observed
in the immunoprecipitates (Figure 2.1B &C, lower panels). Although these results do not
formally rule-out the possibility that subsets of these interacting proteins interact
separately, the simplest explanation is that these proteins participate in a multi-protein
complex that includes GLT-1, HK1, UQCRC2, and VDAC.

Figure 2.1: GLT-1, HK1, and VDAC form immunoprecipitatable interactions within the cortex. Anti-GLT-1 (A), antiHK1 (B), anti-VDAC (C) antibodies or IgG were used for immunoprecipitations from rat cortical lysates (500 µg protein).
Immunoprecipitation of the target protein was confirmed in every immunoprecipitation. Data are representative of at least
3 independent experiments.

Previously, we examined the extent of co-localization of mRFP-GLT-1 with HK1EGFP within the processes of transfected astrocytes in hippocampal slice cultures
(Genda et al. 2011). We found that virtually all exogenous HK1 localized to
mitochondria. Here, we extended this analysis to look at the extent of co-localization of
44

endogenous

HK1

and

GLT-1

within

rat

cortical

tissue.

We

conducted

immunofluorescence imaging of HK1 and GLT-1 in sections derived from adult rat cortex
(Fig. 2.2) followed by intensity co-localization analysis. This analysis is based on the
premise that if HK1 and GLT-1 interact, then their staining intensities should co-vary.
Conversely if the proteins are part of different complexes, then their staining patterns
should be segregated. We calculated Intensity Co-localization Quotients (ICQs) for HK1
and GLT-1 in the cortex of rat

(Genda et al. 2011; Li et al. 2004).

This quotient

describes the extent of correlation of the staining intensities for two proteins. If two
images have staining patterns that are dependent, then their staining intensities will covary around their respective means and the product of their differences from the mean
(PDM) values will be positive. The ICQ values are equal to the ratio of number of
positive PDM values to the total number of pixels and are distributed between -0.5 and
+0.5. Positive ICQ values indicate the relative intensities are correlated and consistent
with co-localization. An ICQ value of 0 would indicate random staining, while negative
values indicate segregated staining. We see a small, but significant co-variance of
signal for GLT-1 and HK1 (ICQ=0.06 ± 0.1, p=0.0006, n=8) within rat cortex.

This

covariance exists despite the fact that the majority of GLT-1 is found in astrocytes in vivo
(Rothstein et al. 1994), while HK1 is present in high amounts in neurons as well (Cahoy
et al. 2008). While the majority of GLT-1 expression in cortex is astrocytic, there is also a
small pool of GLT-1 in neurons; therefore we cannot rule out the possibility that the
observed co-localization is occurring within the neurons (Chen et al. 2004; Furness et al.
2008).
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Figure 2.2: GLT-1 and HK1 co-localize in rat brain cortex. (A-C) Representative images from adult rat cortex
immunostained with antibodies against HK1 (A), GLT-1 (B), and merged (C). (Scale bar=10 µm). (D) Pseudocolor
representation of the product displacement of the mean (PDM) values for the image pair (A, B), where pixel intensity is
equal to the PDM at that location. Images with positive PDM (dependent) values are displayed in yellow, while those with
negative values (segregated) are displayed in violet.

N-terminal HK peptide disrupts HK1-VDAC binding in synaptosomes
For the next series of experiments, we used crude synaptosomal membranes
(P2) from cortex so that we could measure Na +-dependent L-[3H]-glutamate uptake in
parallel.

Several lines of evidence indicate that essentially all of the uptake in this

preparation is mediated by GLT-1, including the demonstration that the pharmacology of
uptake uniquely reflects GLT-1 and genetic deletion of GLT-1 reduces uptake to 5% of
control (Arriza et al. 1994; Tanaka et al. 1997, for review see Robinson 1999; Robinson
et al. 1991).
We hypothesized that HK1 may act as a cytosolic bridge linking GLT-1 and
mitochondria. To test this hypothesis, we used a cell-permeable peptide based on the
N-terminal, VDAC-binding domain of HK2 (Pastorino et al. 2002; Sui and Wilson 1997)
to disrupt the interaction between HK1 and VDAC (mitochondria), and measured the
effect on interactions between GLT-1 and mitochondrial proteins. Several groups have
used this peptide to disrupt the interaction between endogenous HK (1 and 2) and
VDAC in various cell culture models (Majewski et al. 2004; Pastorino et al. 2002;
Sukumaran et al. 2010). The N-terminus of HK2 shares sequence homology (11 of 15
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amino acids) and its VDAC binding site with HK1, making the peptide useful for
displacing both of these isoforms from VDAC. To confirm that the peptide disrupts the
interaction between HK1 and VDAC in the crude synaptosomes, we used an anti-HK1
antibody

to

immunoprecipitate

immunoreactivity.

HK1

and

quantified

the

amount

of

VDAC

As anti-VDAC antibodies detected two bands in the VDAC

immunoblot, we quantified the bands separately.

The total amount of VDAC in the

immunoprecipitation was normalized
to

the

targeted

HK1

immunoprecipitation (which did not
change; Fig 2.3) to yield a VDAC/HK1
ratio for each experiment. We found
that a 30 min incubation with 100 µM
of the N-terminal HK peptide reduced
HK1-VDAC binding by 50.4 ± 5.61%
(48.9 ± 6.89% in the upper band, 66.1
± 4.27% in the lower band) in crude
synaptosomes prepared from adult rat
cortex (Fig. 2.3). The reduction with
peptide treatment compared to control
Figure 2.3: An N-terminal HK peptide displaces HK1 from
VDAC in synaptosomes prepared from adult rat cortex.
Representative western blot of HK1 IPs under control and HKpeptide conditions labeled for HK1 and VDAC (A). The
amount of HK1 found in the immunoprecipitates was not
significantly affected by the HK peptide (93.6% of control,
p=0.781), but normalizing VDAC immunoreactivity to HK1
immunoreactivity (VDAC/HK1 ratio) from each IP slightly
reduced the variance.
Therefore VDAC/HK1 in each
experiment was expressed as percent of control (B). Values
are displayed as mean ± SEM; n=4; ***p<0.001.

was significant for total VDAC as well
as for each individual band.

reductions observed for each band
were not significantly different from
each other.
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The

Effects of disruption of HK1-VDAC interaction on the GLT-1/mitochondria protein
complex and GLT-1 function
In these same experiments that resulted
in a 50% reduction of HK1-VDAC binding, we
performed immunoprecipitations targeting GLT1

and

protein,

the
ANT,

inner-mitochondrial
to

quantify

the

between GLT-1 and mitochondria.

membrane
interaction
ANT was

previously found to co-immunoprecipitate with
GLT-1 (Genda et al. 2011), and also interacts
with VDAC (Vyssokikh et al. 2001). In GLT-1
immunoprecipitations,

co-immunoprecipitation

of ANT or the matrix protein UQCRC2 was not
affected by incubation with the HK peptide (Fig.
2.4A).

Similarly,

in

immunoprecipitations

targeting ANT, co-immunoprecipitation of GLT1 was unaltered by HK peptide incubation (Fig.
2.4B). These data indicate that displacing 50%
of HK1 from VDAC is not sufficient to alter the
Figure 2.4: HK1-VDAC disruption does not
affect the interaction between GLT-1 and
mitochondrial proteins, but does reduce
sodium-dependent glutamate uptake in crude
synaptosomes. Representative western blots
of GLT-1 (A) and ANT (B) IPs under control and
HK-peptide conditions labeled for GLT-1 and
UQCRC2, or ANT and GLT-1, respectively.
Uptake of radiolabeled glutamate following
treatment with a control or HK-peptide is
expressed as percent of control (C). Values are
displayed as mean ± SEM; n=3; *p<0.05.

interaction between GLT-1 and mitochondria.
Glutamate

uptake

in

astrocytes

is

intimately linked to both glycolytic and oxidative
metabolism (Fernandez-Moncada and Barros
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2014; Genda et al. 2011; Loaiza et al. 2003; McKenna et al. 1996; Pellerin and
Magistretti 1994; Yu et al. 1982), which are in turn supported by HK-VDAC binding
(BeltrandelRio and Wilson 1991; Rodrigues-Ferreira et al. 2012). Therefore, we also
investigated the effect of disrupting the interaction between HK1 and VDAC on
glutamate uptake in the same sets of experiments.

We found that disruption of the

HK1-VDAC interaction significantly reduced Na +-dependent L-[3H]-glutamate uptake to
approximately 70% of control (Fig. 2.4C).

2.4 Discussion
The assembly of proteins into macromolecular complexes is thought to both
increase the specificity of reactions and improve the speed of reactions that are
dependent upon multiple proteins by limiting the impact of diffusion (Levitan 2006).
Converging lines of evidence provide examples of macromolecular protein complexes
coupling plasma membrane transport proteins with metabolic support. In erythrocytes,
glycolytic enzymes including phosphoglycerate kinase (Campanella et al. 2005; Mercer
and

Dunham

1981;

Parker

and

Hoffman

1967),

glyceraldehyde

phosphate

dehydrogenase (GAPDH), and aldolase (Campanella et al. 2005) localize to the plasma
membrane and physically interact with membrane proteins such as the anion exchanger
1 (AE1) (Campanella et al. 2005). In this system these proteins contribute to a
membrane-associated pool that fuels the Na+/K+-ATPase (Mercer and Dunham 1981).
The regulation of the glucose transporter GLUT4 by insulin is reciprocally controlled by
its interactions with GAPDH or HK2 (Zaid et al. 2009). Previously, we conducted a
proteomic analysis of GLT-1 with the purpose of identifying proteins that might be
involved in regulating the localization and activity of this astrocytic glutamate transporter.
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This analysis revealed the presence of subunits of the Na +/K+-ATPase, a number of
glycolytic enzymes (HK1, phosphofructokinase, glyceraldehyde dehydrogenase, etc.)
and mitochondrial proteins (e.g. UQCRC2, ANT) in GLT-1 immunoprecipitates (Genda et
al. 2011). Since then, these results have been extended to the other glial glutamate
transporter, GLAST (Bauer et al. 2012), and to human tissue (Shan et al. 2014). These
results suggest that the protein interactions observed in astrocytes might serve to fuel
glutamate uptake and the concomitant Na+/K+-ATPase.
Based on these results, we posited the existence of a macromolecular assembly
of proteins that might fuel glutamate transport, as illustrated in Figure 2.5. Several of the
proteins identified have previously been shown to interact.

Evidence for interaction

between GLT-1 and the Na+/K+-ATPase in the plasma membrane preceded our own
results (Fig. 2.5, arrow #1) (Rose et al. 2009, Genda et al. 2011). Hexokinase is bound
to the outer mitochondrial
membrane in part by its
association with the outer
membrane resident protein,
VDAC (Fig. 2.5, arrow #2)
(Sul and Wilson 1997, AbuHamad 2008).

VDAC in

turn physically interacts with
the

inner

membrane
(Fig.

2.5,

mitochondrial
protein
arrow

ANT
#3)

Figure 2.5: Schematic depiction of the interaction between GLT-1,
HK1, and mitochondrial proteins. Arrows (#1-3) refer to know protein
interactions. A potential model whereby GLT1-1 is linked to mitochondrial
proteins is diagramed (arrow #4). Figure is adapted from Genda et al 2011

(Beutner 1998, Crompton
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1998). Based on these known interactions, we proposed that the cytosolic enzyme
hexokinase might serve to physically coordinate the interaction of the plasma
membrane-bound transporter with the outer mitochondrial membrane protein VDAC and
through this to the inner mitochondrial membrane protein, ANT, and the matrix protein,
UQCRC2. Here, we have extended this work by validating the interaction between GLT1, HK1, and VDAC, and we also tested the hypothesis that the interaction between HK1
and VDAC facilitates GLT-1 binding to mitochondrial proteins.
We have considered the possibility that the co-immunoprecipitations between
GLT-1, glycolytic enzymes, and mitochondrial proteins could be an artifact due to postsolubilization aggregation. However, as shown in Figure 2.2, HK1 and GLT-1 co-localize
within astrocytic processes in cortex. Furthermore, we previously demonstrated that
neuronal activity significantly increases the probability that GLT-1 and mitochondria will
be apposed in perisynaptic astrocytic processes (Jackson et al. 2014). Similarly, coculturing astrocytes with neurons increases the overlap of GLT-1 with mitochondria in
culture (Ugbode et al. 2014).

The close proximity between GLT-1, HK1, and

mitochondria, and its regulation by neuronal activity, provide evidence for an in vivo
interaction between these proteins.
To test whether HK1 serves as a cytosolic link between GLT-1 and mitochondria,
we measured the extent of GLT-1 co-immunoprecipitation with mitochondrial proteins
while displacing HK1 from the outer mitochondrial membrane protein VDAC. Displacing
50% of HK1 from VDAC did not alter the interaction between GLT-1 and mitochondrial
proteins (ANT and UQCRC2; Fig. 2.4A,B). There are two possible explanations for
these results: either HK1 does not serve as a cytosolic bridge between GLT-1 and
mitochondrial proteins, or the pool of HK1 that serves as the bridge possesses a higher
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affinity for VDAC. Displacement of 50% of HK1 from VDAC may not be sufficient to
abrogate this interaction.

Unfortunately, this possibility could not be tested

experimentally, as 100 μM of peptide approaches the solubility limit of the peptide in our
buffer. However, we favor the hypothesis that HK1 does not serve as a cytosolic bridge
between GLT-1 and mitochondrial proteins. Rather, HK1/GLT-1 interactions are likely
indirect through mutual interaction with VDAC. HK1/GLT-1 interactions independent of
HK1/VDAC interactions are less likely, as we have previously shown that exogenous
HK1 is completely relegated to mitochondria in astrocytes (Genda et al. 2011). GLT1/VDAC interaction could be direct, or through a connecting cytosolic protein or protein
complex (Fig 2.5, arrow #4). Lastly, it is possible that GLT-1 may interact with these
proteins through its interaction with the Na +/K+-ATPase.
The glutamate transporters couple the inward movement of glutamate to the Na +
and K+ electrochemical gradients. Specifically, the inward movement of one molecule of
glutamate is accompanied by the inward movement of 3 Na + and a H+ and the countertransport of a K+ ion (Zerangue and Kavanaugh 1996). The Na+ and K+ gradients that
enable this exchange are established, in part, by the actions of the Na +/K+-ATPase,
which moves 3 Na+ ions into the cellin exchange for 2 K+ ions for every ATP hydrolyzed.
These molecules function interdependently, as inhibitors of the Na +/K+-ATPase inhibit
glutamate uptake (Pellerin and Magistretti 1994) and glutamate uptake stimulates
Na+/K+-ATPase activity (Pellerin and Magistretti 1997). Acute energy depletion results in
a reversal of the glutamate transporters, resulting in an increase in extracellular
glutamate; an effect attributed to changes in the Na + and K+ electrochemical gradients
(Jabaudon et al. 2000; Rossi et al. 2000). This functional interdependence is further
supported by the recent demonstration that the glial glutamate transporters physically
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interact with members of the Na+/K+-ATPase family (Bauer et al. 2012; Genda et al.
2011; Illarionava et al. 2014; Rose et al. 2009).
GLT-1 alone accounts for approximately 1% of brain protein (Lehre and Danbolt
1998). The dependence of GLT-1 upon the Na+ electrochemical gradient, and its
functional and physical coupling to the Na +/K+-ATPase, is assumed to impose a
metabolic demand upon astrocytes. Both glycolysis and oxidative phosphorylation can
fuel gutamate uptake and the Na +/K+-ATPase (Fernandez-Moncada and Barros 2014;
Genda et al. 2011). Conversely, glutamate uptake and Na +/K+-ATPase activity stimulate
glucose uptake (Hamai et al. 1999; Loaiza et al. 2003), glycolysis (Pellerin and
Magistretti 1994), and oxidative ATP production (Magi et al. 2013). As an alternative to
utilizing glucose, glutamate may be converted to alpha-ketoglutarate by glutamate
dehydrogenase and subsequently oxidized within the mitochondria (McKenna et al.
1996; Yu et al. 1982).

Increasing extracellular glutamate increases the fraction of

glutamate that is oxidized in astrocytes (McKenna et al. 1996; Yu et al. 1982), and
inhibitors of glutamate dehydrogenase block glutamate uptake (Whitelaw and Robinson
2013).

These results indicate that a portion of transported glutamate is oxidized in

astrocytes, generating energy that could be used to fuel its own uptake (Dienel 2013;
Dienel and McKenna 2014). In astrocytes, it appears that glutamate uptake is deeply
integrated with metabolism.
Displacing HK1 from VDAC alters glutamate uptake without affecting protein
interactions between GLT-1 and mitochondria. Disrupting HK1/VDAC binding changes
ANT to a confirmation that reduces ATP/ADP translocation (for review see Vyssokikh
and Brdiczka 2003), which contributes to impairment of both glycolytic and oxidative
metabolism (BeltrandelRio and Wilson 1991; Rodrigues-Ferreira et al. 2012).
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Knockout

or inhibition of ANT reduces glutamate uptake, and increased ANT expression in
reactive astrocytes is associated with increased glutamate uptake (Buck et al. 2003).
Glutamate uptake can be supported by either glycolytic or oxidative ATP production, but
inhibiting both reduces glutamate uptake (Genda et al. 2011(Genda et al., 2011b).
Thus, the metabolic consequences of displacing HK1 from VDAC are likely responsible
for the impaired glutamate uptake we observed.
Numerous interactions link the uptake and metabolism of glutamate to that of
glucose. Glutamate uptake and Na+/K+-ATPase activity are fueled by both glycolysis
and oxidative phosphorylation (Fernandez-Moncada and Barros 2014; Genda et al.
2011).

Glutamate uptake stimulates glutamate oxidation (Sonnewald and McKenna

2002; Yu et al. 1982), glycolysis (Pellerin and Magistretti 1994), glucose uptake (Hamai
et al. 1999; Loaiza et al. 2003), and glycogen formation (Hamai et al. 1999; Swanson et
al. 1990). L-glutamate itself can be incorporated into glycogen (Schmoll et al. 1995).
Since hexokinase catalyzes the first step of glucose metabolism (i.e. glycolysis, oxidative
phosphorylation, pentose phosphate pathway, or glycogen formation), physically linking
GLT-1 and HK1 may represent a mechanism to coordinate glutamate and glucose
metabolism.

Perhaps the involvement of HK1 in a GLT-1/mitochondria complex

facilitates glutamate oxidation, and thus favors the incorporation of glucose-6-phosphate
into glycogen in astrocytes by reducing the demand for glucose-derived pyruvate.
In summary, we provide evidence that HK1 and VDAC interact with GLT-1. The
interaction of GLT-1 with mitochondrial proteins does not depend upon the interaction of
HK1 with VDAC.

However, the interaction of HK1 with VDAC supports glutamate

uptake. These results highlight the close integration of glutamate uptake and astrocyte
metabolism.
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Abstract

Within neurons, mitochondria are non-uniformly distributed and are retained at
sites of high activity and metabolic demand. Glutamate transport and the concomitant
activation of the Na+/K+-ATPase represent a substantial energetic demand on
astrocytes.

We hypothesized that mitochondrial mobility within astrocytic processes

might be regulated by neuronal activity and glutamate transport.

We imaged

organotypic hippocampal slice cultures of rat, in which astrocytes maintain their highly
branched morphologies and express glutamate transporters. Using time-lapse confocal
microscopy, the mobility of mitochondria within individual astrocytic processes and
neuronal dendrites was tracked. Within neurons, a greater percentage of mitochondria
were mobile than in astrocytes. Furthermore, they moved faster and further than in
astrocytes. Inhibiting neuronal activity with tetrodotoxin (TTX) increased the percentage
of mobile mitochondria in astrocytes.

Mitochondrial movement in astrocytes was

inhibited by vinblastine and cytochalasin D, demonstrating that this mobility depends on
both the microtubule and actin cytoskeletons. Inhibition of glutamate transport tripled the
percentage of mobile mitochondria in astrocytes. Conversely, application of the
transporter substrate D-aspartate reversed the TTX-induced increase in the percentage
of mobile mitochondria. Inhibition of reversed Na +-Ca2+ exchange also increased the
percentage of mitochondria that were mobile. Lastly, we demonstrated that neuronal
activity increases the probability that mitochondria appose GLT-1 particles within
astrocyte processes, without changing the proximity of GLT-1 particles to VGLUT1.
These results imply that neuronal activity and the resulting clearance of glutamate by
astrocytes regulates the movement of astrocytic mitochondria and suggests a
mechanism by which glutamate transporters might retain mitochondria at sites of
glutamate uptake.
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3.1 Introduction
Astrocytes express a large cohort of neurotransmitter receptors and transporters
that allow them to sense and respond to neuronal stimuli. They possess enormously
elaborate processes that contact synapses and the vasculature.

A single astrocyte

domain can contact tens of thousands of synapses (Halassa et al., 2007b), thus allowing
astrocytes to monitor the activity of a large number of synapses (Newman, 2003).
Glutamate is the principle excitatory neurotransmitter in the central nervous
system. Synaptic levels of glutamate are kept low (approximately 25 nM), against brain
levels that approach 10 mmol/Kg (Herman and Jahr, 2007), to ensure appropriate
excitatory signaling and to limit excessive activation of glutamate receptors that can
cause excitotoxicity (for review, see Choi, 1992; Conti and Weinberg, 1999).
Extracellular glutamate is cleared via a family of Na+-dependent glutamate transporters
(for reviews, see Danbolt, 2001; Sheldon and Robinson, 2007).
These transporters couple the inward movement of glutamate to the inward
movement of 3 Na+ ions and 1 H+, and the outward movement of a K + ion, providing the
energy to maintain up to a million-fold concentration gradient of glutamate (Zerangue
and Kavanaugh, 1996).

Because of this coupling, glutamate uptake results in a

significant increase in the Na+ concentration within the fine astrocytic processes (Rose
and Ransom, 1996; Bergles and Jahr, 1997).

Glutamate uptake also activates the

Na+/K+-ATPase in astrocytes; an effect attributed to increased Na + concentration
(Magistretti and Pellerin, 1999). Not surprisingly, the glial glutamate transporters colocalize and physically interact with Na+/K+-ATPase isoforms, glycolytic enzymes, and
mitochondria (Rose et al., 2009; Genda et al., 2011; Bauer et al., 2012) and glutamate
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uptake is functionally coupled to increases in glucose uptake, glycolysis, and oxidative
phosphorylation (Pellerin and Magistretti, 1994; Magistretti, 2006; Loaiza et al., 2003).
While much research has examined the link between glutamate uptake and
glycolysis, the role of mitochondria in astrocytes is often overlooked. Astrocytes have a
high oxidative metabolism (Hertz et al., 2007) and possess a large number of
mitochondria even in the very fine processes (Lovatt et al., 2007; Ito et al., 2009; Lavialle
et al., 2011; reviewed in Parpura and Verkhratsky, 2012). In neurons, mitochondria are
not uniformly distributed; instead mitochondria are concentrated at sites with heightened
demand for ATP or Ca2+ buffering, including at axon branches, synapses, nodes of
Ranvier, and growth cones.

This distribution is established by movement of

mitochondria along the microtubule and actin cytoskeleton (Morris and Hollenbeck,
1995; Ligon and Steward, 2000; Hollenbeck, 2005).

Little is known about the

mechanisms regulating transport of mitochondria in astrocytes.
Here, we present the first description of mobile mitochondria within the processes
of astrocytes. We provide evidence that the movement of mitochondria in astrocytic
processes is regulated by neuronal activity, astrocytic glutamate uptake, and reversed
Na+-Ca2+ exchange. Furthermore, we demonstrate that neuronal activity increases the
probability that mitochondria appose GLT-1 protein in astrocyte processes. We suggest
that regulation of mitochondrial mobility may represent a mechanism to retain
mitochondria near sites of glutamate uptake in astrocytes.

3.2 Methods
cDNA contructs.

pBluescript-GfaABC1D was a gift from Dr. Brenner (University of

Alabama-Birmingham).

This construct encodes a 681 bp fragment of the glial fibrillary
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acidic protein (GFAP) promoter that is sufficient to result in selective expression in
astrocytes throughout the CNS (Lee et al., 2008). This 681 bp GFAP promoter fragment
was inserted into pTY-CMV-mCherry between Nhe1 and Age1 restriction sites to form
pTY-GfaABC1D-mcherry and was a gift from Dr. John Wolf (University of Pennsylvania).
pTY-GfaABC1D-gp43mCherry (referred to as GfaABC1D-mCherry) was generated by PCR
amplification of the membrane-targeting myristoylation sequence of gap43 into pTYGfaABC1D-mcherry immediately after the initiating methionine of mCherry. pEGFP-mito (a
gift from Dr. Stanley Thayer-University of Minnesota, Minneapolis) is a fusion of EGFP
with the mitochondrial matrix targeting sequence from CoxVIII and has been shown to
result in specific targeting of EGFP into mitochondria (Rizzuto et al., 1993; Wang et al.,
2003).
Reagents.

Rabbit anti-GLT-1 was a gift from Dr. Jeffrey Rothstein (Johns Hopkins

University). Rabbit anti-glial fibrillary acidic protein (GFAP) polyclonal antibody and Daspartate were purchased from Sigma-Aldrich (St. Louis, MO). Rabbit anti-MAP2 and
guinea pig anti-VGLUT1 were purchased from Millipore (Bellerica, MA). Highly crossadsorbed secondary antibodies conjugated to AlexaFluor dyes were purchased from
Invitrogen (Carlsbad, CA).

Goat anti-rabbit antibody conjugated to Dylight 405 was

purchased from Thermo Fisher Scientific (Rockford IL).

Tetrodotoxin (TTX) was

purchased from Alamone Labs (Jerusalem, Israel). Vinblastine, cytochalasin D, 6,7Dinitroquinoxaline-2,3-dione (DNQX), D-(-)-2-amino-5-phosphonopentanoic acid (DAPV),

bicuculline,

aspartic

acid

(3S)-3-[[3-[[4-(trifluoromethyl)benzoyl]amino]phenyl]methoxy]-L-

(TFB-TBOA),

(phenylethynyl)pyridine

(S)-3,5-dihydroxyphenylglycine
hydrochloride

(MPEP),

(DHPG),
and

2-methyl-62-[2-[4-(4-

Nitrobenzyloxy)phenyl]ethyl] isothiourea mesylate (KB-R7943), N-[(3-Aminophenyl)
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methyl]-6-[4-[(3-fluorophenyl)

methoxy]

phenoxy]-3-pyridine

carboxamide

dihydrochloride (YM 244769) were purchased from Tocris (Minneapolis, MN).
Slice culture and transfection. Organotypic cultures of rat hippocampus were prepared
as previously described (Benediktsson et al., 2005; Genda et al., 2011; Kayser et al.
2006).

Six to 12 day old rat pups of either sex were decapitated and their brains

removed into sucrose-artificial cerebrospinal fluid (aCSF) composed of: sucrose 280,
KCl 5, MgCl2 1, CaCl2 2, glucose 20, and HEPES 10 (in mM). Hippocampal slices (300
µm) were prepared using a McIlwain tissue chopper (Brinkman Instruments, Westbury,
NY) and placed on 0.4 µm Millicell culture inserts (Millipore, Bellerica, MA) in six-well
plates. Slices were maintained in a humidified incubator with 5% CO 2 at 37°C with 1 ml
of medium containing the following: 50% Neurobasal medium, 25% horse serum, 25%
Hank’s-buffered saline solution (HBSS), supplemented with 10 mM HEPES, 36 mM
glucose, 2 mM glutamine, 10 U/ml penicillin and 100 µg/mL streptomycin, pH 7.2-7.3.
Slices were allowed to recover for 2 days prior to transfection with plasmids encoding a
mitochondrial-targeted EGFP (mito-EGFP) and GfaABC1D-mCherry fluorescent protein
using a Helios Gene-Gun (BioRad, Hercules, CA) (McAllister, 2004; Benediktsson et al.,
2005). Gene-gun bullets were generated as follows: cDNAs (10 µg total) were combined
with 8-10 µg of 1.0 or 1.6 µm gold particles (BioRad) in a solution of 0.02 mg/mL
polyvinylpyrrolidone 20 (PVP-20), 0.05 M spermidine, and 1 M CaCl2. This suspension
was used to coat Teflon tubing that was subsequently cut and loaded into the GeneGun. The cDNA-coated gold particles were shot using high-pressure helium (100-120
psi) into cultured slices in inserts sitting on warmed agarose slabs. We used 1.0 µm
gold particles for transfection of astrocytes and 1.6 µm particles for the non-selective
transfection of astrocytes and neurons (Benediktsson et al., 2005).
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Live Slice Imaging.

Two days post transfection, slices were excised from their

membrane supports and placed in a closed, flow-through chamber for imaging. Slices
were continuously superfused with heated (34°C) ACSF composed of the following:
NaCl 130, KCl 3, NaH2PO4 1.25, NaHCO3 26, glucose 10, MgCl2 1, CaCl2 2 (mM) and
continuously bubbled with 95% O2/ 5% CO2.

Slices were imaged on an Olympus

Fluoview 1000 Laser Scanning Confocal Microscope equipped with a 40x UPlanApo
objective (NA=1.4). Slices were allowed to equilibrate in the imaging chamber for 10
minutes prior to imaging.

Cells expressing EGFP-mito and/or membrane-targeted

mCherry were identified using epifluorescence and were imaged using the 488 and 546
laser lines, respectively (Figure 3.1B-G).

To control for possible culture-to-culture

variability in the percentage of mobile mitochondria, all experiments included control and
experimental slices from the same cultures and were imaged on the same day. Cells
were visually selected based on their complex morphology and lack of reactive
phenotype. Cells at the surface of the slice or at the slice margins were not imaged.
Image stacks (15-25 optical sections, 1 µm z-spacing) were collected from the identified
cell to aid in retrospective identification. A subfield of processes was identified and was
imaged at 512 x 512 pixels with an additional 4-5x digital zoom. Image stacks (3-8
optical sections; 1 µm z-spacing) were collected every 6 to 10 seconds for 15 minutes
from a field containing 3-8 astrocyte processes and at least 10 mitochondria. Under
these conditions, we do not observe significant decreases in fluorescence intensity with
time (Figure 3.1A). We also did not observe evidence of cell swelling during the imaging
epochs as examined with the membrane-targeted mCherry.
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Figure 4.1. Method for imaging of astrocytic mitochondria in hippocampal organotypic cultures. (A)
Schematic summary of the experimental approach. Hippocampi from early postnatal rat pups were isolated and
plated onto membranes. Two days later slices were transfected via particle based biolistics. Slices were
imaged at 4 DIV via confocal. Slices were subsequently fixed for immnofluorescent analysis. (B-D)
Representative images of an astrocyte in hippocampal slice culture transfected with a membrane-targeted
mCherry fluorescent protein driven by a minimal GFAP promoter (GFAABC1D-mCherry; B and E) and a
mitochondrial matrix-targeted enhanced green fluorescent protein (mitoEGFP; C and F) and overlay (D and G).
EGFP fluorescence is shown as green and GFAABC1D-mCherry as red. Scale bar is 25 μm. Panels E-G
depict magnified views of the astrocyte processes depicted in D (white box). Mitochondria are present in some
(G; arrowhead), but not all (chevron) of the small astrocyte processes. Scale bar is 10 μm.

Immediately following the imaging epoch, slices were removed from the chamber
and immersed in 4% paraformaldehyde in phosphate buffered saline (0.1 M PBS).
Tissues were processed as free-floating sections for subsequent immunostaining. These
sections were extracted for 1 hour in a solution of PBS and 1% Triton X-100 at room
temperature. Sections were blocked in 5% goat serum for 1 hour at room temperature
and incubated with primary antibodies against GFAP (Sigma; 1:100) or MAP2 (Millipore
1:100) for two days at 4°C in a solution containing 1% Triton X-100 and 5% goat serum.
Sections were rinsed 3 x 15 min in PBS and incubated overnight with secondary
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antibody (goat anti-rabbit or mouse Alexa Fluor 633; Invitrogen). Slices were rinsed 3 x
15 min in PBS before mounting on precoated slides (Superfrost Plus; Fisher Scientific).
Sections were imaged on a laser confocal microscope as described above (depicted in
Figure 3.1A).
Although there is evidence that the smaller gold particles (1 µm) selectively
transduce astrocytes (Benediktsson et al., 2005), a GFAP promoter-driven mCherry was
used to ensure selectivity (Lee et al., 2008). To confirm that the combination of 1.0 µm
gold particles with this promoter fragment results in selective expression in astrocytes in
this system, cells expressing the Gfa ABC1D-driven mCherry fluorescent protein were
tested for co-localization with the astrocytic marker, GFAP. In four randomly chosen
experiments, all cells expressing Gfa ABC1D-driven mCherry fluorescent protein also
expressed GFAP immunoreactivity (data not shown). To confirm neuronal identity, we
immunostained every slice previously used to examine mitochondrial mobility in neurons
with antibodies against the dendritic marker MAP2.

The process that was used for

dynamic imaging was re-identified in the fixed and immunostained slices and confirmed
to come from a neuronal dendrite (data not shown).
Image Analysis. All data analyses were performed by individuals who were blinded to
condition for the particular day. All images were processed using NIH ImageJ software
((http://rsb.info.nih.gov/ij/; Schneider et al., 2012). Images were background corrected
and filtered using a Gaussian filter (σ = 1). Maximal projections of image stacks were
generated. Motion artifacts due to slice drift were corrected using the TurboReg plugin
of ImageJ to implement rigid registration; aligning all images in a time-lapse series to the
original image. The resulting movies were used to examine the mobility of individual
mitochondria within the processes of neurons or astrocytes. Individual mitochondria
were tracked using the MTrackJ plugin to ImageJ (Meijering et al., 2012).
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A

mitochondrion was considered mobile if the displacement exceeded 2 µm within the 15
min imaging window. Anterograde and retrograde motion were defined relative to the
cell body. Kymographs (displacement vs time) were constructed for individual astrocytic
processes for display purposes. Kymographs are displayed such that time is on the yaxis (time increases descending down the page).

Mitochondria that are stationary

appear as vertical lines, while mitochondria that moved over the imaging period will
appear as diagonal lines.
Puncta analysis.

The distribution of GLT-1 particles relative to mitochondria and

synapses were analyzed in the manner of MacAskill et al. (2000) as detailed below.
Hippocampal slice cultures were transfected with EGFP-mito and GfaABC1D-mCherry as
described above. Slices were immersed in pre-warmed (34°C), oxygenated, ACSF ±
TTX (1 μM) for 30 minutes. Slices were immediately immersed in 4% paraformaldehyde
(0.1 M PBS) and processed as described earlier in the Methods section. These sections
were incubated with primary antibodies against GLT-1 (1:100) or VGLUT1 (Millipore
1:200) and visualized with fluorescent molecule-conjugated secondary antibodies (goat
anti-rabbit Dylight 405 (1:400) or goat anti-guinea pig AlexaFluor 633 (1:400)).
Slices were visualized on an Olympus laser scanning confocal microscope
equipped with a 40x (1.4 N.A.) objective at an additional 5x optical zoom, using the 405,
488, 546, and 633 laser lines.

All images were collected sequentially to avoid

contamination of signals from other fluorophores. Sections from each experiment were
singly labeled or transfected to verify that the signal measured was specific.
Single optical sections were background corrected and filtered using a Gaussian
y fluorescent images were used to create binary masks that were
applied to GLT-1 immunofluorescent images; defining GLT-1 immunoreactivity within
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single astrocyte processes.

Mitochondria and GLT-1 puncta were identified by

thresholding at 3.5 times the standard deviation of the mean image and converted to
binary (as per Genda et. al. 2011). VGLUT1 particles were thresholded using an autolocal thresholding plug-in to the FIJI implementation of ImageJ (Gabriel Landini) and
converted to binary. The coordinates (centroid) of all particles were recorded and used
to calculate the minimum distance between mitochondria:GLT-1 and GLT-1:VGLUT1+
pairs. Using this same dataset, we also determined the distance between the edge of
each mitochondrion and the edge of the nearest GLT-1 particle using Matlab. These
results are displayed as cumulative probabilities.
Statistics.

All data are presented as mean ± standard error of the mean (SEM) of

separate cells that were acquired from at least 3 independent sets of experiments
(separate sets of slices prepared on separate days).

Statistical significance was

assessed by unpaired Student’s t-test or ANOVA with Bonferroni’s multiple comparisons
test.

Statistical significance between cumulative probability distributions was

determined using the Kolmogrov-Smirnov test. Statistical analysis was conducted using
Graphpad Prism software

3.3 Results
Mitochondrial mobility in astrocyte processes
While numerous groups (for reviews see Cai and Sheng, 2009; MacAskill and
Kittler, 2010; Schwarz, 2013) have examined mitochondrial movement in dissociated
cultures of neurons, few have looked at mitochondrial movement in neurons in more
complex systems (Ohno et al., 2011) and none have examined mitochondrial movement
within the processes of astrocytes.

Here, we used organotypic cultures of rat
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hippocampus to examine the mobility of mitochondria in the processes of astrocytes and
neuronal dendrites.

Transverse sections of rat hippocampus were cultured on

membrane inserts for 2 days. Cultures were transfected via a gene gun with plasmids
encoding EGFP-mito and a membrane-targeted mCherry fluorescent protein and
visualized 2 days later (Figure 3.1A). Astrocytes in organotypic cultures maintain much
of their characteristic three-dimensional morphology (Figure 3.1B-G), with many fine
processes radiating from the cell body and the presence of numerous fine branchlets
(Benediktsson et al., 2005). Within astrocytes, EGFP-expressing mitochondria were
readily identifiable within the astrocyte processes (Figure 3.1C, F). Mitochondria are
capable of investing into very small (<0.6 μm diameter) processes, where they occupy a
substantial portion of the width of some (Figure 3.1G; white arrowheads) but not all
(white chevron) of these processes. Mitochondria within the processes of astrocytes
and neurons exist as discrete organelles, whereas those localized to the cell body
appear to form a reticular structure, making individual mitochondria more difficult to
identify.

For our studies of mitochondrial mobility, we confined our analysis to the

smaller processes of the astrocyte, where single mitochondria are readily identifiable.
We compared the mobility of mitochondria within individual astrocytes and
neuronal dendrites using time-lapse confocal microscopy (Figure 3.2A, B). The majority
of mitochondria were stationary for the duration of the 15 min imaging window within
both the neurons and astrocytes. However, significantly more mitochondria were mobile
within the dendrites of the neurons than in astrocytic processes (Figure 3.2C). The
movement of mitochondria within astrocytes and neurons was bidirectional.

In

astrocytes, 44% of the mitochondria that were mobile moved in the retrograde direction
(toward the cell body), while 56% moved in the anterograde direction. In neurons, 61%
moved in the retrograde direction, while 39% moved in the anterograde direction. Since
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the movement was characterized by brief pauses accompanied by changes in speed
and direction, we quantified the maximal instantaneous velocity of each mitochondrion.
Neuronal mitochondria moved significantly further (Figure 3.2D) and faster (Figure 3.2E)
than did astrocytic mitochondria. The mean maximal velocity of mitochondrial movement
in neurons was 0.55 ± 0.05 μm/sec; (n=30) in the anterograde direction and 0.65 ± 0.05
μm/sec (n=47) in the retrograde direction. Within astrocytes, the mean maximal velocity
was 0.15 ± 0.01 μm/sec (n=47) in the anterograde direction and 0.2 ± 0.02 μm/sec
(n=34) in the retrograde direction (Figure 3.2E inset). These values are similar to those
previously observed for the movement of mitochondria along actin filaments in
sympathetic ganglia neurons (Morris and Hollenbeck, 1995). The lengths of individual
mitochondria in astrocytes and neuronal dendrites, however, were similar (Figure 3.2F).
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Figure 3.2. Comparison of mitochondrial mobility in astrocytes and neurons in organotypic cultures of
hippocampus. Mitochondria in astrocytes and neurons were transfected with plasmids encoding EGFPmito and a
membrane-targeted mCherry fluorescent protein. Representative images of astrocytic (A; red box) and neuronal (B:
green box) processes are displayed above kymographs that depict the movement of mitochondria in these
processes over a 15 min imaging epoch (time increases down page). Stationary mitochondria are seen as straight
lines and moving mitochondria as diagonal lines. Scale = 10 μm. (C) Histogram depicts the percentage of
mitochondria in astrocytes and neurons that were mobile during the imaging epoch, normalized to the total number
of mitochondria that were visualized during that period. Results are mean ± SEM. (D) Histogram displays the
average displacement of individual mobile mitochondria. (E) Normalized frequency distribution depicts the maximal
instantaneous velocity of individual mitochondria that were mobile within astrocytes (red) and neurons (green). The
mean maximal velocity of mobile mitochondria is depicted in inset histogram. (F) Normalized frequency distribution
of mitochondrial lengths (mobile and stationary) in astrocytes (red) and neurons (green). The mean length (μm) of
mitochondria in astrocytes and neurons is depicted in inset. *p<0.05; **p<0.005 unpaired Student’s t-test.
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Neuronal activity regulates the percentage of mobile mitochondria in astrocytes
In neurons, mitochondria are retained at sites of high activity and metabolic
demand (Li et al., 2004; MacAskill et al., 2010; Ohno et al., 2011). Astrocytic activity and
metabolism are highly integrated with neuronal
activity.

Therefore,

we

tested

whether

mitochondrial mobility in astrocytic processes
was regulated by neuronal activity within the
slice. Slices were pretreated for 15 minutes
prior to imaging with TTX (1 μM), a Na +
channel

antagonist

commonly

used

to

decrease neuronal activity (Figure 3.3). The
percentage

of

mobile

mitochondria

in

astrocytes increased more than 3-fold in TTXtreated

slices

compared

controls (Figure 3.3C).
astrocytic

with

untreated

The relative ratio of

mitochondria

moving

in

the

anterograde vs retrograde directions changed
Figure 3.3.
Inhibiting neuronal activity
increases
the
percentage
of
mobile
mitochondria in astrocytes. Slice cultures were
continuously superfused with ACSF ± TTX (1 μM)
for a period of 15 minutes prior to imaging and
throughout the imaging period. (A, B) Kymographs
show the movement of mitochondria along
astrocyte processes in slices treated with control
(A; ACSF) or TTX (B) over a 15 minute period
(time increases down the page); scale bar is 10
μm. (C) The percentage of mobile mitochondria
was calculated and is presented as the mean ±
SEM.
(D) Histogram depicts the results of
inhibiting ionotropic receptors. Slices were treated
with APV (50 μM), DNQX (10 μM), and bicuculline
(30 μM) for 15 minutes prior to imaging and were
continuously superfused with agents for imaging
period.
Results are mean ± SEM. *p<0.05;
**p<0.005 unpaired Student’s t-test.

from 2.6 in controls to 0.9 in TTX-treated
slices. Inhibition of neuronal activity did not
alter the velocity of mitochondrial movement or
mitochondrial

length

(data

not

shown).

Astrocytes in vivo and in situ express TTXsensitive Na+ channels (Sontheimer et al.,
1994). Therefore, as an alternative approach
to inhibit neuronal activity, we treated slices
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with inhibitors of NMDA (D-APV; 50 μM), AMPA, (DNQX; 10 μM), and GABA
(bicuculline; 30 μM) receptors. Bicuculline was included, as GABA may be excitatory
during the early post-natal period (Taketo and Yoshioka, 2000), prior to the
developmental induction of the chloride pump KCC2 (Rivera C 1999).

With this

alternative method of blocking neuronal activity, the percentage of mobile mitochondria
was again significantly higher in treated
slices than in untreated controls (Figure
3.3D).

These results suggest that the

mobility of mitochondria in astrocytes is
influenced by neuronal activity.
Mitochondrial movement depends on
both microtubule and actin cytoskeleton
Mitochondrial mobility in neurons
depends

on

both

the

actin

and

microtubule cytoskeletons (Morris and
Hollenbeck, 1995; Quintero et al., 2009).
We

examined

the

dependence

of

mitochondrial movement in TTX-treated
slices in the presence and absence of
inhibitors of microtubule (vinblastine)
and actin (cytochalasin D) assembly
(Figure 3.4). All slices were pretreated
with either TTX or ACSF for 15 minutes.
Slices were then treated with ACSF or
TTX (1 μM), in the presence or absence

Figure 3.4. Mitochondrial mobility depends on both the
actin and microtubule cytoskeletons. (A-D) Kymographs
depict the movement of mitochondria along astrocyte
processes in slices treated with vehicle (A; ACSF), TTX (B; 1
μM), TTX + vinblastine (C; 1 μg/mL), or TTX + cytochalasin
D (D; 20 μM). Slices were continuously superfused with
ACSF or TTX for 15 minutes prior to the application of
vinblastine (1 μg/mL) or cytochalasin D (20 μM). Slices were
continuously superfused with these compounds (in the
continued presence of TTX) for an additional 15 minutes
prior to the initiation of confocal imaging. Treatments were
continued for the entire imaging period. The percentage of
mobile mitochondria in astrocytes was determined over a 15
minute imaging epoch. (E) Results are presented as mean ±
SEM.
**p<0.005 by ANOVA with Bonferonni’s multiple
comparison test.

76

of vinblastine (1 μg/ml), or cytochalasin D (20 μM) for an additional 15 minutes prior to
imaging. No changes in cell viability or mitochondrial shape were observed following
these treatments (data not shown). A greater percentage of mitochondria were mobile in
slices treated with TTX than in untreated (ACSF) controls. Application of vinblastine or
cytochalasin D decreased the percentage of mobile mitochondria relative to the TTXtreated slices. These results suggest that both the actin and microtubule cytoskeletons
contribute to the movement of mitochondria in astrocytic processes.
Mitochondrial mobility in astrocytes is not controlled by mGluR5 activation
Astrocytes express a large complement of neurotransmitter receptors, including
metabotropic glutamate receptors and purinergic receptors that allow them to sense and
respond to neuronal activity (Newman, 2003). mGluR5 receptors in particular have been
linked to increases in astrocytic Ca 2+ concentration in response to neuronal activity
(D'Ascenzo et al., 2007).

We hypothesized that the activity-dependent decrease in

mitochondrial mobility in astrocytes might be secondary to activation of mGluR5
receptors. Slices were treated with the mGluR5 antagonist (MPEP; 5 μM) for 15 minutes
prior to imaging. Inhibition of mGluR5 did not change the percentage of mitochondria
that were mobile relative to untreated controls (13 ± 3%, n=12 vs 13 ± 2%, n=9). In
another set of experiments, we asked whether activation of mGluR5 receptors is
sufficient to decrease mitochondrial mobility. Slices were pre-treated with TTX (1 μM)
prior to the addition of DHPG (50 μM).

Addition of the mGluR5 agonist did not

significantly decrease the TTX-induced increase in mitochondrial mobility (45 ± 7%, n=4
vs. 36 ± 8%, n=6).

Together, these results suggest that mitochondrial mobility in

astrocytes is not controlled by mGluR5 activation.
Glutamate transport regulates the percentage of mobile mitochondria in astrocytes
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Synaptic glutamate concentrations are kept low (approx 25 nM) via the actions of
the Na+-dependent glutamate transporters in astrocytes, particularly GLT-1 and GLAST
(Herman and Jahr, 2007). Glutamate transporter activity results in the activation of the
Na+/K+-ATPase, glycolysis (Pellerin and Magistretti, 1994) and oxidative phosphorylation
(Loaiza et al., 2003). We tested whether glutamate uptake influenced mitochondrial
mobility in astrocytes by inhibiting glutamate uptake with TFB-TBOA (3 μM) (Shimamoto
et al., 2004). Similar to the effects of TTX, inhibition of glutamate uptake resulted in a
more than 3-fold increase in the percentage of mitochondria that were mobile relative to
untreated controls (Figure 3.5C). Treatment with TFB-TBOA did not alter either the rate
of mitochondrial movement (Figure 3.5D) or the proportion of mitochondria moving in the
anterograde vs. retrograde directions.

We also asked whether activation of the

transporters is sufficient to decrease mitochondrial mobility.

We inhibited neuronal

activity with TTX (1 μM; 15 min) prior to addition of the transporter substrate D-aspartate
(1 or 10 mM).

Treatment with TTX (Figure 3.5E) increased the percentage of

mitochondria that were mobile relative to untreated controls. Application of D-aspartate
to TTX-treated slices decreased the percentage of mitochondria that were mobile in a
concentration-dependent manner relative to TTX-treated controls (Figure 3.5E).
Combined, these results demonstrate that glutamate (aspartate) uptake into astrocytes
regulates the mobility of mitochondria in astrocytes.
Glutamate transport results in a significant increase in intracellular [Na +] (Rose
and Ransom, 1996) and stimulates Na+/K+-ATPase activity (Pellerin and Magistretti,
1994). It is unsurprising, therefore, that the Na +/K+-ATPase physically interacts with both
GLT-1 and GLAST (Rose et al., 2009; Genda et al., 2011). Activation of Na+/K+-ATPase
decreases mitochondrial mobility at the nodes of Ranvier in sciatic nerves (Zhang et al.,
2010). Given this, we tested whether an inhibitor of Na +/K+-ATPase activity (ouabain)
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would influence mitochondrial mobility in astrocytes. Astrocytes possess two isoforms of
the Na+/K+-ATPase α subunits (α1 and α2) (Juhaszova and Blaustein, 1997). These
subunits possess different sensitivities to ouabain; α2 is inhibited at nM concentrations,
while the α1 isoform is inhibited at concentrations above 10 μM (Juhaszova and
Blaustein, 1997; Pellerin and Magistretti, 1997). We treated slice cultures with either
100 nM or 100 μM ouabain for 15 minutes prior to the start of imaging. Treatment with
100 μM ouabain resulted in a significant increase in the percentage of mitochondria that
were mobile in astrocytes (Figure 3.5F).
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Figure 3.5. Glutamate transport and Na+K+-ATPase activation regulate mitochondrial mobility in astrocytes.
Astrocytes in slice culture were transfected with mitoEGFP and GFA ABC1D-mcherry at 2 DIV and imaged at 4 DIV. (AE) Slices were continuously superfused with ACSF ± TFB-TBOA (3 μM) for 15 minutes prior to the initiation of
imaging and throughout the imaging period. Representative kymographs show the movement of mitochondria in
astrocytes in ACSF-treated (A) and TFB-TBOA-treated (B) slices over a 15 min period (time increases down the
page). In these kymographs, stationary mitochondria are seen as straight lines and moving mitochondria as diagonal
lines. Scale bar, 10 μm. (C). Histogram shows the mean percent of mitochondria that were mobile. **p<0.005 by
unpaired Student’s t-test. (D). Histogram depicts the mean maximal instantaneous velocity of individual astrocytic
mitochondria in control (open) and TFB-TBOA-treated (gray) slices. (E) Histogram depicts the effect of treatment
with TTX ± D-aspartate on the percentage of mobile mitochondria. Slices were treated with ACSF ± TTX for 15 min at
which point D-aspartate (1 or 10 mM) was applied to TTX-treated slices. (F) Histogram depicts the effects of ouabain
(100 nM or 100 μM) on the percentage of mobile mitochondria in astrocytes. Results are mean ± SEM. *p<0.05;
**p<0.005 by ANOVA with Bonferroni’s multiple comparisons test.
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Reversed Na+-Ca2+ exchange regulates mitochondrial mobility
The bidirectional Na+/Ca2+ exchanger (NCX) normally couples the inward
movement of 3 Na+ ions to the
outward movement of one Ca2+ ion
(Blaustein and Lederer, 1999). In
astrocytes, activation of glutamate
transport

activates

the

reverse

mode of the NCX subsequent to
Na+ entry, resulting in an increase
in intracellular [Ca2+] (Rojas et al.,
2013; Magi et al., 2013). We tested
the hypothesis that reversal of the
NCX contributes to immobilization
of mitochondria in astrocytes.

We

treated hippocampal slice cultures
with

two

structurally

dissimilar

inhibitors of the reverse mode of
the NCX (Na+ efflux/ Ca2+ influx) for
15 minutes prior to the start of
imaging.

At concentrations that

selectively block the reversed mode
operation of NCX, while minimally
affecting normal inward flux of Na+,
KB-R7943 (15 μM) or YM-244769
(1 μM) increased the percentage of

Figure 3.6. Mitochondrial mobility in astrocytes is increased
by inhibition of the reverse-mode operation of the Na+/Ca2+
exchanger. (A-D) Slices were continuously superfused with
ACSF ± TTX (1 μM), KB-R7943 (15 μM), or YM-244769 (1 μM)
for 15 minutes prior to the initiation of imaging and throughout the
imaging period. Representative kymographs show the movement
of mitochondria in astrocytes treated with ACSF (A), TTX (B), KBR7943 (C), or YM-244769 (D) over a 15 min period (time
increases down the page). In these kymographs, stationary
mitochondria are seen as straight lines and moving mitochondria
as diagonal lines. Scale bar, 10 μm. (E) Histogram depicts the
percentage of mitochondria that were mobile following treatment.
Results are mean ± SEM. *p<0.05; **p<0.005 by ANOVA with
Bonferroni’s multiple comparisons test.
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mitochondria that were mobile within the processes of astrocytes to a similar degree to
TTX (1 μM; positive control) (Figure 3.6E). While KB-7943 also blocks NMDARs and
inhibits complex 1 of the mitochondrial electron transport chain, no such off-target effects
have been reported for YM-244769 (Brustovetsky et al., 2011; Clerc and Polster, 2012).
Thus, these results suggest that tonic activation of the reverse mode of the NCX is
contributing to mitochondrial immobilization in astrocytes.
Association of mitochondria with glutamate transporters
In neurons, the positioning of mitochondria at sites of heightened energy use
(presynaptic termini, post-synaptic spines, or nodes of Ranvier) or elevated [Ca2+] is
critical to maintain energy and Ca 2+ homeostasis. We tested whether the neuronal
activity-induced decreases in mitochondrial mobility in astrocytes were correlated with
the positioning/retention of mitochondria near glutamate transporters (GLT-1), where
demand would be predicted to be elevated.

GFA ABC1D-mCherry (Figure 3.7A) and

EGFP-mito (Figure 3.7B) transfected slices were treated with TTX (1 μM) or vehicle for
30 minutes. Slices were subsequently immunostained for VGLUT1 (Figure 3.7C) and
GLT-1 (Figure 3.7D).

mCherry fluorescence was used to construct a digital mask

allowing for the identification of GLT-1 puncta within individual astrocyte processes. In
an earlier study, we examined the overlap between mitochondria and exogenously
expressed GLT-1 tagged with a fluorescent epitope using the same system, except that
slices were not incubated with artificial CSF for 30 min at 34 o C (Genda et al., 2011). As
this approach results in over-expression of transporter that could influence the extent of
overlap between GLT-1 puncta and mitochondria, we first examined overlap of
endogenous GLT-1 with mitochondria. We find that 38 ± 6 % of GLT-1 puncta were
overlapped by a mitochondria and 64 ± 7 % of mitochondria were overlapped by GLT-1.
These values are somewhat lower than observed in the earlier study, but are indicative
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of substantial overlap between GLT-1 and mitochondria under these conditions. These
images were also used to compare the anatomic relationship of GLT-1 puncta,
mitochondria, and synapses (VGLUT+) in the presence and absence of TTX (Figure
3.7E).

The minimum distance between the centers of GLT-1 puncta and VGLUT1

(Figure 3.7F) and between mitochondria and GLT-1 puncta (Figure 3.7G) was measured
and expressed as a cumulative probability distribution. Interestingly, reducing neuronal
activity (TTX) did not change the relationship between GLT-1+ and VGLUT1+ puncta,
suggesting that GLT-1 remains near synapses in the presence of TTX.

However,

reducing neuronal activity decreased the probability (evident as a rightward shift in the
cumulative distribution) that mitochondria approach a GLT-1 puncta (i.e. increased
distance), suggesting that neuronal activity regulates the position of mitochondria
relative to GLT-1 (P < 0.0001). As mitochondria are quite long relative to the distances
being measured, we also examined the relationship between the edges of mitochondria
and GLT-1 puncta, as any overlap would presumably allow for functional coupling
between transporters and mitochondria. As was observed using the centers of the
particles, the cumulative probably plot revealed a significant difference in the presence
and absence of TTX (P = 0.02). In the presence of TTX, there was greater likelihood
that mitochondria were further from GLT-1 puncta (data not shown).
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Figure 3.7. Neuronal activity increases the probability that mitochondria appose GLT-1 in astrocytic
processes without affecting the relationship of GLT-1 to VGLUT1. Astrocytes were transfected with plasmids
encoding EGFPmito and a membrane-targeted mCherry fluorescent protein. Slices were treated in the absence or
presence of TTX (1 μM) for 30 minutes. Slices were fixed and subsequently immunostained with antibodies against
VGLUT1 and GLT-1. Representative images of an astrocyte process expressing GFA ABC1D-mCherry (A), and
EGFPmito (B), and immunostained for VGLUT1 (C) and GLT-1 (D). (E) Representative image depicting GLT-1 (red),
mitochondria (green) and VGLUT1+ (blue) puncta from the process depicted in (A-D). Cumulative probability
distributions depicting the distance between each GLT-1 and the nearest VGLUT1+ (F) puncta and between each
mitochondrion and the nearest GLT-1 puncta (G) in the absence (black boxes) and presence (red circles) of TTX.
***p<0.0001 by Kolmogorov-Smirnov test.
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3.4 Discussion
In neurons, mitochondria accumulate at sites of high activity and energetic
demand, including pre- and post-synaptic terminals (Li et al., 2004; Miller and Sheetz,
2004), growth cones (Morris and Hollenbeck, 1993), and nodes of Ranvier (Ohno et al.,
2011), where they provide local energetic support and regulate ionic homeostasis (for
review, see Schwarz, 2013). Mitochondria have been localized within the processes of
astrocytes (Lovatt et al., 2007; Ito et al., 2009, Lavialle et al., 2011) in close proximity to
glutamate transporters (Chaudhry et al., 1995; Genda et al., 2011). Here we describe
the mobility of mitochondria within the processes of astrocytes. In addition, we describe
a potential mechanism by which glutamate release from neurons is converted to
mitochondrial immobilization in astrocytes via glutamate uptake through the astrocytic
glutamate transporters, and reversed Na +-Ca2+ exchange.

Further, we show that

neuronal activity is associated with an increased probability that mitochondria approach
glutamate transporter clusters in the processes of astrocytes without changing the
relationship of GLT-1 puncta to VGLUT1 (synapses). Together, this work suggests a
mechanism by which mitochondria may be recruited to, or retained at, areas of high
GLT-1 expression that surround synapses.
Mitochondria in astrocyte processes
We used time-lapse imaging of mitochondria to examine mitochondrial
movement in neuronal and astrocytic processes. While mitochondria in neurons and
astrocytes displayed similar lengths, there were significant differences with regard to rate
of movement and the fraction mobile. Our findings in neurons are similar to that which
has been observed (fraction mobile, velocity, and size) (see MacAskill et al., 2010, for
review).

The difference between astrocytic and neuronal mitochondrial movement
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suggests that mitochondrial mobility in astrocytes might be regulated by different motor
proteins or move along different cytoskeletal elements. Indeed, the rates of movement
observed in astrocytes match those observed for short-range mitochondrial transport
along actin filaments (Morris and Hollenbeck, 1995).
In neurons, mitochondrial mobility has been linked to both the actin and
microtubule cytoskeleton. Long-range mitochondrial movement in neurons depends on
transport by kinesins (anterograde) and dynein (retrograde) motors along the
microtubule cytoskeleton (reviewed in Schwarz, 2013). Short range-movement along
actin fibers has been described (Morris and Hollenbeck, 1995; Ligon and Steward, 2000;
Hollenbeck, 2005).

We examined the movement of mitochondria in response to

treatment with inhibitors of actin and microtubule assembly. Our results suggest that, in
astrocytes (as in neurons), mitochondrial movement depends on both the actin and
microtubule cytoskeleton. It will be interesting to identify the motor proteins involved.
Anterograde transport along microtubules in neurons is mediated primarily by the kinesin
isoforms Kif5 and Kif1B (MacAskill and Kittler, 2010). The major kinesin isoforms in
astrocytes have yet to be determined, however KIF5A and C are thought to be neuronspecific motor proteins (Kanai et al., 2000).
Retention of mitochondria by neuronal activity.
Why move mitochondria? The coordinated transport of mitochondria along
cellular processes likely serves several functions. Firstly, movement of mitochondria
appears necessary for the distribution of mitochondria into cellular processes.
Mitochondria are primarily generated in the cell body and are transported in an
anterograde direction into the processes (reviewed in Schwarz, 2013). Conversely, the
observation that depolarized mitochondria move primarily in the retrograde direction has
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been used to suggest that dysfunctional mitochondria move toward the cell body for
repair/degradation (Frederick and Shaw, 2007). Secondly, movement of mitochondria
facilitates the processes of fusion and fission that allow the exchange of proteins and
genetic material between discreet mitochondria (Misko et al., 2010).

Lastly,

mitochondrial transport provides a mechanism for the redistribution of mitochondria to
sites of high activity (reviewed in MacAskill and Kittler, 2010; Schwarz, 2013).
In neurons, mitochondria are retained at sites of high activity and metabolic
demand (Li et al., 2004; Wang and Schwarz, 2009; Ohno et al., 2011). Neuronal activity
and glutamate receptor activation decrease mitochondrial mobility and cause
mitochondria to pause at synapses and at nodes of Ranvier in neurons. Astrocytes
sense neuronal activity (Halassa et al., 2007a), and much of their activity is devoted to
processes such as glutamate uptake that are integrated with neuronal activity (Parpura
and Verkhratsky, 2012).

We hypothesized that neuronal activity might influence

mitochondrial movement within astrocytic processes. Inhibition of neuronal activity with
TTX or ionotropic receptor antagonists increased the percentage of mitochondria that
were mobile in astrocytes.

While, astrocytes in vitro and in situ express multiple

isoforms of the voltage-dependent Na+ channel family (Sontheimer et al., 1994), the
observation that inhibition of ionotropic receptors (NMDARs, AMPARs, and GABARs)
also increased mitochondrial mobility suggests that this effect is mediated by neurons.
Additionally, our results also indicate that the increased mobility of mitochondria in TTXtreated slices is blocked by application of the transporter substrate D-aspartate (Figure
3.5).

Together, these results strongly suggest that mitochondrial mobility in astrocytes

is regulated by neuronal activity.
Astrocytes are the primary route of clearance for extracellular glutamate
(Danbolt, 2001). Glutamate transport and concomitant activation of the Na +/K+-ATPase
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represent a substantial energetic demand on astrocytes (Hertz et al., 2007).

We

hypothesized that glutamate uptake might influence astrocytic mitochondrial mobility.
Our results suggest that neuronal activity regulates astrocytic mitochondrial mobility via
activation of glutamate transporters.

It remains to be determined whether this

immobilization is a result of the glutamate transport cycle, or is subsequent to another
process, such as activation of the Na +/K+-ATPase. Although inhibition of the Na +/K+ATPase decreased the percentage of mitochondria that were mobile in astrocytes
(Figure 3.5G), there are at least three possible explanations for this result. First, it is
possible the effects of ouabain are related to the spreading depression that ouabain
induces via the neuronal Na+/K+-ATPase isoforms (Balestrino et al., 1999). Second,
ouabain is also known to inhibit glutamate uptake (Li and Stys, 2001; Rose et al., 2009).
Finally, it is possible that activation of the Na +/K+ ATPase is required for mitochondrial
immobilization in astrocytes. Although Zhang et al., 2010, favored this later mechanism
to explain docking of mitochondria near nodes of Ranvier, we cannot discriminate
between these possibilities in the current study.
Several mechanisms contribute to the immobilization of mitochondria in neurons
in response to increased activity. Increases in [ADP] result in decreased mitochondrial
transport (Mironov, 2007). Additionally, increases in intracellular [Ca2+] subsequent to
NMDAR activation stop mitochondria at the base of dendritic spines (Li et al., 2004;
Wang and Schwarz, 2009). As increases in neuronal activity activate mGluR5 receptors
in astrocytes (D'Ascenzo et al., 2007), we tested whether activation of mGluR5
contributed to the neuronal activity dependent immobilization of mitochondria in
astrocytes.

Surprisingly, neither activation nor inhibition of mGluR5 altered

mitochondrial mobility. However, selective inhibition of the reverse mode of Na +-Ca2+
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exchange increased the percentage of mobile mitochondria, suggesting that increases in
[Ca2+]i via the NCX might contribute to the immobilization of mitochondria in astrocytes.
Why move mitochondria to sites of glutamate transport?

Mitochondria play

important roles in a variety of processes, including ATP production, ionic buffering, and
glutamate oxidation.
processes.

Glutamate uptake has been coupled to all three of these

For example, glutamate uptake increases astrocytic glycogen utilization

(Swanson, 1992), glycolysis (Pellerin and Magistretti, 1994), and oxygen consumption
(Eriksson et al., 1995). Glutamate uptake is coupled to an increase in mitochondrial Na+
concentration (Bernardinelli et al., 2006) and accompanied by rapid mitochondrial
acidification (Azarias et al., 2011). These studies imply that mitochondria buffer the ionic
changes associated with transporter function. Mitochondria also play a critical role in
glutamate metabolism (reviewed in Dienel, 2013).

Upon import into astrocytes,

glutamate can either be converted to glutamine via glutamine synthetase or oxidized to
mitochondrial TCA cycle intermediates (Yudkoff et al., 1988). In brain, most glutamate
oxidation is thought to occur in astrocytes (Hertz et al., 1988; Waagepetersen et al.,
2002). In fact the fraction of glutamate that is oxidized increases disproportionately with
increasing extracellular glutamate (McKenna et al., 1996; Yu et al., 1982). The oxidation
of glutamate by mitochondria may fuel glutamate uptake by providing the ATP necessary
for Na+ extrusion (Whitelaw and Robinson, 2013; Peng et al., 2001; reviewed in Dienel,
2013). All of these functions would be supported by the immobilization of mitochondria
near sites of glutamate uptake.

The development of tools to selectively block the

docking of mitochondria in astrocytes will be necessary to test the functional significance
of mitochondrial immobilization.
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Here, we provide the first description of mitochondrial mobility in the processes of
astrocytes. Mitochondrial mobility is regulated by neuronal activity, glutamate transport,
and Na+-Ca2+ exchange. Further, neuronal activity regulates the retention/accumulation
of mitochondria at sites enriched in glutamate transporters that are apposed to
synapses.

The transport of mitochondria within astrocytes likely influences, and is

influenced, by other aspects of astrocyte biology. Future experiments will be necessary
to examine whether other processes influence mitochondrial function in astrocytes, to
determine which motors are responsible for their movement, and to determine why and
how the mitochondria are kept stationary.
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Abstract
Recently, mitochondria have been localized to astrocytic processes where they
shape Ca2+ signaling; this relationship has not been examined in models of
ischemia/reperfusion. We biolistically transfected astrocytes in rat hippocampal slice
cultures to facilitate fluorescent confocal microscopy, and subjected these slices to
transient oxygen/glucose deprivation (OGD) that causes delayed excitotoxic death of
CA1 pyramidal neurons.
astrocytic

processes

and

This insult caused a delayed loss of mitochondria from
increased

autophagosome marker LC3B.

co-localization

of

mitochondria

with

the

The losses of neurons in CA1 and mitochondria in

astrocytic processes were blocked by iGluR antagonists, tetrodotoxin, ziconotide (Ca 2+
channel blocker), two inhibitors of reversed Na +/Ca2+ exchange (KB-R7943, YM244769), or two inhibitors of calcineurin (cyclosporin-A, FK506). The effects of OGD
were

mimicked

by

NMDA.

The

glutamate

uptake

(trifluoromethyl)benzoyl]amino]phenyl]methoxy]-L-aspartate

inhibitor

(3S)-3-[[3-[[4-

(TFB-TBOA)

increased

neuronal loss after OGD or NMDA, and blocked the loss of astrocytic mitochondria.
Exogenous glutamate in the presence of iGluR antagonists caused a loss of
mitochondria without a decrease in neurons in area CA1.

Using the genetic Ca 2+

indicator Lck-GCaMP-6S, we observed two types of Ca 2+ signals: 1) in the cytoplasm
surrounding mitochondria (‘mitochondrially-centered’) and 2) traversing the space
between mitochondria (‘extra-mitochondrial’).

The spatial spread, kinetics, and

frequency of these events were different. The amplitude of both types was doubled and
the spread of both types changed by ~2-fold 24 hrs after OGD. Together, these data
suggest that pathologic activation of glutamate transport and increased astrocytic Ca 2+
through reversed Na+/Ca2+ exchange triggers mitochondrial loss and dramatic increases
in Ca2+ signaling in astrocytic processes.
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Significance Statement
Astrocytes, the most abundant cell type in the brain, are vital integrators of
signaling and metabolism. Each astrocyte consists of many long, thin branches, called
processes, that ensheathe vasculature and thousands of synapses. The majority of
each process is occupied by mitochondria.

This occupancy is decreased by

approximately 50% 24 hrs after an in vitro model of ischemia/reperfusion injury, due to
delayed fragmentation and mitophagy. The mechanism appears to be independent of
neuropathology, instead involving an extended period of high glutamate uptake into
astrocytes. Our data suggest that mitochondria serve as spatial buffers, and possibly
even a source of calcium signals in astrocytic processes. Loss of mitochondria resulted
in drastically altered calcium signaling that could disrupt neurovascular coupling and
gliotransmission.
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4.1 Introduction
Recent studies have shown that mitochondria are found throughout the fine
processes of astrocytes (Lovatt et al., 2007; Genda et al., 2011; Lavialle et al., 2011;
Jackson et al., 2014; Derouiche et al., 2015; Jackson and Robinson, 2015; Stephen et
al., 2015; for review, see Robinson and Jackson, 2016). As is observed in neurons and
other cells, positioning of mitochondria reflects local energy demands and ion buffering
(for reviews, see Frederick and Shaw, 2007; Sheng and Cai, 2012; Schwarz, 2013).
Neuronal activity and Ca2+ influx immobilize mitochondria in astrocytic processes near
clusters of the glutamate transporter GLT-1 that appose synapses (Jackson et al., 2014;
Stephen et al., 2015). Immobilization is facilitated by Ca 2+ binding to motor adaptor
proteins (Miro1 and Miro2), and mitochondria shape Ca 2+ signals in astrocytic processes
(Jackson and Robinson, 2015; Stephen et al., 2015).
Cerebral ischemia/reperfusion (I/R) injury, as occurs with traumatic brain injury,
cardiac arrest, or stroke, is followed by a delayed period of secondary pathology that is
self-propagating and progressive. It involves excitotoxic and inflammatory mechanisms
and can last for weeks after the initial insult (for reviews, see Choi and Rothman, 1990;
Lipton, 1999; Borgens and Liu-Snyder, 2012). This secondary pathology is currently
untreatable.

Although neuron-targeted approaches (e.g. blocking ionotropic glutamate

receptors or their downstream effectors) attenuated damage in preclinical models of I/R
injury, they failed in clinical trials (Liebeskind and Kasner, 2001; Muir, 2006). Astrocytes
are much more resilient to this type of injury and may play an important role in the
damage observed (for reviews, see Chen and Swanson, 2003; Rossi et al., 2007;
Barreto et al., 2011).

In fact, targeting the SNARE pathway, stimulating purinergic

receptors, or manipulating microRNAs in astrocytes all reduce damage in models of
stroke (Hines and Haydon, 2013; Zheng et al., 2013; Ouyang et al., 2014).
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Although astrocytic mitochondria have been studied in the context of I/R injury,
previous work focused mainly on the reticular mitochondria found in cell bodies of
dissociated astrocytic cultures (Bambrick et al., 2004; Dugan and Kim-Han, 2004;
Ouyang et al., 2011, 2012a). Few studies have focused on mitochondria in the fine
astrocytic processes or their role in disease. One such study using electron microscopy
in cortical sections after middle cerebral artery occlusion in gerbils reported signs of
degenerated astrocytic processes and mitochondria near the infarct, correlating with the
progression of neuropathology (Ito et al., 2009). More recently, a study utilizing cortical
stab wound in mice revealed transient, inflammation-induced fragmentation of
mitochondria in the processes of astrocytes adjacent to the injury site. Recovery of
mitochondrial fission/fusion balance required mitophagy (Motori et al., 2013).
Here we present the first evidence that transient oxygen/glucose deprivation
(OGD) results in delayed fragmentation and autophagic degradation of mitochondria in
astrocytic processes.

These effects are blocked by ionotropic glutamate receptor

antagonists, by inhibitors of action potential propagation, vesicular neurotransmitter
release, glutamate transport, or reversal of Na+/Ca2+ exchangers, and by two different
molecules that prevent Ca2+-induced mitochondrial depolarization in astrocytes. The
effects of OGD are mimicked by NMDA. The effects on astrocytic mitochondria are also
mimicked by exogenous glutamate in the presence of iGluR antagonists that block any
glutamate-induced loss of CA1 neurons.

We also demonstrate that spontaneous

cytosolic Ca2+ signaling is dramatically increased 24 hrs after this transient insult.

This

loss of mitochondria and increase in Ca 2+ signaling likely alters various astrocytic
functions including glutamate metabolism, gliotransmitter release, and neurovascular
coupling, all of which are important during recovery after I/R.
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4.2 Materials and Methods
cDNA constructs.

We have used Mito-EGFP, gfap-gap43-mcherry, gfap-

DsRed2-mito, and Lck-GCaMP-6S that are described in previous publications (Jackson
et al., 2014; Jackson and Robinson, 2015). Mito-EGFP (also called pEGFP-mito; a gift
from Dr. Stanley Thayer, University of Minnesota, Minneapolis) is a fusion of the
mitochondrial matrix targeting sequence from CoxVIII with EGFP, and has been shown
to result in specific targeting of EGFP into mitochondria (Rizzuto et al., 1993; Wang et
al., 2003).

gfap-gap43-mcherry (also called pTY-GfaABC1D-gap43mCherry) was

generated by insertion of the membrane-targeting palmitoylation sequence of gap43 into
pTYGfaABC1D-mCherry (a gift from Dr. John Wolfe, University of Pennsylvania). gfapDsRed2-mito (also called pGFAABC1D:DsRed2mito) was generated by replacing the CMV
promoter of pDsRed2-mito (Clontech, Cat# 632421) with the minimal GFAP promoter
(GFAABC1D) from gfap-gap43-mcherry. Lck-GCaMP-6S was generated by transferring
the Lck-derived membrane-tethering domain from Lck-GCaMP-5G (a gift from Baljit
Khakh; Addgene plasmid # 34924; Akerboom et al., 2012) in-frame with GCaMP-6s (a
gift from Douglas Kim; Addgene plasmid # 40753; Chen et al., 2013). EGFP-LC3B (also
called pEGFP-LC3; human) was obtained from Addgene (plasmid # 24920) and was
originally a gift from Toren Finkel (Lee et al., 2008).
Reagents. Bafilomycin A1 (BfA) from Streptomyces griseus (Cat# B1793), FK506 monohydrate (Cat# F4679), ziconotide (ω-conotoxin MVIIA; Cat# C1182), and Lglutamic acid (Cat# G1251) were purchased from Sigma-Aldrich. Tetrodotoxin (TTX)
was purchased from Alomone Labs (Cat# T-550). Cyclosporin A (CsA; Cat# 1101),
(5S,10R)-(+)-5-Methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine
(MK801;

Cat#

0924),

maleate

2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-

sulfonamide disodium salt (NBQX; Cat# 1044), N-Methyl-D-aspartic acid (NMDA; Cat#
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0114),

(3S)-3-[[3-[[4-(Trifluoromethyl)benzoyl]amino]phenyl]methoxy]-L-aspartic

acid

(TFB-TBOA; Cat# 2532), 2-[2-[4-(4-Nitrobenzyloxy)phenyl]ethyl]isothiourea mesylate
(KB-R7943;

Cat#

1244),

and

N-[(3-Aminophenyl)methyl]-6-[4-[(3-

fluorophenyl)methoxy]phenoxy]-3-pyridinecarboxamide

dihydrochloride

(YM-244769;

Cat# 4544) were purchased from Tocris Bioscience.
Hippocampal slice cultures and biolistic transfection. Organotypic hippocampal
slices were cultured based on the method of Stoppini et al., 1991, as previously
described (Genda et al., 2011a; Jackson et al., 2014). Following decapitation of rat pups
(p6-8) of either sex, brains were removed and immediately placed in ice-cold sucrosesupplemented artificial cerebrospinal fluid (ACSF) containing (in mM): 280 sucrose, 5
KCl, 2 MgCl2, 1 CaCl2, 20 glucose, and 10 HEPES, at a pH of 7.3. Hippocampi were
dissected on ice and cut into coronal sections 300 µm thick using a Mcilwain tissue
chopper. Slices were then transferred onto Millicell membrane inserts (EMD Millipore,
Cat# PICM0RG50) in six-well plates atop 1 ml of media consisting of 50% Neurobasal
medium (containing 25 mM glucose and 10 mM HEPES; Gibco, Cat# 21103-049), 25%
horse serum, 25% HBSS, supplemented with 10 mM HEPES, 36 mM glucose, 2 mM
glutamine, 10 U/ml penicillin, 100 µg/ml streptomycin, and Gem21 Neuroplex (1:50
dilution from 50x stock; Gemini, Cat# 400-160), at a pH of 7.3. Slice cultures were
maintained in an incubator at 37°C with 5% CO2.
At 2 DIV, slices were fed (350 µl of media was replaced with 350 µl of fresh
media), and biolistically transfected with cDNAs encoding fluorophores relevant to each
experiment. Biolistic transfection was performed as described previously (Genda et al.,
2011a; Jackson et al., 2014) using the Helios Gene Gun System (Bio-Rad, Cat#
1652431; a generous gift from Dr. Rita Balice-Gordon), in which compressed helium
fires cDNA-coated gold particles into slices, resulting in a sparse transfection pattern
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ideal for imaging individual cells in a slice culture. Using 1 µm diameter gold particles
results in preferential transfection of astrocytes (Benediktsson et al., 2005; Genda et al.,
2011a), and additional astrocyte selectivity was achieved by including one construct
driven by a minimal gfap promoter in each experiment (de Leeuw et al., 2006). At 4 DIV,
inserts were transferred to 1 ml “serum-free” media consisting of Neurobasal-A medium
(containing 25 mM glucose and 10 mM HEPES; Gibco, Cat# 10888-022) supplemented
with 2 mM GlutaMAX (Gibco, Cat# 35050-061), 10 U/ml penicillin, 100 µg/ml
streptomycin, and Gem21 Neuroplex, at a pH of 7.3. Slice cultures were maintained in
an incubator at 37°C with 5% CO2, and fed every other day (350 µl of media replaced).
Experiments were performed at 14-18 DIV, when synapse formation and NMDAR
subunit expression have reached a developmental stage sufficient to sensitize the slice
to excitotoxic injury (Ahlgren et al., 2011), and several weeks before the emergence of
spontaneous epileptiform activity (Albus et al., 2013).
Oxygen/glucose deprivation (OGD) injury.

Two to four days before each

experiment, slice cultures were screened on a Nikon Eclipse TS100 microscope by
brightfield transmission for vitality (Trumbeckaite et al., 2013) and epifluorescence for
transfection quality. Several criteria were used to exclude slices, including a lack of
clear cell body layers containing dentate granule cells or pyramidal cells, darkening of
area CA1, discrete areas of cell loss, disconnection between layers of hippocampus, or
an insufficient number of transfected astrocytes in stratum radiatum. Variable spreading
of slice cultures was observed during the 14-18 DIV, therefore cultures were randomly
assigned to different groups. One day before each experiment, serum-free OGD media
with no pyruvate and equimolar replacement of glucose with non-metabolizable 2deoxyglucose (specialty Neurobasal-A medium (no glucose, no pyruvate, 10 mM
HEPES; Gibco, Cat# A24775-01) supplemented with 25 mM 2-deoxyglucose, 2 mM
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GlutaMAX (Gibco, Cat# 35050-061), 10 U/ml penicillin, 100 µg/ml streptomycin, and
Gem21 Neuroplex, at a pH of 7.3) was distributed onto six-well plates (4 ml / well) and
placed in a modular hypoxia chamber (Billups-Rothenberg Inc.; Cat# MIC-101). The
chamber/media was pre-equilibrated with 95% N2 / 5% CO2 at 37°C overnight.
On the day of the experiment, all slices were rinsed and then pre-equilibrated in
an incubator at 37o C and 5% CO2 for 30 min in fresh serum free media containing
glucose ± drugs.

Drug treatment concentrations were as follows: BfA (50 nM), MK801

(10 µM), NBQX (20 µM), TFB-TBOA (3 µM), TTX (1 µM), Ziconotide (0.5 µM), KBR7943 (15 µM), YM-244769 (1 µM), CsA (10 µM), FK506 (10 µM). These slices were
then rinsed in either OGD or glucose-containing media ± drug(s). Some slices were
moved back to the media used for pre-equilibration (controls).

The remainder of the

slices were submerged in OGD media (4 mL) ± drug and placed in the hypoxia chamber
which was charged with 95% N2 / 5% CO2 for 5 min at 2 psi, sealed, and placed at 37°C
for 30 min.

Slices treated with NMDA were submerged in glucose-containing media

with 10 or 100 µM NMDA and returned to the culture incubator for 30 min. Slices were
submerged in glucose-containing media with iGluR antagonists (10 µM MK801 + 20 µM
NBQX) in the presence or absence of 1 mM L-glutamate for different periods of time in
an incubator. After the insult (OGD, NMDA, or glutamate), the slices were rinsed twice
in serum free media containing glucose ± drugs and then returned to the media used for
pre-equilibration. They were then maintained in an incubator at 37 o C and 5% CO2 for
up to 24 hrs. For experiments involving fixation, slices were rinsed in PBS, submerged
in 4% paraformaldehyde in PBS for 10 min, rinsed again in PBS, and then stored in PBS
in the dark at 4°C.

Slices were cut out and mounted on slides with the transwell

membrane against the slide and the slice against coverslip using Vectashield Antifade
Mounting Medium with DAPI (Vector Laboratories; Cat# H-1200).
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Fixed imaging and analyses.

All images were acquired using an Olympus

Fluoview 1000 laser scanning confocal microscope equipped with 10x and 40x
UPlanApo objectives (numerical aperture 0.4 and 1.3, respectively). All images were
processed and analyzed using freely available FIJI/ImageJ software (Schindelin et al.,
2012).
DAPI image stacks were acquired from area CA1 using the 10x objective and
405 nm laser for the entire thickness of the stained slice with a 5 µm step size and 512 x
512 pixels/section. Image processing consisted of automated background subtraction
(rolling ball algorithm, 50 pixel radius), maximum z-projection, and conversion to binary
masks.

After processing, images were copied and assigned randomized numeric

filenames for blinded analysis.

DAPI area in the neuronal cell body layer of CA1,

stratum pyramidale, was quantified using a standardized rectangular region of interest
(ROI), displayed in Fig. 4.1A and B. All groups were included in at least 3 experiments,
with slice cultures prepared from at least 3 separate animals. Each slice was considered
an n of 1 (2-4 slices/group/experiment).
Images of mitochondrially-targeted EGFP (mito-EGFP) and minimal-gfappromoter-driven,

plasma-membrane-targeted

mcherry

(gfap-gap43-mcherry)

were

acquired from stratum radiatum and pyramidale in area CA1 using the 40x objective with
488 and 546 nm lasers, respectively. Obviously hypertrophic astrocytes were rarely
observed during the 24 hrs after insult, and were therefore excluded to avoid
confounding the analysis by sampling a heterogeneous population.

Image stacks

spanned the depth of each astrocyte with a step size of 1 µm, at 800 x 800
pixels/section. Image processing of both channels consisted of automated background
subtraction and maximum z-projection, and the mitochondrial channel was converted to
a binary mask for cleaner quantification of length and number. After processing, images
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were copied and assigned randomized numeric filenames for blinded analysis.
Channels from the same image received the same randomized numeric filename along
with a channel identifier. Linear ROIs were traced along three separate processes from
distal tip, back through tertiary and secondary branches, and through the primary
process to the edge of the soma in the plasma membrane channel (gfap-gap43mcherry). These ROIs were then transferred to the mitochondrial channel (mito-EGFP),
where they were used to measure the length of the process, the number of
mitochondria, and the lengths of the mitochondria. These values were used to calculate
the mean number of mitochondria, length of mitochondria, and % occupancy (% of the
process occupied by mitochondria) for each astrocyte. All groups were included in at
least 3 experiments, with slice cultures prepared from at least 3 separate animals. Each
slice was considered an n of 1 (2-4 slices/group/experiment, 2 astrocytes/slice, 3
processes/astrocyte).
The microtubule-associated protein LC3B is incorporated into autophagosomes
during their formation, and as such it is a widely used marker for these structures
(Tanida et al., 2008; Maday et al., 2012).

Slices were treated with BfA to inhibit

lysosomal maturation and allow for detection of cumulative mitophagy in fixed slices 9
and 24 hrs after OGD (for review see Dröse and Altendorf, 1997). Images of EGFPtagged LC3B (EGFP-LC3B) and minimal-gfap-promoter-driven, mitochondrially-targeted
DsRed2 (gfap-DsRed2-mito) were acquired from area CA1 using the 40x objective with
488 and 546 nm lasers, respectively. Hypertrophic reactive astrocytes were avoided.
Image stacks spanned the depth of each astrocyte with a step size of 1 µm, at 800 x 800
pixels/section.

Exogenous EGFP-LC3B expression appeared as a bimodal signal due

to a diffuse, low intensity, cytosolic fluorescence, and the higher intensity, punctate
fluorescence from autophagosomes.

To filter out the diffuse cytosolic signal, FIJI’s
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“Minimum” thresholding method was used to generate binary masks for the LC3B
channel (EGFP-LC3B). The mitochondrial channel (gfap-DsRed2-mito) was converted
to a binary mask using the “default” thresholding method.

The “Analyze Particles”

function was then used for each channel to filter out particles smaller than 0.1 µm 2. The
“AND” function of the Image Calculator was used to create a new z-stack containing only
the points in each z plane that were occupied by both mitochondria and LC3B. Analyze
Particles was then used to measure the surface area of the particles in each plane of the
new colocalization z-stack, as well as the mitochondrial z-stack.

By measuring

colocalization area in each plane, we avoid false positives from particles that are close in
the x/y dimension, but separated by several µm in the z dimension. Colocalization area
was normalized to total mitochondrial area in each plane, and mean values from all
planes were calculated for each astrocyte.

All groups were included in at least 3

experiments, with slice cultures prepared from at least 3 separate animals. Each slice
was considered an n of 1 (2-4 slices/group/experiment, 2 astrocytes/slice).
Live calcium imaging. Live recordings of the plasma-membrane-targeted genetic
calcium sensor Lck-GCaMP-6S and minimal-gfap-promoter-driven, mitochondriallytargeted DsRed2 (gfap-DsRed2-mito) in distal astrocytic processes were acquired using
the 40x objective (and 4-5x digital zoom) with 488 and 546 nm lasers, respectively.
Hypertrophic reactive astrocytes were avoided. Twenty-four hours after injury, slices
were excised from membrane inserts with a scalpel and placed face-down on a coverslip
at the bottom of a flow-through chamber in the microscope stage.

The slice was

submerged in ACSF (in mM: 130 NaCl, 3 KCl, 1.25 NaH 2PO4, 26 NaHCO3, 10 glucose,
1 MgCl2, 2 CaCl2; pH 7.3), constantly bubbled with 95%O 2 / 5%CO2 and heated to 35°C,
and continuously flowing at 1-2 ml/min. Ten minute recordings were acquired from a
single z-plane at 512 x 512 pixels/frame with a digital zoom (4-5x) sufficient to achieve a
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sampling rate of 1 Hz. Recordings were excluded from analysis if the process drifted out
of frame or out of the z-plane. In FIJI, automated background and noise (despeckle
median filter) subtraction were performed for each channel of the image time-stack, and
then the channels were merged to perform rigid alignment (StackReg plugin) to correct
for lateral drift during the recording period. After alignment, channels were split again,
and copies of the files were assigned randomized numeric filenames for blinded
analysis. An ROI was traced along the process using the segmented line tool, and the
“Stack Profile Data” plugin (Ver. 1.0, 24-Sep-2010, Michael Schmid) was used to
generate an Excel table of intensity values for each pixel along the ROI, with each frame
as a column. Each pixel was then converted to ΔF/F0 to generate a new table by first
subtracting and then dividing by the mean of all pixels throughout the recording (F0).
Conversion to ΔF/F0 helps to isolate signal and allow comparison between separate
recordings in which raw fluorescence intensities can vary greatly.

Spatial zones of

activity, defined as areas in which ΔF/F0 was >0, were identified. Spikes were identified
within zones of activity as spans of time in which the ΔF/F0 was greater than the mean
ΔF/F0 minus the standard deviation within that zone of activity. In zones of activity
containing large-spread extra-mitochondrial spikes overlapping smaller mitochondriallycentered Ca2+ events, the extra-mitochondrial spikes were isolated by only including
times at which the spread was greater than one standard deviation above the mean.
Mean values for ΔF/F0, spread (µm), duration (sec), and frequency (spikes/min)
were calculated for each zone of activity. Zones of activity were classified as either
mitochondrially-centered (overlapping and contacting only one mitochondrion) or extramitochondrial (traversing extra-mitochondrial space, and contacting two or more
mitochondria), and means were calculated for each category for each recording.

A

single process from each slice was examined and considered an n of 1. Recordings
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were acquired on four separate days and from slices prepared from at least four
separate animals for each group.
Statistical analyses. Values reported in the Results section are mean ± SEM,
unless otherwise noted. All statistical analyses were performed using Graph Pad Prism
6. Means were compared by Student’s t-test for two groups, or one-way ANOVA with
Bonferroni correction for multiple comparisons when comparing more than two groups.
To test for assumptions of normality and equal variance we used the KolmogorovSmirnov and Brown-Forsythe tests, respectively. Data from one control slice (Fig. 4.6)
were excluded because high mito-EGFP expression masked small spaces between
mitochondria, leading to mitochondrial lengths greater than two standard deviations
above the mean. To test for differences between the likelihoods of extra-mitochondrial
spikes being confined between two mitochondria, contingency tables were constructed
and pairs of groups were compared by Fisher’s exact test, with Bonferroni correction
applied to calculated p values. Fluorescence traces (Fig. 4.8A, B) were constructed in
Origin software (Microcal) for display purposes only.

4.3 Results
Astrocytes in organotypic hippocampal slice cultures maintain the highly
branched morphologies that are observed in vivo (Benediktsson et al., 2005). Using this
system, we and others have shown that mitochondria are found throughout processes,
~20 to 40% are mobile, they are immobilized near clusters of GLT1 and synapses, and
they shape Ca2+ signaling (Jackson et al., 2014; Jackson and Robinson, 2015; Stephen
et al., 2015). These slice cultures are also widely used to study secondary pathology
after global I/R injury by utilizing transient oxygen/glucose deprivation (OGD) (Bonde et
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al., 2005; Noraberg et al., 2005; Ahlgren et al., 2011).

To date the effects of OGD on

mitochondria and Ca2+ signaling in astrocytic processes have not been examined. We
biolistically transfected astrocytes with fluorescent markers to achieve sparse labeling
that is ideal for imaging individual astrocytes and their processes.

In previous studies,

we used slices that were maintained in culture for only four days. In the present study,
the slices were maintained in culture for two weeks to develop sensitivity to excitotoxic
insults (Ahlgren et al., 2011).
Astrocytes were transfected with mitochondrially-targeted EGFP (Rizzuto et al.,
1995; for review, see Tsien, 1998) and palmitoylated mcherry under the control of the
minimal GFAP promoter.
(Jackson et al., 2014).

Under these conditions, astrocytes can be easily identified
These slices were subjected to 30 min of OGD and fixed at

various time points for subsequent imaging analysis. Unlike most assays for cell death,
the nuclear stain, DAPI, is compatible with paraformaldehyde fixation and its
excitation/emission spectra does not interfere with imaging of the fluorophores that are
used throughout this study (e.g. EGFP, mcherry, or DsRed2). It allows for quantification
of nuclear condensation and cell number to provide accurate measurement of cell
death/loss (Bonde et al., 2002; Lei et al., 2008; Rininger et al., 2012; Zhou et al., 2013;
Woeffler-Maucler et al., 2014), and is particularly useful in slice cultures containing
phagoctytic microglia that can clear away dead cells. As was previously observed, this
insult caused a delayed loss of neurons (Fig. 4.1), and this damage was selective for
area CA1 (not shown) (Bonde et al., 2005; Noraberg et al., 2005; Ahlgren et al., 2011).
Figures 4.1A & B provide representative examples of the effects of transient OGD on
DAPI staining in area CA1.

There was a significant reduction in cell density at 12, 18

and 24 hrs after OGD in stratum pyramidale, the neuronal cell body layer of CA1 (Fig.
4.1C; Bonferroni corrected p=0.0350 for Baseline (BL) vs. 12 hrs, p<0.0001 for BL vs. 18
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Figure 4.1. 30 min of OGD caused a delayed loss of cells from stratum pyramidale, the neuronal cell
body layer of CA1. Hippocampal slice cultures with astrocytes expressing mitochondrially-targeted EGFP and
plasma-membrane-targeted mcherry were fixed in 4% paraformaldehyde prior to, as well as 3, 9, 12, 18, and 24
hrs after a 30 min OGD injury, and stained with DAPI in mounting medium. Representative images of DAPI
staining in area CA1 at baseline and 24 hrs after OGD, with insets providing magnified views of the neuronal
cell body layer, stratum pyramidale (A, B). Mean DAPI area in stratum pyramidale expressed as a percentage
of baseline values from each individual experiment (C). All groups were included in at least 3 experiments, with
slice cultures prepared from at least 3 separate animals. n=6-12 slices/group (2-4 slices/group/experiment, 2
astrocytes/slice). Error bars indicate SEM. *p<0.05, ****p<0.0001 compared to baseline by one-way ANOVA
with Bonferroni correction for multiple comparisons. Mean values for Baseline (no insult / no incubation) and a
24 hr Control group (no insult / 24 hr incubation) were not different (not shown).

or 24 hrs; n=6-12 slices/group).

Cell density at 18 hrs was also significantly lower

compared to 3 or 9 hrs (Bonferroni corrected p=0.0001 or 0.0281 respectively; n=6-12
slices/group), and at 24 hrs cell density was significantly lower compared to slices fixed
3, 9, or 12 hrs after OGD (Bonferroni corrected p<0.0001, =0.0025, or =0.0396,
respectively; n=6-12 slices/group). While optimizing this injury model, we utilized the
cell-impermeable nucleic acid dyes propidium iodide or TO-PRO-3 to monitor cell death
in CA1, and observed a similar timecourse to that observed with the DAPI method (three
independent preliminary experiments; data not shown). These results strongly indicate a
delayed, time-dependent loss of CA1 pyramidal cells.
In the DAPI-stained slices, we examined the effects of OGD on mitochondria in
the processes of astrocytes in stratum radiatum and pyramidale. As observed by others,
we rarely found signs of reactive gliosis within 24 hrs of the insult (Ouyang et al., 2007),
and therefore we excluded the few cells that appeared obviously hypertrophic. In control
slices (Baseline), there were 5.1 ± 0.3 mitochondria per 50 µm with an average length of
7.2 ± 0.6 µm, occupying 62.7 ± 1.9 % of each astrocytic process (n=7-15 slices/group;
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Fig. 4.2A, D, E, F). These values are higher than what we observed previously (average
length ~3 µm and occupancy ~45%), perhaps due to the fact that we utilized younger
slice cultures and focused only on distal regions of processes in previous studies
(Genda et al., 2011a; Jackson et al., 2014). The numbers of mitochondria, the lengths
of the mitochondria, and the occupancy of processes by mitochondria were not
significantly different in slices 3 hrs after OGD when compared to baseline. By 9 hrs, the
number of mitochondria per 50 µm was increased by ~50% (Bonferroni-corrected
p<0.0001; n=7-15 slices/group), and the length of mitochondria was decreased by ~50%
(Bonferroni-corrected p=0.0010; n=7-15 slices/group), but the % of the process occupied
by mitochondria (% occupancy) remained unchanged relative to baseline (Fig. 4.2B, D,
E, F). The transient increase in the number of mitochondria concurrent with a decrease
in the size of mitochondria is frequently referred to as fragmentation; this process
generally precedes degradation (for reviews, see Itoh et al., 2013; Lemasters, 2014).
The mean length of mitochondria continued to decrease to less than half of the baseline
value by 24 hrs (Fig 4.2C, E). The number of mitochondria was no longer significantly
higher than baseline after 12 hrs, which is consistent with degradation of fragmented
mitochondria. Also consistent with degradation, the mean percentage of process length
occupied by mitochondria (referred to as % occupancy) was significantly reduced to 46.5
± 1.7% 12 hrs post OGD (Bonferroni-corrected p=0.0002; n=7-15 slices/group),
progressing to approximately half of that observed in controls (34.5 ± 2.6% occupancy)
by 24 hrs (Fig. 4.2C, F).

Scholl analysis of astrocyte morphology revealed mean

ramification index values ranging from 1.2 to 1.8, with no significant differences between
time points (one-way ANOVA p=0.80; n=4-8 cells per time point), indicating that the
complex morphology of astrocytic processes was maintained while mitochondria were
lost.
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Figure 4.2. 30 min of OGD caused delayed fragmentation and reduced occupancy of mitochondria in
astrocytic processes. The same slices used for analyses of DAPI (Fig. 1) were also used to analyze
mitochondria in astrocytic processes. Representative images of fluorescently labeled mitochondria (green) and
plasma membrane (red) in astrocytes fixed at baseline (A), the onset of mitochondrial fragmentation at 9 hrs (B),
and peak mitochondrial loss at 24 hrs after OGD (C). Insets provide magnified views of mitochondria in astrocytic
processes. Change in the mean number of mitochondria / 50 µm (D), length of mitochondria in µm (E), and %
occupancy of processes by mitochondria (F) during the 24 hr period following 30 min OGD injury. All groups were
included in at least 3 experiments, with slice cultures prepared from at least 3 separate animals. n=7-15
slices/group (2-4 slices/group/experiment, 2 astrocytes/slice, 3 processes/astrocyte). Error bars indicate SEM.
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 compared to baseline by one-way ANOVA with Bonferroni correction
for multiple comparisons. Mean values for Baseline (no insult / no incubation) and a 24 hr Control group (no insult /
24 hr incubation) were not different (not shown).
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Mitochondria are degraded through a specialized form of autophagy termed
mitophagy (Lemasters, 2005).

Colocalization of the autophagosome marker LC3B with

mitochondria provides a more selective measure of mitophagy compared to assays for
overall autophagy (Wong and Holzbaur, 2014). We co-transfected EGFP-tagged LC3B
with

mitochondrially-targeted

DsRed2

to

measure

colocalization

of

astrocytic

mitochondria and autophagosomes in individual planes of confocal image stacks (40x
objective; NA 1.3) (Fig. 4.3).

Confocal image stacks of astrocytes containing

fluorescently labeled autophagosomes (EGFP-LC3B; green) and mitochondria (gfapDsRed2-MITO; red) were compressed into two-dimensional images for display purposes
(Fig. 4.3A, B). In neurons, autophagosomes form around mitochondria in distal neurite
tips, and subsequent lysosomal cargo degradation occurs during retrograde transport to
the cell body (Maday et al., 2012). Since mitophagy is a transient process, we used
Bafilomycin-A1 (BfA), an inhibitor of the vacuolar H +-ATPase, to prevent maturation of
lysosomes (for review see Dröse and Altendorf, 1997) and allow for accumulation of the
mitophagy signal in processes and cell body. In control slices, BfA did not significantly
alter astrocytic mitochondria or reduce the density of DAPI-labeled cells for up to 24 hrs.
As is observed in neurons (Maday et al., 2012), we observed low levels of
LC3B/mitochondria colocalization in astrocytes in control slices, consistent with
constitutive low level mitophagy (Figure 4.3C).

At 9 hrs post OGD, when there is

evidence for mitochondrial fragmentation but preceding a decrease in occupancy (Fig.
4.2D, E, F), there is no evidence for increased co-localization of EGFP-tagged LC3B and
mitochondrial DsRed2 (Figure 4.3C).

However, at 24 hrs post OGD, when occupancy

was decreased to ~50% of control (Fig. 4.2F), we observed a significant accumulation of
mitochondria-containing autophagosomes in the cell body and out in processes (Fig.
4.3B, C).

This increased signal was not observed in the absence of BfA, providing
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evidence that the mitochondria-containing autophagosomes are degraded when
lysosomal maturation progresses normally.

Figure 4.3.
30 min OGD caused
delayed degradation of mitochondria
by mitophagy.
Hippocampal slice
cultures with astrocytes expressing
autophagosome-targeted EGFP (EGFPLC3B)
and
mitochondrially-targeted
DsRed2 (gfap-DsRed2-mito) were fixed in
4% paraformaldehyde at 9 or 24 hrs after
30 min OGD or control treatment. Slices
were treated 30 min prior to insult, during
the 30 min insult, and during the 9 or 24 hr
recovery period either with no drug or 50
nM BfA to prevent lysosomal maturation.
Representative compressed z-stacks of
fluorescently labeled autophagosomes
(EGFP-LC3B; green) and mitochondria
(gfap-DsRed2-MITO; red) in astrocytes
fixed 24 hrs after rinsing with no insult
(Control) (A) or OGD (B) in the presence
of BfA. Insets provide magnified views of
mitochondria in autophagosomes in
astrocytic processes.
Mean area of
autophagosome/mitochondria
colocalization normalized to mitochondrial
area after OGD or control treatment (C).
All groups were included in at least 3
experiments, with slice cultures prepared
from at least 3 separate animals. n=6
slices/group (2-4 slices/group/experiment,
2
astrocytes/slice).
****p<0.0001
compared to all other groups by one-way
ANOVA with Bonferroni correction for
multiple comparisons.

To probe the mechanisms behind this effect on astrocytic mitochondria, we
examined the role of ionotropic glutamate receptors (iGluRs; Fig. 4.4). As previously
observed, neuronal cell loss was completely blocked by the NMDAR antagonist MK801
(Bonde et al., 2005) (Fig. 4.4A). The protective effect of AMPAR antagonist NBQX was
variable, and DAPI staining in stratum pyramidale was not significantly different than in
control or OGD groups. Only the combination of both MK801 and NBQX significantly
blocked the reduction in mitochondrial length observed after OGD (Fig. 4.4B). Either
drug individually attenuated the loss of mitochondria (change in % occupancy), but only
the combination of both drugs completely blocked the loss of mitochondria (Fig. 4.4C).
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Figure 4.4.
MK801 or
NBQX
blocked,
and
stimulating
NMDARs
mimicked the loss of
astrocytic
mitochondria
after OGD.
Hippocampal
slice cultures with astrocytes
expressing mitochondriallytargeted EGFP and plasmamembrane-targeted mcherry
were
fixed
in
4%
paraformaldehyde 24 hrs
after 30 min OGD, NMDA
(10 or 100 µM), or control
treatment. OGD slices were
treated 30 min prior to insult,
during the 30 min insult, and
during the 24 hr recovery
period either with no drug, 10
µM MK801, 20 µM NBQX, or
both MK801 and NBQX.
Effects of iGluR antagonists
and OGD on mean cell
density in stratum pyramidale
(A), mitochondrial length in
processes (µm; B), and %
occupancy of processes by
mitochondria (C). Effects of
acute NMDA insult on mean
cell density in stratum
pyramidale
(D),
mitochondrial length (µm; E),
and
%
occupancy
of
processes by mitochondria
(F). All groups were included
in at least 3 experiments,
with slice cultures prepared
from at least 3 separate
animals. n=6-13 slices/group
(2-4 slices/group/experiment,
2
astrocytes/slice,
3
processes/astrocyte). Error
bars indicate SEM. *p<0.05,
**p<0.01,
***p<0.001,
****p<0.0001 compared by
one-way
ANOVA
with
Bonferroni correction for
multiple comparisons.

Transient NMDA (30 min) caused a loss of DAPI staining comparable to that observed
after OGD (Fig. 4.4D). It also mimicked the effects of OGD on astrocytic mitochondria,
causing a significant reduction in mitochondrial length and a decrease in mitochondrial
occupancy (Fig. 4.4E, F). Together, these studies demonstrate that activation of iGluRs
is both necessary and sufficient to induce the delayed loss of astrocytic mitochondria
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observed after OGD.

These studies

suggest that either excessive activation
of iGluRs on astrocytes is responsible
for the loss of mitochondria or that
activation of neuronal iGluRs results in
release of one or more substances that
subsequently

cause

a

loss

of

mitochondria in astrocytic processes.
Activation of iGluRs increases
glutamate release in vitro and in vivo
(for review, see Mayer and Westbrook,
1987).

To

involvement

further
of

test

neuronal

for

the

glutamate

release, we separately blocked action
potentials utilizing the voltage-gated Na+
channel blocker tetrodotoxin (1 µM), or
vesicular

neurotransmitter

release

utilizing the N-type Ca2+ channel blocker
ziconotide (0.5 µM). These drugs block
glutamate release and neuronal death
after NMDA exposure in similar models
of I/R injury, both in vitro and in vivo
(Valentino et al., 1993; Buchan et al.,
1994; Dijk et al., 1995; Pringle et al.,

Figure 4.5. TTX or Ziconotide blocked the loss of
astrocytic mitochondria after OGD or NMDA injury.
Hippocampal slice cultures with astrocytes expressing
mitochondrially-targeted EGFP and plasma-membranetargeted mcherry were fixed in 4% paraformaldehyde 24
hrs after a 30 min OGD, NMDA (100 µM), or control
treatment. OGD and NMDA slices were treated 30 min
prior to insult, during the 30 min insult, and during the 24 hr
recovery period either with no drug, 1 µM TTX, or 0.5 µM
Ziconotide. Mean cell density in stratum pyramidale,
mitochondrial length in processes (µm), and % occupancy
of processes by mitochondria 24 hrs after 30 min OGD
(A,B,C) or NMDA (D,E,F) ± TTX or Ziconotide. All groups
were included in at least 3 experiments, with slice cultures
prepared from at least 3 separate animals. n=8-12
slices/group
(2-4
slices/group/experiment,
2
astrocytes/slice, 3 processes/astrocyte). Error bars indicate
SEM. ****p<0.0001 compared by one-way ANOVA with
Bonferroni correction for multiple comparisons.
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1996; Strijbos et al., 1996). We found that they blocked OGD- or NMDA-induced loss of
DAPI staining from stratum pyramidale (Fig. 4.5A, D). These drugs also blocked the
reduction of mitochondrial size (Fig. 4.5B, E) and occupancy (Fig. 4.5C, F) in astrocytic
processes 24 hrs after OGD or exposure to NMDA. These results offer support for the
involvement of glutamate-induced glutamate release in the delayed fragmentation and
degradation of astrocytic mitochondria observed in this model of I/R injury.
Given that astrocytic glutamate transporter activity regulates mitochondrial
mobility in processes (Jackson et al., 2014; Ugbode et al., 2014), we tested the
hypothesis that activation of glutamate transport contributes to the loss of mitochondria
by blocking transporters with TFB-TBOA. The IC50 of TFB-TBOA for iGluRs is >100 µM,
and it has no effect on metabotropic glutamate receptors at 100 µM (Shimamoto et al.,
2004); at 3 µM it should completely and selectively block glutamate transporter activity.
As expected, TFB-TBOA increased the OGD- or NMDA-induced loss of DAPI staining in
stratum pyramidale 24 hrs after insult (Fig. 4.6C, F), likely due to increased
concentrations of extracellular glutamate.

TFB-TBOA also completely blocked the

decrease in mitochondrial size and occupancy in astrocytic processes 24 hrs after OGD
or NMDA (Fig. 4.6D, E, G, H).

These data suggest that OGD induces activation of

neuronal iGluRs, triggering neuronal release of glutamate (or other transporter
substrates) that is cleared by astroglial glutamate transporters, causing mitochondrial
fragmentation and degradation.
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Figure 4.6. TFB-TBOA increased neuronal loss, but blocked the loss of astrocytic mitochondria after OGD or
NMDA injury. Hippocampal slice cultures with astrocytes expressing mitochondrially-targeted EGFP (mito-EGFP,
green) and plasma-membrane-targeted mcherry (gfap-gap43-mcherry, red) were fixed in 4% paraformaldehyde 24
hrs after a 30 min OGD, NMDA (100 µM), or control treatment. OGD and NMDA slices were treated 30 min prior to
insult, during the 30 min insult, and during the 24 hr recovery period either with no drug or 3 µM TFB-TBOA.
Representative images of fluorescently labeled mitochondria (green) and plasma membrane (red) in astrocytes fixed
24 hrs after OGD (A) or OGD in the presence of TFB-TBOA (B). Mean cell density in stratum pyramidale,
mitochondrial length in processes (µm), and % occupancy of processes by mitochondria 24 hrs after 30 min OGD
(C,D,E) or NMDA (F,G,H) insult ± TFB-TBOA. All groups were included in at least 3 experiments, with slice cultures
prepared from at least 3 separate animals. n=8-12 slices/group (2-4 slices/group/experiment, 2 astrocytes/slice, 3
processes/astrocyte). Error bars indicate SEM. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 compared by one-way
ANOVA with Bonferroni correction for multiple comparisons.
Insets provide magnified views of mitochondria in
astrocytic processes.

119

To test the hypothesis that
increases in extracellular glutamate are
sufficient to cause mitochondrial loss in
astrocytic

processes,

we

applied

glutamate to slices in the presence of
MK801 and NBQX to block neuronal
death.

Although µM glutamate is

sufficient to activate iGluRs, robust
glutamate uptake prevents glutamatedependent receptor activation or cell
death in slice preparations (Garthwaite,
1985; Vornov et al., 1991). In animal
models

of

I/R

injury,

extracellular

glutamate is elevated for ~2hrs (longer
in

humans)

as

measured

by

microdialysis (Dávalos et al., 1997).

Figure 4.7.
Glutamate
caused
a
loss
of
astrocytic mitochondria
in the presence of
neuroprotective
iGluR
antagonists.
Hippocampal slice cultures
with astrocytes expressing
mitochondrially-targeted
EGFP
and
plasmamembrane-targeted
mcherry were fixed in 4%
paraformaldehyde 24 hrs
after a 1 or 2 hr glutamate
(1mM) or control treatment.
Slices were treated 30 min
prior to insult, during the
insult, and during the 24 hr
recovery
period
with
MK801 (10 µM) + NBQX
(20 µM). Mean cell density
in stratum pyramidale (A),
mitochondrial length in
processes (µm; B), and %
occupancy of processes
(C) by mitochondria 24 hrs
after 1 or 2 hr submersion
± glutamate. All groups
were
included
in
4
experiments, with slice
cultures prepared from at
least 4 separate animals.
n=8
slices/group
(2-4
slices/group/experiment, 2
astrocytes/slice,
3
processes/astrocyte).
Error bars indicate SEM.
*p<0.05,
**p<0.01,
***p<0.001, ****p<0.0001
compared by one-way
ANOVA with Bonferroni
correction
for
multiple
comparisons.

Therefore we examined the effects of 1
or 2 hr exposure to 1 mM glutamate in
the presence of iGluR antagonists. Control slices were also submerged for 1 or 2 hrs in
the presence of MK801 and NBQX. There was no effect of glutamate on DAPI staining
in the presence of iGluR antagonists (Fig. 4.7A).

In contrast, glutamate caused a

significant, time-dependent decrease in mitochondrial length and occupancy 24 hrs after
incubation with glutamate (Fig. 4.7B, C). These results demonstrate that exogenous
glutamate is sufficient to cause fragmentation and degradation of astrocytic mitochondria
in the absence of detectable neuronal pathology.
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Increased glutamate uptake

Figure 4.8. KB-R7943 or
YM-244769 attenuated the
loss
of
astrocytic
mitochondria after OGD or
NMDA injury. Hippocampal
slice cultures with astrocytes
expressing mitochondriallytargeted EGFP and plasmamembrane-targeted mcherry
were
fixed
in
4%
paraformaldehyde 24 hrs
after a 30 min OGD or control
treatment. OGD slices were
treated 30 min prior to insult,
during the 30 min insult, and
during the 24 hr recovery
period either with no drug, 15
µM KB-R7943, or 1 µM YM244769. Mean cell density in
stratum
pyramidale,
mitochondrial
length
in
processes (µm), and %
occupancy of processes by
mitochondria 24 hrs after 30
min OGD (A,B,C) ± KBR7943 or YM-244769. All
groups were included in at
least 3 experiments, with slice
cultures prepared from at
least 3 separate animals.
n=8-12
slices/group
(2-4
slices/group/experiment,
2
astrocytes/slice,
3
processes/astrocyte).
Error
bars indicate SEM. *p<0.05,
**p<0.01,
****p<0.0001
compared
by
one-way
ANOVA
with
Bonferroni
correction
for
multiple
comparisons.

through Na+-dependent transporters
stimulates influx of Ca2+ via reversal
of the Na+/Ca2+ exchanger (NCX)
(Magi et al., 2013b; Rojas et al.,
2013; Jackson and Robinson, 2015).
High

cytosolic

mitochondrial
permeability

Ca2+

causes

fragmentation,
transition,

and

degradation by mitophagy (for review
see Rodriguez-Enriquez et al., 2004).
Drugs that selectively inhibit the
reverse mode of the NCX (Ca 2+
influx) are neuroprotective in models
of I/R injury in vitro and in vivo
(Schröder et al., 1999; Matsuda et
al., 2001; Iwamoto and Kita, 2006).
We found that two structurally distinct

inhibitors of the reverse-mode of the NCX, KB-R7943 (15 µM) or YM-244769 (1 µM),
attenuated the loss of DAPI staining in stratum pyramidale (Fig. 4.8A) as well as the
reduction of mitochondrial size (Fig. 4.8B) and occupancy (Fig. 4.8C) in astrocytic
processes 24 hrs after OGD. As observed with MK801, these drugs completely blocked
the reduction in DAPI staining but only partially blocked the loss of astrocytic
mitochondria, suggesting that mitochondrial degradation can occur in the absence of
neuronal death.
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Cyclosporin-A (CsA) and FK506 work through different pathways to prevent
Ca2+-induced mitochondrial permeability transition and fragmentation, and are
neuroprotective in in vitro and in vivo models of I/R injury (Nakai et al., 1997; Uchino et
al., 1998; Li et al., 2000; Yokoyama et al., 2012; Trumbeckaite et al., 2013). Both drugs
have been shown to selectively increase Ca2+ buffering capacity and prevent Ca 2+induced depolarization of mitochondria in astrocytes, but not in neurons in primary
culture (Bambrick et al., 2006; Oliveira and Goncalves, 2008; Kahraman et al., 2011),
but at the concentrations used in the present study some effects on neuronal
mitochondria could be expected. Each drug blocked the loss of DAPI staining in stratum
pyramidale after OGD (Fig. 4.9C). Each of the drugs partially blocked the reduction of
mitochondrial size (Fig. 4.9D), and almost entirely blocked loss of mitochondrial
occupancy 24 hrs after OGD (Fig. 4.9E). CsA and FK506 exhibit direct neuronal effects,
such as inhibition of calcineurin-induced nitric oxide synthase activity, which contribute to
their neuroprotective effects in models of I/R injury (Dawson et al., 1993). However, it is
unlikely that the neuronal effects of these drugs would reduce astrocytic mitochondrial
loss, since inhibition of neuronal calcineurin by CsA has been shown to increase
glutamate release (Nichols et al., 1994).

Mitochondrial fragmentation precedes

degradation, and this process is linked to mitochondrial depolarization (for reviews, see
Itoh et al., 2013; Lemasters, 2014).

The fact that the loss of mitochondria can be

blocked while only attenuating the reduction in size suggests that fragmentation does not
necessarily need to progress to degradation.
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Figure 4.9. CsA or FK506 blocked the loss of astrocytic mitochondria after OGD. Hippocampal slice cultures
with astrocytes expressing mitochondrially-targeted EGFP (mito-EGFP, green) and plasma-membrane-targeted
mcherry (gfap-gap43-mcherry, red) were fixed in 4% paraformaldehyde 24 hrs after 30 min OGD or control
treatmeant. OGD slices were treated 30 min prior to insult, during the 30 min insult, and during the 24 hr recovery
period either with no drug, 10 µM CsA, or 10 µM FK506. Representative images of fluorescently labeled
mitochondria (green) and plasma membrane (red) in astrocytes fixed 24 hrs after OGD (A) or 24 hrs after OGD in
the presence of CsA (B). Insets provide magnified views of mitochondria in astrocytic processes. Effects of CsA or
FK506 on mean cell density in stratum pyramidale (C), mitochondrial length in processes (µm; D), and %
occupancy of processes by mitochondria (E) 24 hrs after 30 min OGD. All groups were included in at least 3
experiments, with slice cultures prepared from at least 3 separate animals. n=6 slices/group (2
slices/group/experiment, 2 astrocytes/slice, 3 processes/astrocyte). Error bars indicate SEM. *p<0.05, **p<0.01,
***p<0.001, ****p<0.0001 compared by one-way ANOVA with Bonferroni correction for multiple comparisons.
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We previously reported that neuronal activity immobilizes astrocytic mitochondria
near glutamate transporters and synapses through a mechanism involving glutamate
uptake and reversal of the NCX (Jackson et al., 2014). More recently, our lab and
others found that this immobilization was dependent on Ca 2+ binding to motor-adaptor
proteins, and that mitochondria shape Ca2+ signals in astrocytic processes (Jackson and
Robinson, 2015; Stephen et al., 2015). We therefore hypothesized that loss of astrocytic
mitochondria would be accompanied by increased Ca 2+ signaling.

For this study,

DsRed2-labeled mitochondria were imaged together with spontaneous cytosolic Ca2+
signals in astrocytic processes using the high affinity Lck-GCaMP-6s Ca2+ sensor (Kd =
144 nM; Koff = 1.12 s-1) (Chen et al., 2013).
As was recently reported (Jackson and Robinson, 2015), all of the Ca 2+ signals
observed overlapped with one or more mitochondria. The sensitivity of Lck-GCaMP-6s,
along with the presence of a mitochondrial label, revealed a stark anatomical difference
between two types of spontaneous Ca 2+ events that has not been previously described.
In addition to the brief, far-reaching Ca2+ spikes traversing extra-mitochondrial space that
have been previously reported, we also observed a nearly-constant, fluctuating Ca2+
signal in the cytosol surrounding individual mitochondria (Fig. 4.10). Mitochondriallycentered events and extra-mitochondrial Ca2+ spikes had similar signal amplitudes
(ΔF/F0; Fig. 4.10D). However, spread of extra-mitochondrial spikes covered roughly
three times the distance of mitochondrially-centered events (Fig. 4.10E). Furthermore,
duration and frequency of extra-mitochondrial spikes were much lower than
mitochondrially-centered

events,

at

approximately

one-third

and

one-ninth

of

mitochondrially-centered values, respectively (Fig. 4.10F, G). Duration was used as a
measure of kinetics since the dissociation of Ca2+ from Lck-GCaMP-6s was too slow for
an accurate measurement of decay.
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Figure 4.10. Spontaneous cytosolic Ca2+ signals were observed surrounding mitochondria or spanning the
space between mitochondria with distinct properties. Hippocampal slice cultures with astrocytes expressing a
plasma-membrane-targeted Ca2+ sensor (Lck-GCaMP-6S, green) and mitochondrially-targeted DsRed2 (gfapDsRed2-mito, red) were imaged at 1 Hz for 10 min (600 s) in a flow-through chamber 24 hrs after OGD or control
treatment to obtain live recordings of Ca2+ activity in astrocytic processes. OGD slices were treated 30 min prior to
insult, during the 30 min insult, and during the 24 hr recovery period either with no drug or 10 µM CsA, but CsA was
not present during live Ca2+ imaging. A representative image of a single frame displaying an extra-mitochondrial
Ca2+ spike (top), and a kymograph displaying both extra-mitochondrial (white arrow and bracket) and
mitochondrially-centered (black arrow and bracket) Ca2+ signals over time throughout the recording (A). The time at
which the representative frame (top) appears in the kymograph is indicated by the black arrows to the right of the
image. Corresponding mitochondrial (gfap-DsRed2-MITO) signal (B), and merged Ca2+ and mitochondrial signals
(C). Comparison of mitochondrially-centered and extra-mitochondrial Ca2+ signals by mean intensity (ΔF/F0; D),
spread (E), duration (F), and frequency (G). Mitochondrially-centered and extra-mitochondrial Ca2+ signals were
pooled from Control, OGD, and OGD+CsA groups for this analysis. Means from each recording were considered an
n of 1 (mito-centered n=18, extra-mito n=22), and recordings were acquired from 4 separate experiments with slices
prepared from at least 4 different animals. Error bars indicate SEM. ****p<0.0001 by one-way ANOVA with
Bonferroni correction for multiple comparisons.

We analyzed the effects of OGD on these two types of Ca 2+ signals.

The

amplitudes (ΔF/F0) of both signals were more than doubled 24hrs after transient OGD
(Fig. 4.11A, B).

The frequencies and durations of both events were unchanged (data

not shown). The spatial spread of mitochondrially-centered events was decreased to
half of that observed in controls 24 hrs after OGD (Fig 4.11C); this correlates with the
decrease in mitochondrial length (e.g. Fig 4.2E). The spread of extra-mitochondrial Ca2+
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spikes was doubled after OGD (Fig. 4.11D). CsA was used to prevent the loss of
astrocytic mitochondria after OGD, but CsA also changes some mitochondria-dependent
Ca2+ signals (Ichas et al., 1997). To separate the effects of protecting mitochondria from
direct effects on Ca2+ signaling, CsA was not present during live Ca2+ imaging. When we
used CsA to prevent the loss of mitochondria in astrocytes after OGD, all effects on
ΔF/F0 and spread were completely blocked (Fig. 4.11A-D).

Figure 4.11. Ca2+ signal intensity
and spread were drastically
altered following OGD-induced
loss of mitochondria in astrocytic
processes.
Hippocampal slice
cultures with astrocytes expressing
a plasma-membrane-targeted Ca2+
sensor
(Lck-GCaMP-6S)
and
mitochondrially-targeted
DsRed2
(gfap-DsRed2-mito) were imaged at
1 Hz for 10 min (600 s) in a flowthrough chamber 24 hrs after OGD
or control treatment to obtain live
2+
recordings of Ca
activity in
astrocytic processes. OGD slices
were treated 30 min prior to insult,
during the 30 min insult, and during
the 24 hr recovery period either with
no drug or 10 µM CsA, but CsA was
not present during live Ca2+ imaging.
Example traces (left) and mean
ΔF/F0 values (right), for 24 hr
Control, OGD, or OGD+CsA slices,
in both mitochondrially-centered (A)
and extra-mitochondrial (B) Ca2+
signals.
Effects of OGD or
OGD+CsA on mean spread among
mitochondrially-centered
fluctuations
(C),
and
extramitochondrial spikes (D). Means
from
each
recording
were
considered an n of 1 (n=5-9
recordings/group), and recordings
were acquired from 4 separate
experiments with slices prepared
from at least 4 different animals.
Error bars indicate SEM. *p<0.05,
**p<0.01, ***p<0.001 by one-way
ANOVA with Bonferroni correction
for multiple comparisons.
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To further understand the increased spread of extra-mitochondrial Ca2+ spikes
after OGD, it is helpful to consider Ca2+ in the anatomical context of mitochondria (Fig.
4.12). Extra-mitochondrial spikes were observed in 8 of 11 recordings in both control
and OGD groups. In control slices, 86% of extra-mitochondrial spikes were contained
between two mitochondria (Fig. 4.12A, C).

24 hrs after OGD, none of the extra-

mitochondrial spikes were contained between two mitochondria; instead they all
traversed multiple mitochondria (Fig. 4.12B, C). Preventing the OGD-induced loss of
mitochondria with CsA blocked this effect (Fig. 4.12C).

Figure 4.12. Extra-mitochondrial Ca2+ spikes were no longer contained between two mitochondria after OGD.
Extra-mitochondrial spikes from experiments summarized in Figs. 7 and 8 were analyzed for their anatomic
relationship to mitochondria (contained between two mitochondria, or traversing multiple mitochondria). A
representative image of a single frame (top) displaying an extra-mitochondrial Ca2+ spike (Lck-GCaMP-6S, green)
contained between two mitochondria (gfap-DsRed2-mito, red), and a kymograph (bottom) displaying Ca2+ and
mitochondria over time throughout the recording acquired 24 hrs after control treatment, with the example spike
indicated by a white bracket (A). A representative image of a single frame (top) displaying an extra-mitochondrial
Ca2+ spike (green) traversing greater than two mitochondria (red), and a kymograph (bottom) displaying Ca2+ and
mitochondria over time throughout the recording acquired 24 hrs after OGD, with the example spike indicated by a
white bracket (B). The times at which the representative frames appear in the kymographs are indicated by the black
arrows to the side of the image. Distribution of extra-mitochondrial spikes classified into two categories: between two
mitochondria or traversing greater than two mitochondria (C). **p<0.01, ****p<0.001 by Fisher’s exact test with
Bonferroni correction for multiple comparisons.
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4.4 Discussion
Mitochondria in astrocytic processes are positioned near glutamate transporters
and synapses through a mechanism involving neuronal activity and Ca2+-sensitive
motor adaptor proteins.

These mitochondria shape Ca2+ signaling (Jackson et al.,

2014; Jackson and Robinson, 2015; Stephen et al., 2015). Here we present evidence
that the delayed neuronal death observed in area CA1 after transient OGD was
accompanied by fragmentation and autophagic degradation of mitochondria in astrocytic
processes.

The loss of mitochondria was associated with a dramatic increase in

spontaneous Ca2+ signals in distal astrocytic processes.

Mechanism of mitochondrial loss
We show that the OGD-induced loss of astrocytic mitochondria is completely
blocked by a combination of iGluR antagonists (MK-801 and NBQX), an inhibitor of
neuronal action potentials (TTX), an inhibitor of vesicular glutamate release (ziconotide),
a glutamate transport inhibitor (TFB-TBOA), or two different inhibitors of calcineurin (CsA
or FK506).

NMDA or glutamate mimicked the effect of OGD, and the NMDA-induced

loss of mitochondria was blocked by TFB-TBOA. The simplest explanation for these
data is that OGD triggers an iGluR-dependent increase in extracellular glutamate (or
aspartate), activation of astrocytic transporters, and loss of astrocytic mitochondria.
Previous studies have demonstrated that OGD or activation of iGluRs causes an
increase in extracellular glutamate (and aspartate) (Bustos et al., 1992; Dijk et al., 1995;
Fujimoto et al., 2004; Bonde et al., 2005). During 30 min of OGD, elevated extracellular
glutamate is mainly attributed to reversal of neuronal glutamate transporters and some
vesicular release (for review, see Rossi et al., 2007).
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After reperfusion, additional

periods of elevated extracellular glutamate have been observed by in vivo microdialysis
in CA1, but the source(s) for this glutamate have not been identified (Yang et al., 2001).
The fact that inhibitors of neuronal Na+ channels or the N-type Ca2+ channel block the
changes in astrocytic mitochondria are consistent with the notion that this glutamate is
released from neuronal vesicles.
Glutamate uptake increases intracellular Ca 2+ through reversed operation of
plasma membrane Na+/Ca2+ exchangers, and blocking this reversed mode after OGD
attenuated the loss of astrocytic mitochondria (Magi et al., 2013b; Rojas et al., 2013;
Jackson and Robinson, 2015).
reactive

oxygen

species

In other systems, coincident increases in Ca 2+ and

(ROS)

cause

mitochondrial

swelling,

depolarization,

fragmentation, opening of the permeability transition pore, and mitophagy (He and
Lemasters, 2002; Kim et al., 2012). High mitochondrial Ca 2+ also activates several TCA
cycle dehydrogenases that generate ROS (Denton et al., 1972; for review, see Brookes
et al., 2004). Increased oxidation of glutamate itself could contribute to the loss of
mitochondria via increased generation of ROS. Glutamate enters the TCA cycle through
conversion to α-ketoglutarate (for review, see McKenna, 2013).

Conversion of α-

ketoglutarate to succinyl CoA by the α-ketoglutarate dehydrogenase complex generates
2- to 3-fold more ROS than the other TCA cycle dehydrogenases (Starkov et al., 2004;
Tretter and Adam-Vizi, 2004).

However, testing this hypothesis is difficult because

inhibiting glutamate dehydrogenase or α-ketoglutarate dehydrogenase inhibits glutamate
uptake (Whitelaw and Robinson, 2013, unpublished observations).
Preventing Ca2+-induced mitochondrial depolarization with CsA or FK506
(Bambrick et al., 2006; Oliveira and Goncalves, 2008; Kahraman et al., 2011) likely
contributed to the prevention of mitochondrial loss in astrocytes after OGD. However,
Ca2+-mediated activation of calcineurin can cause inflammation in astrocytes through
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activation of NFAT and NFκB (for review, see Furman and Norris, 2014). The efficacy of
CsA and FK506, both calcineurin inhibitors, could imply a role for inflammation in the
loss of astrocytic mitochondria after transient OGD, similar to the inflammationdependent mitophagy observed in astrocytes after cortical stab wound (Motori et al.,
2013).

Consequences of mitochondrial loss and insights into Ca 2+ signaling
We observed two anatomically-distinct, spontaneous Ca2+ signals in the
cytoplasm of astrocytic processes, one of which has not been previously described.
There were constant, fluctuating Ca 2+ signals surrounding mitochondria, and brief, farreaching spikes that traversed extra-mitochondrial space. The fact that photo-ablation of
individual mitochondria causes a large transient increase in cytoplasmic Ca 2+ strongly
suggests that the mitochondria contain Ca 2+ (Jackson and Robinson, 2015). Decreased
spread of mitochondrially-centered Ca2+ signals after OGD correlated with decreased
mitochondrial size, implicating mitochondria as the source. With the identification of a
localized Ca2+ cloud surrounding mitochondria, we suspect that mitochondria may play a
role in generating Ca2+ spikes in astrocytic processes, as they do in primary culture
(Parnis et al., 2013) and other cells (for review, see Rizzuto et al., 2012). While the
current study was under review, Jiang et al. described two types of Ca 2+ signals in
astrocytic processes with similar properties to those described in the current study, but
without the anatomic relationship to mitochondria (Jiang et al., 2016).
Our lab and others have recently demonstrated that mitochondria shape Ca 2+
signals in astrocytic processes (Jackson and Robinson, 2015; Stephen et al., 2015). In
our recent study, uncoupling oxidative ATP production with FCCP or photo-ablating
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mitochondria with KillerRed-mito caused a large increase in cytoplasmic Ca 2+. These
effects were associated with increased spatial spread, indicating that mitochondria
spatially restrict these signals.

OGD-induced mitochondrial loss also resulted in

increased spread of extra-mitochondrial spikes, and the likelihood of spikes staying
confined between two mitochondria went from 86% to zero after OGD. In agreement
with observations from recent studies (Jackson and Robinson, 2015; Stephen et al.,
2015), this suggests that mitochondria provide spatial restriction for Ca 2+ signals in
astrocytic processes.
A recent study utilizing in vivo two-photon imaging in awake mice found that the
spread of Ca2+ “hotspots” in astrocytic processes increased with sensory stimulation and
decreased with tetrodotoxin treatment (Asada et al., 2015).

Another study using

hippocampal cultures found that activity of local synapses is coordinated by Ca 2+
signaling in astrocytic processes (Sasaki et al., 2014).

Activity-driven positioning of

mitochondria at glutamate transporters apposing synapses (Jackson et al., 2014), along
with spatial restriction of Ca2+ signals by those mitochondria (Jackson and Robinson,
2015; Stephen et al., 2015), could represent a system for coordinating weak signals
between neighboring sites of activity, while larger signals are relayed beyond
neighboring mitochondria to more distant zones of activity, as was observed in response
to sensory stimulation (Asada et al., 2015). Exploring this phenomenon could reveal a
new mechanism for integrating local neuronal signaling events via mitochondriallysegmented Ca2+ signaling in astrocytic microdomains.

Implications for I/R injury
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Following cerebral I/R injury the neurovascular coupling response is depressed in
humans, likely impairing recovery (Salinet et al., 2015). Although the mechanisms are
not fully understood, astrocytic Ca 2+ signaling has been implicated in mediating
neurovascular coupling (Takano et al., 2006; Dunn et al., 2013; Otsu et al., 2015), which
is not surprising given the positioning of astrocytes between synapses and the
vasculature, and their reliance on Ca 2+ for propagating information (for review, see
Parpura et al., 2012).

In addition to altered neurovascular coupling, Ca 2+-induced

vesicular glutamate release from astrocytes has been shown to increase excitotoxic
damage from seizure and stroke (Ding et al., 2007; Hines and Haydon, 2013; Takemiya
and Yamagata, 2013). Increased astrocytic Ca 2+ signaling with a lower threshold for
induction has been observed in in vitro and in vivo models of I/R (for review, see Ding,
2014), however, none of these studies focused on the period of delayed secondary
pathology, or on microdomain Ca2+ signaling in the distal astrocytic process. In the
current study we provide evidence of dramatically amplified, spatially deregulated Ca 2+
signaling in astrocytic processes after OGD-induced mitochondrial loss, which could
disrupt neurovascular coupling and stimulate vesicular glutamate release from
astrocytes during secondary neuronal pathology.
Glutamate metabolism will likely be impaired following the loss of mitochondria.
The mitochondrial enzyme glutamate dehydrogenase converts glutamate to αketoglutarate for entry into the TCA cycle and generation of ATP (for review, see Dienel,
2013). Glutamate dehydrogenase is enriched (~5 fold) in astrocytes (Zaganas et al.,
2001; Zhang et al., 2014), and brain-specific knockouts demonstrate increased glucose
deployment from the periphery and utilization in brain to compensate for the loss of
glutamate as a fuel source (Karaca et al., 2015). We are currently testing the hypothesis
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that the loss of astrocytic mitochondria after OGD will result in a significant reduction of
glutamate oxidation, which could impair recovery after I/R injury.

Conclusion
We have presented the first evidence that increased activation of iGluRs,
neuronal glutamate release, and glutamate uptake into astrocytes after transient OGD
causes a delayed fragmentation and autophagic degradation of mitochondria in
astrocytic processes. This effect is associated with a dramatic increase in the amplitude
and spread of extra-mitochondrial Ca2+ spikes in astrocytic processes. The removal of
damaged, dysfunctional mitochondria may be beneficial for astrocyte survival. However,
it may also exacerbate neuronal damage, not just through Ca 2+-associated effects on
neurovascular coupling and glial glutamate release, but also through the loss of
astrocytic support of neurons. Astrocytes are more resilient than neurons after I/R injury,
so it could be easier to target and correct their less-severe dysfunction, allowing the
astrocytes to continue to support and protect neurons (for reviews, see Chen and
Swanson, 2003; Rossi et al., 2007; Barreto et al., 2011). Healthy astrocytes providing
potassium homeostasis, glutamate clearance, antioxidants, and metabolic support are in
a better position to rescue neighboring neurons than any neuronally-targeted therapy.
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CHAPTER 5
Conclusions and Future Directions
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5.1 Summary
Mitochondria in astrocytes have been recognized for some time as the site of
brain glutamate synthesis and subsequent oxidation following neurotransmission (for
review, see Hertz et al., 2007). Although pervasive electron micrograph images of
mitochondria in fine astrocytic processes have existed in the literature for some time
(Mugnaini, 1964; Fernandez et al., 1983; Aoki et al., 1987; Xu et al., 2003; Lovatt et al.,
2007; Ito et al., 2009; Oberheim et al., 2009; Lavialle et al., 2011; Pardo et al., 2011),
their presence in these unique cellular compartments has only recently gained wide
acceptance (Genda et al., 2011a; Motori et al., 2013; Jackson et al., 2014; Derouiche et
al., 2015; Jackson and Robinson, 2015; Stephen et al., 2015; O’Donnell et al., 2016; for
review, see Benjamin Kacerovsky and Murai, 2016). Chapter 2 of this thesis provided
evidence for an immunoprecitatible complex between the astrocytic glutamate
transporter, GLT-1, and several glycolytic and mitochondrial proteins (Jackson et al.,
2015).

Chapter 3 described the regulation of astrocytic mitochondrial mobility by

glutamate transporter activity and NCX reversal to position mitochondria near
transporters and synapses (Jackson et al., 2014). Finally, Chapter 4 detailed a delayed
loss of mitochondria from astrocytic processes following transient OGD, due to
fragmentation and, at least in part, increased mitophagy (O’Donnell et al., 2016).
Surprisingly, the loss of mitochondria occurs independently from the concomitant
neuropathology, depending instead on an extended period of high glutamate transporter
activity.

I also reveal a previously overlooked distinction between two types of

spontaneous cytosolic Ca2+ signals in astrocytic processes: brief, far-reaching spikes in
spaces between mitochondria, and high frequency, long duration Ca 2+ clouds
surrounding mitochondria. Both signals increased in intensity 24 h after OGD. The
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extramitochondrial spikes spread farther, no longer contained by mitochondria, while the
mitochondrially-centered signals covered less area, corresponding to the decreased size
of mitochondria. An expanded discussion of these results, their broader implications,
and future directions is provided below.

5.2 Transporter-Mitochondria Interactions in Astrocytic Processes
Chapter 2 provides evidence that the mitochondrial matrix protein UQCRC2,
inner mitochondrial membrane protein ANT, outer mitochondrial membrane protein
VDAC, and the glycolytic enzyme HK1 coimmunoprecipitate with each other, and with
the plasma membrane protein GLT-1, an astrocytic glutamate transporter (Jackson et
al., 2015). We hypothesized that HK1 may act as a cytoplasmic bridge between the
transporter and mitochondria, since it binds VDAC on the surface of mitochondria
(Lindén et al., 1982; Nakashima et al., 1986; Sui and Wilson, 1997) and its isoform HK2
also interacts with the plasma membrane glucose transporter, GLUT4 (Zaid et al., 2009).
Using a peptide to displace 50% of HK1 from VDAC did not affect the interaction
between GLT-1 and mitochondrial proteins, and therefore HK1 does not serve as a
cytoplasmic link between the transporter and mitochondria. While displacing HK1 from
VDAC did not affect GLT-1 interactions with mitochondria, it did reduce its glutamate
uptake activity by ~30%. When HK1 is bound to VDAC, it favors interactions with ANT in
a manner that provides nucleotide transfer (ATP out, ADP in) facilitating glycolysis and
oxidative phosphorylation.

Therefore, the metabolic consequences of disrupting this

interaction likely lead to the reduced transport activity of GLT-1.
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This study raises some obvious follow up questions. For one, if HK1 isn’t a
cytoplasmic bridge, how is GLT-1 interacting with mitochondria? Protein interactions
between mitochondria and ER facilitate efficient Ca 2+ signaling between the organelles
that is important for regulating energy production and apoptosis (Rizzuto et al., 1998;
Csordás et al., 2010). These junctions are formed between VDAC on mitochondria and
IP3R on ER via linkage by the chaperone protein Grp75 (Szabadkai et al., 2006).
Grp75, also called Hsp70-9, is a member of the 70kD heat-shock protein family, and
another member of that protein family, Hsp70-12A, was identified in previous proteomic
analysis of GLT-1 (Genda et al., 2011a). Synapsin 1, synapsin 2, and Syntaxin-binding
protein 1 (also known as MUNC18-1) were also identified in the proteome, and are
known to be involved in Ca 2+-regulated docking of synaptic vesicles at the plasma
membrane (Hilfiker et al., 1999; Voets et al., 2001; Gulyás-Kovács et al., 2007; Coleman
et al., 2008). These proteins represent some of the most appealing bridge candidates
from the proteome, and future investigations will provide more details on the
organizational structure of these interactions.
The protein complex between mitochondria and ER served as a model for
envisioning the structure of the interactions between mitochondria and GLT-1 in the
plasma membrane, but mitochondria/ER junctions are also likely to play an important
role in astrocytic processes in their own right. Astrocytic ER is perinuclear in primary
culture, but has been observed in processes in situ (Pivneva et al., 2008; Patrushev et
al., 2013).

Previous studies have shown that IP3R-induced Ca2+ release is not

relevant to neurovascular coupling (Schulz et al., 2012; Nizar et al., 2013), and IP3Rindependent Ca2+ signaling is prevalent in processes (Lind et al., 2013; Otsu et al., 2015;
Srinivasan et al., 2015; Tang et al., 2015; for review see Bazargani and Attwell, 2016).
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However, mitochondrial fission, which we have frequently observed in astrocytic
processes, typically involves interaction with ER (for review, see Phillips and Voeltz,
2016).

Furthermore, overexpression of the ER protein Grp78 (Hsp70-5), another

member of the 70kD heat-shock protein family, prevented the loss of mitochondrial
membrane potential and respiration under hypoglycemic conditions in primary astrocyte
cultures (Ouyang et al., 2011). In truth, little is known about the role of ER in astrocytic
processes, let alone the interactions between ER and mitochondria, and further
investigation is needed.

5.3 Mitochondrial Mobility and Ca2+ Signaling in Astrocytic Processes
As detailed in Chapter 3, mitochondria in astrocytic processes are immobilized
near glutamate transporters and synapses by a mechanism involving neuronal activity,
astrocytic glutamate uptake, and Ca 2+influx through reversal of the NCX (Jackson et al.,
2014). This positions mitochondria in processes at sites of high energy and ion-buffering
demand, similar to immobilization of neuronal mitochondria near nodes of Ranvier,
growth cones, and pre and post synaptic terminals (for reviews, see Sheng and Cai,
2012; Schwarz, 2013).

Since this paper was published, additional studies have

replicated these results and found that Ca 2+ binding to MIRO motor adaptor proteins
causes mitochondrial immobilization in astrocytes (Jackson and Robinson, 2015;
Stephen et al., 2015), again resembling neuronal mechanisms (for review, see Schwarz,
2013). Mitochondria were also found to buffer and shape Ca 2+ signals in astrocytic
processes (Jackson and Robinson, 2015; Stephen et al., 2015), and I found that 86% of
extramitochondrial Ca2+ spikes are contained between two mitochondria under control
conditions, as described in Chapter 4 (O’Donnell et al., 2016). I also found that the long
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duration, high frequency Ca2+ signals in astrocytic processes reported by another lab
while our paper was under review (Jiang et al., 2016), are in fact Ca2+ clouds
surrounding mitochondria (O’Donnell et al., 2016).
Astrocytic mitochondria move more slowly, and don’t travel as far as their
neuronal counterparts (Jackson et al., 2014). This may indicate that isoforms of the
kinesin and dynein motor proteins are different in astrocytes compared to neurons.
While these motors have been studied in some detail in neurons, which appear to rely
primarily on the KIF5 motors of the kinesin 1 family along with dynein (for reviews, see
Hirokawa et al., 2009; Schwarz, 2013; Sheng, 2014), they have yet to be identified in
astrocytes. Motor proteins use microtubules and actin filaments as tracks to transport
cargo, and in Chapter 3 we demonstrated that mitochondrial mobility in astrocytic
processes is impaired when microtubules or actin filaments are destabilized (Jackson et
al., 2014). Microtubules of the neuronal cytoskeleton are unipolar and aligned so that
the plus ends extend into the periphery; this means that the plus-end-directed KIF5 is
responsible for anterograde mitochondrial mobility away from the cell body, and dynein
provides retrograde transport (for reviews, see Hirokawa et al., 2009; Schwarz, 2013;
Sheng, 2014).

The tortuous, highly ramified morphology of astrocytic processes

suggests that their cytoskeletons may be organized very differently from neurons.
Remodeling of the actin cytoskeleton in astrocytes is essential for stellation during
development, and remodeling at the synapse to facilitate structural plasticity involved in
learning and memory (Oliet et al., 2001; Haber et al., 2006; Schweinhuber et al., 2015;
for reviews, see Bernardinelli et al., 2014; Heller and Rusakov, 2015;). However, the
organization of the cytoskeleton in astrocytic processes largely remains a mystery. For
example, future investigations can reveal whether the astrocytic microtubules are
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unipolar and aligned like their neuronal counterparts, as well as the role that positioning
and activity of mitochondria play in the motility of astrocytic processes.
As has been observed in neurons, most mitochondria in astrocytes are in a more
permanent stationary phase. My unpublished preliminary observations indicate that the
stationary population of mitochondria may increase with development, as the
morphology of primary and secondary astrocytic processes becomes more static. It has
been suggested that in neurons this stationary phase arises after an extended period of
pausing without reestablishing mobility, and may be facilitated by disengaging motors
from the cytoskeleton or mitochondria, or by engaging anchoring proteins like syntaphilin
(for reviews, see Schwarz, 2013; Sheng, 2014).

Syntaphilin is also expressed in

astrocytes, but no data are available on its function in these cells (Miki et al., 2014;
Zhang et al., 2014). The mechanisms maintaining the stationary pool of mitochondria in
neurons have yet to be defined, and even less is known in astrocytes. This field is wide
open for future studies.
Mitochondria positioned at glutamate transporters and synapses spatially restrict
Ca2+ signals, integrating sites of activity into the information coded in the signal. Thus,
the positioning of mitochondria in astrocytic processes may provide another level of
signaling plasticity in the brain. Although IP3R-induced Ca2+ signaling in astrocytes is
not necessary for neurovascular coupling (Schulz et al., 2012; Nizar et al., 2013), the ER
is not the only intracellular Ca2+ store. Mitochondrial Ca2+ signaling has been observed
in primary astrocyte cultures (Parnis et al., 2013) and in many other cell types (for
review, see Rizzuto et al., 2012).

Future studies are necessary to explore the

mechanisms and relevance of mitochondrial Ca2+ release in astrocytic processes.
However, cytosolic Ca2+ signals may not even reveal half of the story.
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For many

astrocytic processes, most of their volume is occupied by mitochondria. The possibility
that mitochondria form close junctions with ER as well as plasma membrane glutamate
transporters and NCX suggests that by focusing on cytoplasmic Ca2+ we may be missing
the majority of Ca2+ signaling events in astrocytic processes. Therefore, future studies
should include Ca2+ sensors targeted to mitochondria and ER in addition to the
cytoplasm in order to obtain a more complete picture.

5.4 Loss of Astrocytic Mitochondria after Transient OGD
In Chapter 4 I described the delayed fragmentation and loss of mitochondria from
astrocytic processes that correlates with, but is not dependent on delayed neuronal
pathology following transient OGD or treatment with NMDA. I also observed increased
mitophagy in astrocytes between 9 and 24 h after OGD, indicating that at least some of
the mitochondrial loss is due to autophagic degradation. While the NMDAR antagonist
MK801 was completely neuroprotective, completely blocking the loss of astrocytic
mitochondria required combination of MK801 with the AMPAR antagonist NBQX. This
was our first indication that the mitochondrial effect may be independent of neuronal
pathology. Given that iGluR activation increases glutamate release (for review, see
Mayer and Westbrook, 1987), and that glutamate elevations in area CA1 have been
observed by in vivo microdialysis after reperfusion from ischemia (Yang et al., 2001), I
hypothesized that the loss of mitochondria was dependent on glutamate release, and not
neuropathology. Blocking action potentials or the neuronal Ca 2+ channels involved in
vesicular neurotransmitter release during and after OGD or NMDA also blocked the loss
of mitochondria, but since they were neuroprotective the contribution of glutamate per se
was not clear. When 1 mM glutamate was applied for 1 – 2 h in the presence of iGluR
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antagonists, there was no measurable neuropathology, but there was clear
fragmentation and degradation of astrocytic mitochondria that was greater with longer
exposure to glutamate.

This was compelling evidence that glutamate was involved

independent of neuropathology, and since we knew that astrocytic glutamate transporter
activity regulates mitochondrial distribution, I hypothesized that glutamate was driving
mitochondrial loss through a mechanism involving transporter activity.

Incredibly,

blocking glutamate transporters with TFB-TBOA completely blocked the loss of
mitochondria even though it increased neuronal pathology after OGD or NMDA. Na +dependent glutamate transporter activity causes cytosolic Ca 2+ elevation due to localized
reversal of NCX, which immobilizes mitochondria (Magi et al., 2013a; Rojas et al., 2013;
Jackson et al., 2014; Jackson and Robinson, 2015). High Ca2+ concentrations can drive
mitochondrial fragmentation and autophagic degradation (He and Lemasters, 2002; Kim
et al., 2012), but blocking NCX reversal only attenuated the loss of mitochondria after
OGD, suggesting that additional mechanisms are involved.

Blocking mitochondrial

depolarization with CsA or FK506 blocked the loss of astrocytic mitochondria. These
results suggest that after transient OGD, an extended period of high glutamate
transporter activity causes delayed fragmentation and loss of mitochondria from
astrocytic processes that is due at least in part to increased mitophagy.
In neurons, PINK1/Parkin-mediated ubiquitination of dysfunctional mitochondria
facilitates engulfment by autophagosomes and degradation via mitophagy (Matsuda et
al., 2010 p.1; Chan et al., 2011; Wang et al., 2011; Yoshii et al., 2011; Wong and
Holzbaur, 2014, 2015). Parkin is also present in astrocytes, where it maintains a healthy
pool of mitochondria (Ledesma et al., 2002; Schmidt et al., 2011). Parkin knockdown
increases anterograde transport of mitochondria and prevents degradation of
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dysfunctional mitochondria (Wang et al., 2011; Cai et al., 2012). Transfection with a
dominant-negative Parkin mutant lacking E3 ligase activity also inhibits mitophagy
(Lazarou et al., 2013). Utilizing the tools available for genetic Parkin inhibition, future
studies can determine its contribution to loss of astrocytic mitochondria after transient
OGD.

This could potentially provide a tool for direct and selective prevention of

mitochondrial loss in astrocytes, allowing for studies that more directly evaluate the
effects of astrocytic mitochondrial loss after OGD.
In a recent study utilizing a mouse model of focal I/R injury, Ca 2+-dependent
release of astrocytic mitochondria and transfer into neurons was observed, and blocking
this phenomenon exacerbated neuropathology (Hayakawa et al., 2016). Therefore, in
addition to the increased mitophagy I observed, some of the mitochondrial loss after
OGD could be due to extracellular release. The transfer of mitochondria from astrocytes
to neurons was prevented by using shRNA to knock down expression of the glycoprotein
CD38, which is involved in synthesis of cyclic ADP ribose along with other molecules
and influences Ca2+ signaling in many cell types, including astrocytes (for review, see
Malavasi et al., 2008).

Interestingly, astrocytic expression of CD38 is increased in

response to glutamate (Bruzzone et al., 2004). Future studies will determine if this
mitochondrial transfer occurs in our injury model, and if increased CD38 expression
and/or mitochondrial transfer can be prevented by blocking glutamate transporters.
Astrocytic glutamate transporters GLAST and GLT-1 have been found on neurons in
hippocampal slices after transient OGD (Bonde et al., 2005). Future work is needed to
determine if mitochondria are encapsulated within astrocytic plasma membrane
containing glutamate transporters for transfer to neurons.
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Application of FCCP causes loss of mitochondrial membrane potential, efflux of
Ca2+ from mitochondria into the cytoplasm, eliminates mitochondrial Ca 2+ uptake,
prolongs cytoplasmic Ca2+ elevations, and increases speed of propagation for Ca 2+
waves in primary astrocyte cultures (Boitier et al., 1999). Similar results are found in
astrocytic processes, with the additional observation that cytoplasmic Ca 2+ signals
spread farther after FCCP treatment (Jackson and Robinson, 2015).

The higher

intensity and farther spread of extramitochondrial Ca 2+ signals I observed after OGD are
consistent with loss of membrane potential, which has been observed in primary
astrocyte cultures after similar insults (Dugan and Kim-Han, 2004; Ouyang et al., 2011,
2012b). However, the increased intensity of mitochondrially centered Ca2+ signals after
OGD indicates that while efflux is increased, mitochondria still contain and replenish
Ca2+, otherwise the Ca2+ clouds surrounding mitochondria would dissipate as observed
after FCCP treatment. However, if mitochondria/ER junctions are present in astrocytic
processes and maintained after injury, depolarized mitochondria could potentially leak
Ca2+ into the cytosol without rapid depletion of their stores. Multiple sources, including
glutamate transporters, impose a constant influx of extracellular Na + into astrocytes (for
review, see Chatton et al., 2016); loss of mitochondria means loss of a major
intracellular Na+ buffer, and could also reduce ATP available for Na + extrusion via the
Na+/K+ATPase. It is possible that mitochondrial membrane potential recovers to some
extent 24 h after OGD, allowing for some Ca 2+ retention, but high cytoplasmic Na+
concentrations could simultaneously increase Ca2+ efflux through the mitochondrial
NCX.

Further investigation into mitochondria/ER interaction, changes in Na +

concentrations, and mitochondrial membrane potential in astrocytic processes after
OGD will be necessary to understand the observed dysregulation of Ca 2+ signaling.
Developing genetic fluorescent sensors for measuring mitochondrial membrane potential
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will greatly enhance the specificity of signal as compared to available dyes, and provide
precision in studies examining mitochondrial membrane potential in fine astrocytic and
neuronal processes in slice cultures and in vivo.
Additional studies are needed to determine whether preventing the loss of
astrocytic mitochondria is a viable therapeutic goal, or if the loss—and possible neuronal
transfer—of astrocytic mitochondria is neuroprotective in its own right. CsA and FK506
may be selective for astrocytic mitochondria but they also have neuronal and general
anti-inflammatory effects, so their neuroprotective effects can’t be attributed to
preventing mitochondrial loss in astrocytes. We need to develop more specific tools in
order to evaluate the effects of preventing mitochondrial loss. Furthermore, we need to
study the effect in vivo to understand how the dysregulation of Ca2+ signaling after
mitochondrial loss effects neurovascular coupling, metabolic cycles, and greater brain
function.

During my doctoral career we’ve been fortunate enough to make a few

surprising discoveries, and generate many new and exciting avenues for continuing
research.
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